DGE	Genes	Process~name	num_of_Genes	gene_group	percentage%	P-value	Benjamini and Hochberg (FDR)	 Hommel singlewise process	Bonferroni single-step process	Hommel singlewise process	Hochberg step-up process	Benjamini and Yekutieli
up	TRAV19; CD300LB; NCR3; TYROBP; SH2D1A; LILRA1; NCR1; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-40; IGLV2-14; IGLV2-11; IGLV3-19; IGLV6-57; TRBV12-3; TRAV8-4; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-13; IGHV3-30; IGHV3-33; IGHV3-7; IGKC; TRAC; TRBC1; HLA-B; CD3D; IGKV3-11; TRBV7-9; TRAV29DV5; ITGB2; IGKV2-30; IGKV4-1; IGHV4-34; FCGR3A; CD3G; IGLC2; IGLC3; HLA-C; CD8B; IFITM1; ICAM2; SELL; CD1D; HLA-G; LAG3; CD33; CD22; CD247; ITGB7; KLRC1; CD1C; CD40LG; HLA-F; FCGR2B; ICAM3; KIR2DL1; KIR2DL3; KIR3DL1; KIR3DL2; B2M; CD300C; CD300E; TREML2; LAIR2; JAML; TREML1; OSCAR; LILRB2; LILRB1; CD300LF; HCST; CD300A; PILRA; COL17A1; ICAM5; SIGLEC9; HHLA2;	GO:0050776~regulation of immune response	81	216	37.5	0	0	0	0	0	0	0
down	PANO1; PLSCR1; ALOX15B; BIRC5; CFLAR; TNFSF12; NOL3; TNFRSF21; UNC5C; GJB6; IL1A; IL1B; S100A8; CDK1; S100A9; CGB7; CSNK2A2; MAL; DNASE1; ADRA1A; AHR; LTBR; TGFBR2; CEACAM6; IFI27; SERPINB9; EFNA5; DAPK1; CTSC; DAB2; MECOM; ZFP36L1; ADAM15; SQSTM1; SEMA3A; ESPL1; KANK2; GRAMD4; GDF6; ADAMTSL4; RASSF6; BNIPL; PEG10; SIAH1; DRAM1; PHLDA1; RFFL; KREMEN1; ZNF385A; GSDMA; FAIM2; CARD6; CARD14; PEG3; TP63; SAV1; PIDD1; S100A14; PTPRH; PAK6; TNFRSF19; GULP1; FBXO10; TPX2; PLAGL1; EPB41L3; HIF3A; CASP12;	GO:0006915~apoptotic process	68	552	12.3188405797101	0	0	0	0	0	0	0
down	SHISA3; RTL1; LEFTY2; UPK2; TDRD6; DIAPH2; CREG1; IGF2; FGF1; MMP11; THPO; HOXA1; MEOX2; TBX4; ELF3; DAB2; FGD1; BEX3; C19orf57; ZMYM3; HIC1; PCOLCE; ERMARD; ANO1; TMEM88; CBLL1; DZIP1; EGFL6; GCNT2; LTBP4; SPATA20; TWIST2; MOV10L1; PDGFD; EBF3; EDA2R; SCUBE2; OLFML3; EHF; EBF1; OSGIN1; ANGPTL2; CEP131; RARG; TYRO3; CDH5; EPHA1; ROR2; FGFR3; PDGFRB; CDH15; DDR2; PDGFRA; PTCD2; EGFR; ERBB3; LDB2; FGFR1; MST1R; NTRK2; FGFR4; CDH10; SPINK6; MUSK; CDH26; CDH1; NR1H3; PPARG; ROS1; CDH18; SPINK5;	GO:0007275~multicellular organism development	71	513	13.8401559454191	0	0	0	0	0	0	0
down	SSPO; N4BP3; DCLK1; ZEB2; OPHN1; CHRM2; CXCL1; FGF5; PCSK2; NTF3; EDNRB; ADORA1; GDNF; NBL1; EFNA5; DLG4; JAG1; PCDH1; LSAMP; CRMP1; EFNB3; DPYSL2; SIAH1; CNTN4; NLGN1; FGF13; FGF14; ATOH8; NDN; NRTN; CHRDL1; SDCBP2; RAPGEFL1; PCDHA7; PCDHA4; PCDHA3; ROBO1; NUMBL; ERBB3; GFRA3; ROR2; UNC119B; ACVR1B; NTRK2; TYRO3; NAV1; MUSK;	GO:0007399~nervous system development	47	294	15.9863945578231	0	0	0	0	0	0	0
down	DLL1; EREG; TBX3; BIRC5; HOXA3; VEGFD; CLDN7; TBC1D8; GLP2R; SLC25A27; EGFR; IGF2; IL1B; KRT6A; IGF1; FGF1; CAPN1; WNT2; CSF1; PDGFRB; AR; FGFR1; FGF5; BMP4; RARG; PDGFRA; EPCAM; NTF3; KITLG; EPHA1; FGF7; FGFR4; FGFR3; EDNRB; ALDH3A1; TGFBR2; COL18A1; GDNF; CEACAM6; THPO; PBX1; PTGFR; NAMPT; ID4; VEGFC; AKR1C2; EMP2; RAB25; ISL1; MST1R; CDC20; TBX2; KLF5; CTF1; NTRK2; HES5; TNS3; EPGN; NCCRP1; SAPCD2; TSPYL5; GCNT2; OSR2; SFRP1; DBF4B; TSLP; S1PR3; HIPK2; ARNT2; CD248; HSF4; CEP131; CLEC11A; ERBB3; PDGFD;	GO:0008284~positive regulation of cell population proliferation	75	490	15.3061224489796	0	0	0	0	0	0	0
down	FOXN1; TGM5; SCEL; GJB5; KRT14; STS; KRT5; DSP; KRT15; FGF7; SPRR2D; CRABP2; KLK7; ALDH3A2; EMP1; ELF3; FABP5; ZNF750; SVEP1; CERS3; GRHL3; EVPL; EDA2R; GRHL1; POU2F3; KLK5; KRTDAP;	GO:0008544~epidermis development	27	82	32.9268292682927	0	0	0	0	0	0	0
down	SH3PXD2B; MUSK; PLSCR1; KLF4; RAMP2; MITF; LRP3; ALOX12B; PRDM1; IL1A; IL1B; IGF1; HPN; CDK1; CSF1; HSPA1B; CCL3; AR; BMP2; BMP4; BMP7; AZU1; ERBB3; FGFR4; ITGB8; CDH5; PTGFR; STAR; SERPINB9; HAND2; ACTC1; LCN2; SMAD3; ANK2; PKP1; ANGPT1; TWIST1; SMAD1; NTRK2; HFE; TMEM119; SFRP4; SLC26A9; PID1; ZNF804A; CAMK2N1; OSR2; OSR1; SEC16B; SMO; EPB41L4B; SLC24A3; MOV10; PPARGC1A; PKP3; EMILIN1; ROBO1; IL36A; IL36G;	GO:0010628~positive regulation of gene expression	59	374	15.7754010695187	0	0	0	0	0	0	0
down	CCL22; EREG; BIRC5; IL1A; IL1B; ANXA1; ICAM1; VIM; CXCL1; HMOX1; CSF1; CXCL8; CCL3; CCL2; HGF; IL1R1; ALOX15; IL1RN; VCAM1; CXCL2; MAOA; PTPRZ1; IL1R2; CCL11; LCN2; IL10RB; IL18; TWIST1; CTF1; IL17REL; RHOU; IL22RA1; NDN; IL1RL2; IL1RAPL2; DUOX2; DUOX1; IL36G; IL36RN; IL36A; IL20RA; FZD4; IRAK3; NUMBL; IRAK2;	GO:0019221~cytokine-mediated signaling pathway	45	278	16.1870503597122	0	0	0	0	0	0	0
down	DAPL1; SSPO; CFAP69; DLL1; TNFSF12; SOX15; TDRD6; KRT6A; INHA; FGF1; ROS1; SRD5A1; MAL; COL15A1; KRTDAP; MECOM; SQSTM1; ANGPT1; ZNF750; TMEM176B; PKDCC; NKAPL; SFRP4; CXCL17; CHRDL2; PEG10; EGFL6; OSR2; OSR1; SPATA20; ABHD5; TWIST2; ATOH8; MMP19; RARRES2; CHRDL1; AMBRA1; TWSG1; OSGIN1; NDRG2; CEP131; DLX2; SOX12; NR2F2; HES5; NR2F1; POU2F3; FOXA1; SPINK6; ZFPM2; NKX6-1; CDX1; FOXC2; SOX18; EGFR; FOXQ1; NR1H3; PTK6; EHF; HES2; SPINK5; ID4; ELF3; RARG; PPARG; DLX3; FOXE1;	GO:0030154~cell differentiation	67	572	11.7132867132867	0	0	0	0	0	0	0
down	TYW5; C5orf63; AKR1B15; QSOX1; PIR; AKR1B10; ALOX12B; CBR3; CYP7B1; ALDH1L1; BBOX1; TM7SF2; CH25H; ALDH1A1; CP; CYP11A1; CYP2E1; SOD3; TXN; MGST1; BMP2; CYP4B1; HPGD; CBR1; POR; TYRP1; VCAM1; AOC1; MAOA; GPX3; FDXR; HSD11B1; ALDH3A1; FMO4; FMO3; HIBADH; HPD; SPR; ADH7; ALDH3B1; ALDH3B2; ALDH9A1; ALDH7A1; ALDH3A2; PGD; AKR1C2; HCCS; DIO3; HSD11B2; ALDH6A1; AKR1C1; AOX1; CYP24A1; PTGR1; OXA1L; PTGIS; CYP1B1; CYBRD1; PHYHD1; CYB5RL; HEPHL1; CYP4F22; MOXD1; HSDL2; FRRS1; COX15; FA2H; KDM3B; P4HA3; SCD5; P3H3; FOXRED2; SDR16C5; D2HGDH; PTGR2; RDH13; SDR9C7; HSD17B8; DHRS1; RDH12; IL4I1; HSD17B14; HEPH; MTHFD2L; CYP4F11; VAT1L; CYP4F12; NOX4; DUOX2; DUOX1; CYP39A1; TECR; PCYOX1; HIGD1A; CRYL1; MSRB2; CYP2J2; CYP2S1; PTGES;	GO:0055114~oxidation-reduction process	99	526	18.8212927756654	0	0	0	0	0	0	0
down	CCL3; CCL2; LGALS3; AZU1; EDNRB; CXCL17;	GO:0048246~macrophage chemotaxis	6	14	42.8571428571429	0.00010353037819044	0.00249015209638058	0.501397621576309	0.522931940239921	0.347655009963503	0.501294091198119	0.0226719786595119
down	FOXP2; PDGFRB; BMP4; ENG; ITGA8; SMO;	GO:0048745~smooth muscle tissue development	6	14	42.8571428571429	0.00010353037819044	0.00249015209638058	0.501397621576309	0.522931940239921	0.347655009963503	0.501294091198119	0.0226719786595119
down	CFAP69; WFS1; ATP6V1B1; GJB4; SHANK1;	GO:0042048~olfactory behavior	5	8	62.5	0.00010582249082014	0.00250943380813393	0.512286678060297	0.534509401132527	0.351224847032044	0.512075033078657	0.0228475320154801
down	SULT2B1; BMP4; SFN; SFRP4; KDF1;	GO:0045606~positive regulation of epidermal cell differentiation	5	8	62.5	0.00010582249082014	0.00250943380813393	0.512286678060297	0.534509401132527	0.351224847032044	0.512075033078657	0.0228475320154801
down	NRP1; NRP2; SLIT3; SLIT2; SEMA3A;	GO:0048846~axon extension involved in axon guidance	5	8	62.5	0.00010582249082014	0.00250943380813393	0.512286678060297	0.534509401132527	0.351224847032044	0.512075033078657	0.0228475320154801
down	TBKBP1; PRDM1; C1R; F12; SLPI; ANXA1; S100A8; SERPING1; S100A9; KRT16; CSF1; C1S; C6; MIF; LGALS3; PTX3; APOBEC3A; PPARG; IFI27; DEFB1; LCN2; MST1R; ADAM15; TRIM29; TTLL12; COLEC12; SDHAF4; TRIL; NLRP10; HAVCR2; PGLYRP4; PGLYRP3; RARRES2; SPON2; RNASE7; IL1RL2; CLEC5A; IL36G; C1RL; IL36RN; IL36A;	GO:0045087~innate immune response	41	505	8.11881188118812	0.00013386025457995	0.00307330975401521	0.646812750130337	0.676128145883347	0.394855019760426	0.646812750130337	0.0279814286277449
down	NRP1; NRP2; CTSV; SEMA3A; NRTN; NTF3;	GO:0021675~nerve development	6	15	40	0.00013998099684953	0.00315644649592403	0.676248195780086	0.707044015086983	0.404385722534996	0.675828252789537	0.0287383600782847
down	PLA2G4C; GDPD3; PLA2G4A; PLA2G4F; PLA2G4E; GPCPD1;	GO:0046475~glycerophospholipid catabolic process	6	15	40	0.00013998099684953	0.00315644649592403	0.676248195780086	0.707044015086983	0.404385722534996	0.675828252789537	0.0287383600782847
down	MEIS1; KCNK2; TGFBR2; CXADR; TBX5; SAV1;	GO:0060044~negative regulation of cardiac muscle cell proliferation	6	15	40	0.00013998099684953	0.00315644649592403	0.676248195780086	0.707044015086983	0.404385722534996	0.675828252789537	0.0287383600782847
down	BMP4; HOXA5; FOXA1; FOXF1; RSPO2; ESRP2;	GO:0060441~epithelial tube branching involved in lung morphogenesis	6	15	40	0.00013998099684953	0.00315644649592403	0.676248195780086	0.707044015086983	0.404385722534996	0.675828252789537	0.0287383600782847
down	CYP7B1; CYP11A1; FDXR; CYP1B1; CYP4V2; EBPL; CYP39A1;	GO:0016125~sterol metabolic process	7	23	30.4347826086957	0.0001576964163541	0.00347923228337351	0.7610429053249	0.796524599004573	0.427960633393689	0.760727512492192	0.0316772136909959
down	DLL1; DAB2; LRP1; CBLL1; CLIP3; MAPK8IP2; MAPK8IP1;	GO:0045807~positive regulation of endocytosis	7	23	30.4347826086957	0.0001576964163541	0.00347923228337351	0.7610429053249	0.796524599004573	0.427960633393689	0.760727512492192	0.0316772136909959
down	EGFR; CCL2; GLUL; ROR2; NLGN1; NLGN2; SHANK1;	GO:0051968~positive regulation of synaptic transmission, glutamatergic	7	23	30.4347826086957	0.0001576964163541	0.00347923228337351	0.7610429053249	0.796524599004573	0.427960633393689	0.760727512492192	0.0316772136909959
down	ALDH1A1; ALDH3A1; ALDH9A1; ALDH7A1; ALDH3A2;	GO:0006081~cellular aldehyde metabolic process	5	9	55.5555555555556	0.00015911753265873	0.00347923228337351	0.767423860013088	0.80370265745928	0.42976900554862	0.76710562494777	0.0316772136909959
down	PLA2G4A; CYP2J2; PTGIS; CYP4F22; CYP2S1;	GO:0006690~icosanoid metabolic process	5	9	55.5555555555556	0.00015911753265873	0.00347923228337351	0.767423860013088	0.80370265745928	0.42976900554862	0.76710562494777	0.0316772136909959
down	MATN2; AZU1; CD9; P2RY1; NDN;	GO:0008347~glial cell migration	5	9	55.5555555555556	0.00015911753265873	0.00347923228337351	0.767423860013088	0.80370265745928	0.42976900554862	0.76710562494777	0.0316772136909959
up	IGHV2-26; IGLC3; IGHV3-15; IGHD; IGHM; IGHV3-13; TRBC1; IGHV1-24; IGHV3-74; IGHV3-48; IGHV3-11; TRBC2; IGHG2; IGHV3-33; IGLC2; IGHV1-46; IGHV5-51; IGHV1-3; IGHV4-34; IGHV3-7; IGHA2; TRDC; IGKC; IGHV3-35; IGHV3-30;	GO:0050871~positive regulation of B cell activation	25	98	25.5102040816327	0.00016374805563501	0.0367916026055727	0.696092984504452	0.699040449505882	0.695765488393182	0.696092984504452	0.32878696723187
down	FGF10; FGFR1; HGF; FGF7;	GO:0060665~regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling	4	4	100	0.00016416666592866	0.0035436146564346	0.790954996444316	0.829205829605695	0.435369998042824	0.790954996444316	0.0322633930614092
down	FGF10; HOXA3; AGT; ACVRL1; JAG1; EPAS1; FOXC2; RSPO3;	GO:0001974~blood vessel remodeling	8	32	25	0.00017139232329921	0.00362218671541559	0.82559682133231	0.865702624984326	0.443379455117864	0.824911252039113	0.032978764643346
down	NRP1; RAMP2; ENG; ANGPT1; CCBE1; RSPO3; VEGFC; VEGFD;	GO:0002040~sprouting angiogenesis	8	32	25	0.00017139232329921	0.00362218671541559	0.82559682133231	0.865702624984326	0.443379455117864	0.824911252039113	0.032978764643346
down	TSPAN12; KRT1; HMOX1; EFNA1; EMP2; GPNMB; SFRP1; PLXND1;	GO:0045765~regulation of angiogenesis	8	32	25	0.00017139232329921	0.00362218671541559	0.82559682133231	0.865702624984326	0.443379455117864	0.824911252039113	0.032978764643346
down	BMP4; PDGFRA; TGFBR2; PRRX1; SMAD3; DLX2; TWIST1; SIX2;	GO:0048701~embryonic cranial skeleton morphogenesis	8	32	25	0.00017139232329921	0.00362218671541559	0.82559682133231	0.865702624984326	0.443379455117864	0.824911252039113	0.032978764643346
down	NRP1; PLXNB1; SEMA3A; PLXND1; SEMA3B; SEMA6B; SEMA4B; SEMA6D;	GO:0071526~semaphorin-plexin signaling pathway	8	32	25	0.00017139232329921	0.00362218671541559	0.82559682133231	0.865702624984326	0.443379455117864	0.824911252039113	0.032978764643346
down	SSPO; CSTA; CSTB; ECM1; PI16; WFDC10B;	GO:0010466~negative regulation of peptidase activity	6	16	37.5	0.00018589065550012	0.00383238245278004	0.89413405295558	0.938933700931109	0.457578283052173	0.893576380989079	0.0348925245613742
down	ALOX15B; ALOX12B; HPGD; ALOX15; PON2; PLA2G3;	GO:0019372~lipoxygenase pathway	6	16	37.5	0.00018589065550012	0.00383238245278004	0.89413405295558	0.938933700931109	0.457578283052173	0.893576380989079	0.0348925245613742
down	IL1B; THY1; ALOX15; BMP7; CEACAM6; GCNT2;	GO:0034116~positive regulation of heterotypic cell-cell adhesion	6	16	37.5	0.00018589065550012	0.00383238245278004	0.89413405295558	0.938933700931109	0.457578283052173	0.893576380989079	0.0348925245613742
down	GLI3; CXCL8; FOXF2; PKDCC; RARRES2; SALL1;	GO:0048566~embryonic digestive tract development	6	16	37.5	0.00018589065550012	0.00383238245278004	0.89413405295558	0.938933700931109	0.457578283052173	0.893576380989079	0.0348925245613742
up	IGHV3-11; IGHV3-74; IGHG2; IGHV3-30; TRDC; IGHV1-46; TRBC2; IGHA2; IGHV1-3; IGHV3-35; IGHV3-15; IGLC3; IGHV3-13; IGHV3-7; IGHM; IGHD; IGHV2-26; TRBC1; IGHV5-51; IGLC2; IGKC; IGHV3-48; IGHV1-24; IGHV4-34; IGHV3-33;	GO:0006910~phagocytosis, recognition	25	99	25.2525252525253	0.00018707718167554	0.0399316244286447	0.79507802212106	0.798632488572895	0.794890944939384	0.79507802212106	0.356847670738527
down	MEIS2; FGF10; WFS1; ISL1; NKX6-1; FOXF1; MSLN;	GO:0031016~pancreas development	7	24	29.1666666666667	0.00019659969779728	0.00403668729095155	0.944858147613747	0.993025073574081	0.467710681059738	0.944858147613747	0.0367526498676927
down	LAMB1; BMP4; AQP1; PAX9; TWIST1; OSR2; OSR1; AQP3;	GO:0042476~odontogenesis	8	33	24.2424242424242	0.00020542791099753	0.00415046551379421	0.986670256521163	1	0.476097713156479	0.986464828610165	0.0377885614668096
down	SPINT1; SPINT2; BMP2; BMP4; BMP7; ACVRL1; SFRP1; TMEM100;	GO:0071773~cellular response to BMP stimulus	8	33	24.2424242424242	0.00020542791099753	0.00415046551379421	0.986670256521163	1	0.476097713156479	0.986464828610165	0.0377885614668096
down	CTSD; MMP11; COL15A1; CTSK; ADAM15; KLK6; MMP28; MMP23B; MMP19;	GO:0030574~collagen catabolic process	9	43	20.9302325581395	0.00021810345999007	0.00437158958892797	1	1	0.488115543457779	0.999999733847336	0.0398018201427852
up	F2; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-40; IGLV2-14; IGLV2-11; IGLV3-19; IGLV6-57; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-13; IGHV3-30; IGHV3-33; IGHV3-7; IGKC; IGHG2; IGKV3-11; IGKV2-30; IGKV4-1; IGHV4-34; IGLC2; IGLC3; CR1; CFP;	GO:0030449~regulation of complement activation	27	113	23.8938053097345	0.00022858083413479	0.0464672181391162	0.971239964238744	0.97581158092144	0.876512010062948	0.971239964238744	0.415252792639907
down	FGF10; SPRY1; FGF1; FGFR1; GDNF;	GO:0001759~organ induction	5	10	50	0.00023071696039644	0.00458799750772623	1	1	0.500037618533801	0.999999733847336	0.0417721398368613
down	IGF1; CCL3; PDGFRA; CD24; SLURP1;	GO:0001775~cell activation	5	10	50	0.00023071696039644	0.00458799750772623	1	1	0.500037618533801	0.999999733847336	0.0417721398368613
down	FUCA1; GNS; SDC2; IDUA; HGSNAT; HPSE; GPC6;	GO:0006027~glycosaminoglycan catabolic process	7	25	28	0.00024289234764685	0.00466505200209597	1	1	0.511545573048514	0.999999733847336	0.0424736945147901
down	CYP2E1; ADH1A; CBR1; FMO1; AOX1; FMO2; CYP4F12;	GO:0017144~drug metabolic process	7	25	28	0.00024289234764685	0.00466505200209597	1	1	0.511545573048514	0.999999733847336	0.0424736945147901
down	CRABP2; CYP2S1; SCPEP1; ADH1B; ADH7; ADH1C; ADH1A;	GO:0042573~retinoic acid metabolic process	7	25	28	0.00024289234764685	0.00466505200209597	1	1	0.511545573048514	0.999999733847336	0.0424736945147901
down	CDK1; WNT2; FGFR1; CCNB1; TBX2; ZFPM2; TBX5;	GO:0060045~positive regulation of cardiac muscle cell proliferation	7	25	28	0.00024289234764685	0.00466505200209597	1	1	0.511545573048514	0.999999733847336	0.0424736945147901
down	EFNA5; PTPRS; NLGN1; LRRC4; LRRC4B; GPC6; LRFN5;	GO:0099560~synaptic membrane adhesion	7	25	28	0.00024289234764685	0.00466505200209597	1	1	0.511545573048514	0.999999733847336	0.0424736945147901
down	KRT6A; KRT16; SERPINB5; RIPK4; TBX4; TBX5;	GO:0002009~morphogenesis of an epithelium	6	17	35.2941176470588	0.00024290411335403	0.00466505200209597	1	1	0.511556062723601	0.999999733847336	0.0424736945147901
down	COL12A1; COL6A1; COL14A1; MATN2; COL6A3; COL6A2;	GO:0003429~growth plate cartilage chondrocyte morphogenesis	6	17	35.2941176470588	0.00024290411335403	0.00466505200209597	1	1	0.511556062723601	0.999999733847336	0.0424736945147901
down	CTSV; CTSK; ZFP36L1; AQP3; GRHL1; SERPINB13;	GO:0045616~regulation of keratinocyte differentiation	6	17	35.2941176470588	0.00024290411335403	0.00466505200209597	1	1	0.511556062723601	0.999999733847336	0.0424736945147901
down	BMP4; ENG; CDH5; MSX2; ACVRL1; GDF5; HES5; TWSG1;	GO:0030513~positive regulation of BMP signaling pathway	8	34	23.5294117647059	0.00024481433853307	0.00468392887852481	1	1	0.513375667903853	0.999999733847336	0.0426455619843214
down	CLEC3B; BMP2; ALOX15; FGFR3; ROR2; GPNMB; PKDCC; RSPO2; SLC24A3;	GO:0030282~bone mineralization	9	44	20.4545454545455	0.00025335149610439	0.00481082107828303	1	1	0.521489440135934	0.999999733847336	0.0438008718343336
down	PLXNB1; CLDN7; ERBB3; FBLN1; ACVRL1; ANGPT1; CBLL1; ARHGDIG; PLXND1;	GO:0007162~negative regulation of cell adhesion	9	45	20	0.00029319067457556	0.00550522712743925	1	1	0.55149165887663	0.999999733847336	0.0501232001573259
down	OIP5; GJB3; GJB5; ANG; TRIP10; GJD3; KREMEN1;	GO:0007154~cell communication	7	26	26.9230769230769	0.00029756781498624	0.00556672234627969	1	1	0.554666407134358	0.999999733847336	0.0506830929812378
down	BMP2; ENG; ACVRL1; ISL1; TBX2; TWIST1;	GO:0003203~endocardial cushion morphogenesis	6	18	33.3333333333333	0.00031281293497953	0.00576648954226871	1	1	0.564644509309386	0.999999733847336	0.0525019046156422
down	ALOX12B; ALOX15; CYP2J2; ELOVL3; ELOVL2; ALOX15B;	GO:0043651~linoleic acid metabolic process	6	18	33.3333333333333	0.00031281293497953	0.00576648954226871	1	1	0.564644509309386	0.999999733847336	0.0525019046156422
down	FGF10; BMP4; BMP7; OSR2; OSR1;	GO:0001823~mesonephros development	5	11	45.4545454545455	0.00032440896765739	0.00591548626583939	1	1	0.571816769236926	0.999999733847336	0.0538584685548657
down	NPR1; AZU1; BDKRB2; CDH5; HRH1;	GO:0043114~regulation of vascular permeability	5	11	45.4545454545455	0.00032440896765739	0.00591548626583939	1	1	0.571816769236926	0.999999733847336	0.0538584685548657
down	ADCY6; ADCY3; AHR; EFNA5; ADCY2;	GO:1904322~cellular response to forskolin	5	11	45.4545454545455	0.00032440896765739	0.00591548626583939	1	1	0.571816769236926	0.999999733847336	0.0538584685548657
down	DLL1; ZEB2; SMAD3; ROR2; FOXF1; FOXC2; MESP2; TBX18; MESP1;	GO:0001756~somitogenesis	9	46	19.5652173913043	0.00033807121794138	0.00609856329222115	1	1	0.57945406755153	0.999999733847336	0.0555253219335036
down	TBX3; ELN; SOX18; TGFBR2; ISL1; TBX2; FZD2; FZD1; PLXND1;	GO:0003151~outflow tract morphogenesis	9	46	19.5652173913043	0.00033807121794138	0.00609856329222115	1	1	0.57945406755153	0.999999733847336	0.0555253219335036
down	PTGES; TRPA1; CDK1; EPHX1; EDNRB; NAMPT; LUM; SFRP1; PLIN2;	GO:0014070~response to organic cyclic compound	9	46	19.5652173913043	0.00033807121794138	0.00609856329222115	1	1	0.57945406755153	0.999999733847336	0.0555253219335036
down	ICAM1; VCAM1; CEACAM6; CXADR; NECTIN1; FAT4; CADM3; NLGN1; NECTIN4;	GO:0007157~heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules	9	47	19.1489361702128	0.00038847167258748	0.00690905076844858	1	1	0.602215377960041	0.999999733847336	0.0629045317382133
down	ALDH1A1; NOVA1; ACTN3; NR1H3; LAMA4; FLCN; ACOT11; FOXC2; ADAMTS5;	GO:0120163~negative regulation of cold-induced thermogenesis	9	47	19.1489361702128	0.00038847167258748	0.00690905076844858	1	1	0.602215377960041	0.999999733847336	0.0629045317382133
down	FOXN1; LDB2; EGFR; SOX18; ACVR1B; APCDD1; SAV1; TNFRSF19;	GO:0001942~hair follicle development	8	37	21.6216216216216	0.00040148841351284	0.00711550167246792	1	1	0.607730736320278	0.999999733847336	0.0647841962362038
down	IL1A; IL1B; ISL1; CYP1B1; CXCL17; CCBE1; HPSE;	GO:0010575~positive regulation of vascular endothelial growth factor production	7	28	25	0.00043642136089328	0.0076540426870554	1	1	0.622336860633817	0.999999733847336	0.0696874270098366
down	EREG; IGF2; IL1A; IL1B; IGF1; PDGFRB; EPGN;	GO:0045840~positive regulation of mitotic nuclear division	7	28	25	0.00043642136089328	0.0076540426870554	1	1	0.622336860633817	0.999999733847336	0.0696874270098366
down	SULT1C4; ALDH2; ADH7; ALDH3B1; ALDH3B2;	GO:0006068~ethanol catabolic process	5	12	41.6666666666667	0.0004442858415159	0.00765900268087651	1	1	0.625629689182024	0.999999733847336	0.0697325860482049
down	CTDNEP1; CDK1; CCNB1; PLK1; NEK9;	GO:0007077~mitotic nuclear envelope disassembly	5	12	41.6666666666667	0.0004442858415159	0.00765900268087651	1	1	0.625629689182024	0.999999733847336	0.0697325860482049
down	DLG4; ASIC2; NLGN1; NLGN2; SHANK1;	GO:0035418~protein localization to synapse	5	12	41.6666666666667	0.0004442858415159	0.00765900268087651	1	1	0.625629689182024	0.999999733847336	0.0697325860482049
down	NRP1; HPN; HGF; MST1; MST1R;	GO:0048012~hepatocyte growth factor receptor signaling pathway	5	12	41.6666666666667	0.0004442858415159	0.00765900268087651	1	1	0.625629689182024	0.999999733847336	0.0697325860482049
down	FGF10; MAP4K4; FGF7; ADAM9; EPB41L4B;	GO:0051549~positive regulation of keratinocyte migration	5	12	41.6666666666667	0.0004442858415159	0.00765900268087651	1	1	0.625629689182024	0.999999733847336	0.0697325860482049
down	DSP; NECTIN1; GRHL1; PERP;	GO:0002934~desmosome organization	4	6	66.6666666666667	0.00046137316676464	0.00780310561513352	1	1	0.632877726536343	0.999999733847336	0.0710445937183374
down	ALDH2; ADH1A; ALDH3B1; ALDH3B2;	GO:0006066~alcohol metabolic process	4	6	66.6666666666667	0.00046137316676464	0.00780310561513352	1	1	0.632877726536343	0.999999733847336	0.0710445937183374
down	PLA2G7; ALOX15B; ALOX12B; ALOX15;	GO:0034440~lipid oxidation	4	6	66.6666666666667	0.00046137316676464	0.00780310561513352	1	1	0.632877726536343	0.999999733847336	0.0710445937183374
down	HEXB; CCL3; CCL2; APCDD1;	GO:0043615~astrocyte cell migration	4	6	66.6666666666667	0.00046137316676464	0.00780310561513352	1	1	0.632877726536343	0.999999733847336	0.0710445937183374
down	TBX18; NFIA; FOXF1; NPHP3;	GO:0072189~ureter development	4	6	66.6666666666667	0.00046137316676464	0.00780310561513352	1	1	0.632877726536343	0.999999733847336	0.0710445937183374
down	IL1B; IGF1; CCL3; CCL2; TSC2; TYRO3; ZFP36L1; TMEM100;	GO:0043491~protein kinase B signaling	8	38	21.0526315789474	0.00046891083571509	0.00784261136157933	1	1	0.635979189922981	0.999999733847336	0.0714042799566396
down	PPARG; NR1H3; ABCA12; PNPLA3; TM6SF2; ABHD5; ACOXL; ACOX2;	GO:0055088~lipid homeostasis	8	38	21.0526315789474	0.00046891083571509	0.00784261136157933	1	1	0.635979189922981	0.999999733847336	0.0714042799566396
down	TF; HMOX1; HFE; EPAS1; HEPH; HEPHL1; CP;	GO:0055072~iron ion homeostasis	7	29	24.1379310344828	0.00052296663771012	0.0086323676048164	1	1	0.658709470476602	0.999999733847336	0.0785947390129007
down	CAPN1; GRIA1; DAPK1; DLG4; MAPK8IP2; NLGN1; PPARGC1A;	GO:2000310~regulation of NMDA receptor activity	7	29	24.1379310344828	0.00052296663771012	0.0086323676048164	1	1	0.658709470476602	0.999999733847336	0.0785947390129007
down	EGFLAM; MEGF8; LAMB1; LAMC1; LAMB2; TMEFF1; LAMA2; NTN3;	GO:0009888~tissue development	8	39	20.5128205128205	0.00054522488971853	0.00891239779277769	1	1	0.667900489905202	0.999999733847336	0.0811443175927414
down	BMP2; BMP4; BMP7; SMAD3; TMEM119; PKDCC; OSR2; OSR1;	GO:0030501~positive regulation of bone mineralization	8	39	20.5128205128205	0.00054522488971853	0.00891239779277769	1	1	0.667900489905202	0.999999733847336	0.0811443175927414
down	EGFR; MT1A; HMOX1; MT1G; STAR; MT1H; MT1X; MT1M;	GO:0071276~cellular response to cadmium ion	8	39	20.5128205128205	0.00054522488971853	0.00891239779277769	1	1	0.667900489905202	0.999999733847336	0.0811443175927414
down	FOXP2; CFLAR; DCN; ELN; NR2F2; MEOX2; MYH14; GPCPD1; POPDC3;	GO:0007519~skeletal muscle tissue development	9	50	18	0.00057801235960275	0.00938758980177976	1	1	0.679396292996856	0.999999733847336	0.0854707774515287
down	FZD2; SFRP1; GRHL3; FZD1; DVL3;	GO:0090179~planar cell polarity pathway involved in neural tube closure	5	13	38.4615384615385	0.00059471596692961	0.00962791778513297	1	1	0.683923361969058	0.999999733847336	0.0876588811090471
down	CLDN4; CLDN11; CLDN7; CLDN1; CLDN6; CLDN23;	GO:0016338~calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules	6	21	28.5714285714286	0.00061996801644848	0.00988960558249283	1	1	0.690644370323607	0.999999733847336	0.0900414585290452
down	BMP2; BMP4; TBX5; MESP1; NOX4; CBY1;	GO:0055007~cardiac muscle cell differentiation	6	21	28.5714285714286	0.00061996801644848	0.00988960558249283	1	1	0.690644370323607	0.999999733847336	0.0900414585290452
down	PIR; ALPI; PRSS3; AKR1C2; AKR1C1; CYP39A1; PPARGC1A;	GO:0007586~digestion	7	30	23.3333333333333	0.00062262810834146	0.00988960558249283	1	1	0.691334426388296	0.999999733847336	0.0900414585290452
down	HOXA2; SLIT2; RHOBTB3; EGFLAM; TMEFF1; SEMA3A; NTN3;	GO:0008045~motor neuron axon guidance	7	30	23.3333333333333	0.00062262810834146	0.00988960558249283	1	1	0.691334426388296	0.999999733847336	0.0900414585290452
down	CCL24; CCL21; ICAM1; ALOX15; CCL11; CDC42EP5; CCL26; C15orf62; CDC42EP4;	GO:0030838~positive regulation of actin filament polymerization	9	51	17.6470588235294	0.00065585956174529	0.0103200830105156	1	1	0.700298127929361	0.999999733847336	0.0939608075020333
down	BMP4; GDNF; SIX2; SALL1;	GO:0003337~mesenchymal to epithelial transition involved in metanephros morphogenesis	4	7	57.1428571428571	0.00070178006841148	0.0108732856611853	1	1	0.712514668805935	0.999999733847336	0.098997527431149
down	ANTXR2; PCSK4; ANTXR1; KCNU1;	GO:0022414~reproductive process	4	7	57.1428571428571	0.00070178006841148	0.0108732856611853	1	1	0.712514668805935	0.999999733847336	0.098997527431149
down	CD9; CNTNAP1; ANK2; EPB41L3;	GO:0030913~paranodal junction assembly	4	7	57.1428571428571	0.00070178006841148	0.0108732856611853	1	1	0.712514668805935	0.999999733847336	0.098997527431149
down	ANXA8; SPINK6; SPINK5; ANXA8L1;	GO:1900004~negative regulation of serine-type endopeptidase activity	4	7	57.1428571428571	0.00070178006841148	0.0108732856611853	1	1	0.712514668805935	0.999999733847336	0.098997527431149
down	PLD2; ALPI; PLA2G4A; PLD1; GPAT3; ABHD5; LIPH; PNPLA3;	GO:0006654~phosphatidic acid biosynthetic process	8	41	19.5121951219512	0.00072794922193297	0.0112219657118056	1	1	0.719552897839703	0.999999733847336	0.10217213940692
down	EGFR; AGT; ANG; GNA15; ADRA1A; NTRK2; LPAR1;	GO:0007202~activation of phospholipase C activity	7	31	22.5806451612903	0.00073677647654713	0.0112219657118056	1	1	0.722017596021939	0.999999733847336	0.10217213940692
down	EREG; CPNE3; EGFR; ERBB3; GAB1; PTK6; GRB7;	GO:0038128~ERBB2 signaling pathway	7	31	22.5806451612903	0.00073677647654713	0.0112219657118056	1	1	0.722017596021939	0.999999733847336	0.10217213940692
down	NRP1; TNFSF12; S100P; S100A2; PRSS3; CYP1B1; PLXND1;	GO:0043542~endothelial cell migration	7	31	22.5806451612903	0.00073677647654713	0.0112219657118056	1	1	0.722017596021939	0.999999733847336	0.10217213940692
down	CLDN1; EGFR; HMOX1; GLI3; CSNK2A2; RGN; HFE;	GO:0097421~liver regeneration	7	31	22.5806451612903	0.00073677647654713	0.0112219657118056	1	1	0.722017596021939	0.999999733847336	0.10217213940692
down	KLK10; OIP5; EPB41L2; USP2; CSNK2A2; AHR; PLK5; FIGN; AVPI1; TRNP1; PMF1; TMPRSS11A; SIAH1; GSPT2; DBF4B; CABLES1; PARD3; TTC28; CDCA3; SPIN2A; KIF13A; TRIOBP; TXNL4B;	GO:0007049~cell cycle	23	248	9.2741935483871	0.00073816429369211	0.0112219657118056	1	1	0.722295303068258	0.999999733847336	0.10217213940692
down	S100A8; S100A9; ELANE; AZU1; PRSS3; DEFB1; LCN2; PGLYRP3; RNASE7;	GO:0019730~antimicrobial humoral response	9	52	17.3076923076923	0.00074205831473828	0.0112219657118056	1	1	0.723413987181293	0.999999733847336	0.10217213940692
down	SH3PXD2B; NRP1; RAPGEF3; EPHA1; S100A10; SMAD3; SFRP1; LPAR1; NOX4;	GO:0051496~positive regulation of stress fiber assembly	9	52	17.3076923076923	0.00074205831473828	0.0112219657118056	1	1	0.723413987181293	0.999999733847336	0.10217213940692
up	IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-40; IGLV2-14; IGLV2-11; IGLV3-19; IGLV6-57; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-13; IGHV3-30; IGHV3-33; IGHV3-7; IGKC; IGKV3-11; IGKV2-30; IGKV4-1; IGHV4-34; LYN; IGLC2; IGLC3; FCER1A; PSMB8; PSMB9; FCER1G; PSMB10; PSMB3; LILRA4; PSMA8; CARD11; LAT2;	GO:0038095~Fc-epsilon receptor signaling pathway	34	171	19.8830409356725	0.00074851482816606	0.145245900065498	1	1	0.999999999999999	0.999999999999999	1
down	KRIT1; SLIT2; DCN; NR2F2; SERPINF1; ACVRL1;	GO:0010596~negative regulation of endothelial cell migration	6	22	27.2727272727273	0.00076219727805815	0.0114579120579516	1	1	0.727940586562229	0.999999733847336	0.104320349764185
down	FOXE1; FGF10; HOXA3; HOXB3; HOXA5; SMAD3;	GO:0030878~thyroid gland development	6	22	27.2727272727273	0.00076219727805815	0.0114579120579516	1	1	0.727940586562229	0.999999733847336	0.104320349764185
down	ANG; ADRA1A; SFRP4; MMP19; FOXC2; TIMP4; TIMP2; POR;	GO:0009725~response to hormone	8	42	19.047619047619	0.00083618371144489	0.0123295116788092	1	1	0.742414608088535	0.999999733847336	0.112255964633833
down	FOXP2; MITF; CACNA1C; HES5; FOXC2; TWSG1; HSF4; B9D1;	GO:0043010~camera-type eye development	8	42	19.047619047619	0.00083618371144489	0.0123295116788092	1	1	0.742414608088535	0.999999733847336	0.112255964633833
down	IL33; IL1B; ISL1; IL17D; TSLP; RAB7B; SPON2; IL1RL2; IL36A;	GO:0032755~positive regulation of interleukin-6 production	9	53	16.9811320754717	0.00083726440424303	0.0123295116788092	1	1	0.742648654527781	0.999999733847336	0.112255964633833
down	BCAS1; TNFRSF21; HEXB; MAL; LPAR1; KLK6; MAL2; PMP22; MALL;	GO:0042552~myelination	9	53	16.9811320754717	0.00083726440424303	0.0123295116788092	1	1	0.742648654527781	0.999999733847336	0.112255964633833
down	BMP7; SMAD3; WLS; TWSG1; CHRD; MESP1; MESP2;	GO:0001707~mesoderm formation	7	32	21.875	0.00086685494688376	0.0127281521415986	1	1	0.748224548950543	0.999999733847336	0.115885448984735
down	NRP1; PRDM1; ENG; HOXA1; PRRX1; FOXC2;	GO:0048844~artery morphogenesis	6	23	26.0869565217391	0.00092835363933652	0.0135523532725109	1	1	0.760320845825243	0.999999733847336	0.123389516900245
down	RAPGEF3; PENK; SRD5A1; IGFBP5; AQP1; AHR; STAR; ZFP36L1; NOX4;	GO:0071320~cellular response to cAMP	9	54	16.6666666666667	0.00094216359690035	0.0137143179479646	1	1	0.762952183132402	0.999999733847336	0.12486414958265
down	SMAD6; SLIT2; BMP4; JAG1; ROBO1;	GO:0003184~pulmonary valve morphogenesis	5	15	33.3333333333333	0.00100590823728497	0.014336730531037	1	1	0.774878763947883	0.999999733847336	0.130531002150146
down	GABRA2; ICA1; SLC6A16; SLC6A15; SLC6A14;	GO:0006836~neurotransmitter transport	5	15	33.3333333333333	0.00100590823728497	0.014336730531037	1	1	0.774878763947883	0.999999733847336	0.130531002150146
down	DLL1; S100A8; VIM; LAMB2; ROR2;	GO:0014002~astrocyte development	5	15	33.3333333333333	0.00100590823728497	0.014336730531037	1	1	0.774878763947883	0.999999733847336	0.130531002150146
down	ALOX15; POR; PPARG; CYGB; PPARGC1A;	GO:0019395~fatty acid oxidation	5	15	33.3333333333333	0.00100590823728497	0.014336730531037	1	1	0.774878763947883	0.999999733847336	0.130531002150146
down	GFRA3; GDNF; HAND2; SEMA3A; TP63;	GO:0048485~sympathetic nervous system development	5	15	33.3333333333333	0.00100590823728497	0.014336730531037	1	1	0.774878763947883	0.999999733847336	0.130531002150146
down	TACSTD2; EDNRB; SERPINB5; SMAD3; HES5;	GO:0050678~regulation of epithelial cell proliferation	5	15	33.3333333333333	0.00100590823728497	0.014336730531037	1	1	0.774878763947883	0.999999733847336	0.130531002150146
down	CEACAM1; GLUL; EMP2; BMPER;	GO:0010594~regulation of endothelial cell migration	4	8	50	0.00101898361921249	0.014336730531037	1	1	0.777307302590022	0.999999733847336	0.130531002150146
down	CSF1; MT1G; AZU1; ADAM9;	GO:0042117~monocyte activation	4	8	50	0.00101898361921249	0.014336730531037	1	1	0.777307302590022	0.999999733847336	0.130531002150146
down	EGFR; SERPINF1; TYRO3; TIMP4;	GO:0042698~ovulation cycle	4	8	50	0.00101898361921249	0.014336730531037	1	1	0.777307302590022	0.999999733847336	0.130531002150146
down	FGFR1; BMP2; BMP7; ISL1;	GO:0048762~mesenchymal cell differentiation	4	8	50	0.00101898361921249	0.014336730531037	1	1	0.777307302590022	0.999999733847336	0.130531002150146
down	ICAM1; HTR1B; STAR; TRPV1;	GO:0071312~cellular response to alkaloid	4	8	50	0.00101898361921249	0.014336730531037	1	1	0.777307302590022	0.999999733847336	0.130531002150146
down	SH3PXD2B; FOXE1; TP63; COLEC10;	GO:1904888~cranial skeletal system development	4	8	50	0.00101898361921249	0.014336730531037	1	1	0.777307302590022	0.999999733847336	0.130531002150146
down	F12; GLI3; PCSK4; ADAMTS13; XPNPEP3; CPZ; CPM; CPXM1; PCSK2;	GO:0016485~protein processing	9	55	16.3636363636364	0.00105747153452107	0.0148369131135165	1	1	0.783543585249129	0.999999733847336	0.135084992588046
up	TYROBP; CTLA4; IL10; FCGR2B; MNDA; PAWR; CD300A; LYN;	GO:0030889~negative regulation of B cell proliferation	8	16	50	0.00108609557178474	0.201588782432568	1	1	0.999999999999999	0.999999999999999	1
down	HEXB; GM2A; SLC1A3; DLG4; CNTNAP1; IGDCC3; NLGN2; SHANK1;	GO:0050885~neuromuscular process controlling balance	8	44	18.1818181818182	0.00109129470471403	0.0152690569349323	1	1	0.78899622765804	0.999999733847336	0.139019513499929
down	CXCL2; PF4V1; CXCL6; CXCL3; CXCL8; CXCL1;	GO:0030595~leukocyte chemotaxis	6	24	25	0.00112101794503283	0.0155985169155946	1	1	0.793680705083245	0.999999733847336	0.142019133347084
down	TBX3; SLIT3; SLIT2; TGFBR2; ZFPM2; SAV1; ROBO1;	GO:0060412~ventricular septum morphogenesis	7	34	20.5882352941176	0.00118092572939199	0.0162538681282599	1	1	0.803187079055592	0.999999733847336	0.14798588081188
down	NRP1; CFLAR; NOL3; IGF1; AR; BMP4; LGALS3;	GO:2001237~negative regulation of extrinsic apoptotic signaling pathway	7	34	20.5882352941176	0.00118092572939199	0.0162538681282599	1	1	0.803187079055592	0.999999733847336	0.14798588081188
down	IL1A; IL1B; TRPV1;	GO:0001660~fever generation	3	3	100	0.00120673144884131	0.0162538681282599	1	1	0.807303339274839	0.999999733847336	0.14798588081188
down	THY1; ICAM1; PLVAP;	GO:0002693~positive regulation of cellular extravasation	3	3	100	0.00120673144884131	0.0162538681282599	1	1	0.807303339274839	0.999999733847336	0.14798588081188
down	TBX3; HOXA3; BMP4;	GO:0010159~specification of animal organ position	3	3	100	0.00120673144884131	0.0162538681282599	1	1	0.807303339274839	0.999999733847336	0.14798588081188
down	SFN; KDF1; TP63;	GO:0010482~regulation of epidermal cell division	3	3	100	0.00120673144884131	0.0162538681282599	1	1	0.807303339274839	0.999999733847336	0.14798588081188
down	NRP1; NRP2; SEMA3A;	GO:0021828~gonadotrophin-releasing hormone neuronal migration to the hypothalamus	3	3	100	0.00120673144884131	0.0162538681282599	1	1	0.807303339274839	0.999999733847336	0.14798588081188
down	TMEM79; DUOX2; DUOX1;	GO:0042335~cuticle development	3	3	100	0.00120673144884131	0.0162538681282599	1	1	0.807303339274839	0.999999733847336	0.14798588081188
down	TCF21; PDGFRB; PDGFRA;	GO:0072277~metanephric glomerular capillary formation	3	3	100	0.00120673144884131	0.0162538681282599	1	1	0.807303339274839	0.999999733847336	0.14798588081188
down	HPN; ADRA1A; NPNT;	GO:0097195~pilomotor reflex	3	3	100	0.00120673144884131	0.0162538681282599	1	1	0.807303339274839	0.999999733847336	0.14798588081188
down	NRP1; NRP2; SEMA3A;	GO:1903375~facioacoustic ganglion development	3	3	100	0.00120673144884131	0.0162538681282599	1	1	0.807303339274839	0.999999733847336	0.14798588081188
down	MT1X; MT1A; MT1H; MT1M; MT1G;	GO:0010273~detoxification of copper ion	5	16	31.25	0.00127651049995492	0.0170122810957053	1	1	0.817764758904908	0.999999733847336	0.154890970118678
down	MAP4K4; EGFR; GRIK2; MAPK8IP2; MAPK8IP1;	GO:0046328~regulation of JNK cascade	5	16	31.25	0.00127651049995492	0.0170122810957053	1	1	0.817764758904908	0.999999733847336	0.154890970118678
down	AGT; IGFBP5; LRP1; DOCK4; ADAMTS1;	GO:1904754~positive regulation of vascular associated smooth muscle cell migration	5	16	31.25	0.00127651049995492	0.0170122810957053	1	1	0.817764758904908	0.999999733847336	0.154890970118678
down	IL1A; IL36A; IL1RN; IL36RN; IL36G; IL1B;	GO:0002437~inflammatory response to antigenic stimulus	6	25	24	0.00134287832440938	0.0176637458765411	1	1	0.827426835496422	0.999999733847336	0.16082233295792
down	TBX3; ICAM1; CDK1; MIF; TBX2; NOX4;	GO:0007569~cell aging	6	25	24	0.00134287832440938	0.0176637458765411	1	1	0.827426835496422	0.999999733847336	0.16082233295792
down	NRP1; SEMA6B; SEMA3B; SEMA6D; SEMA3A; SEMA4B;	GO:0048843~negative regulation of axon extension involved in axon guidance	6	25	24	0.00134287832440938	0.0176637458765411	1	1	0.827426835496422	0.999999733847336	0.16082233295792
down	NRP1; MAP4K4; THY1; S100A10; SMAD3; SFRP1;	GO:0051894~positive regulation of focal adhesion assembly	6	25	24	0.00134287832440938	0.0176637458765411	1	1	0.827426835496422	0.999999733847336	0.16082233295792
down	ARHGAP33; LIN7A; NACAD; RAMP2; SFT2D2; SNAP29; SLC15A1; RAB38; VAMP2; DAB2; ANK2; CALCRL; DUOXA1; DUOXA2; PKDCC; SLC15A3; VPS52; TTC8; RAB3IL1; SPIRE2; SNX21; RHBDF1; CHMP4C; SEC16B; DENND2A; MYO5B;	GO:0015031~protein transport	26	310	8.38709677419355	0.0013547472685389	0.0177735803984156	1	1	0.829134148671911	0.999999733847336	0.161822338515667
down	LRP3; MMP11; MSX2; ID4; JAG1; SMAD3; RUNX1T1; ZFPM2;	GO:0045599~negative regulation of fat cell differentiation	8	46	17.3913043478261	0.00140497050987443	0.0181738169990489	1	1	0.836730358464422	0.999999733847336	0.165466355152845
down	SLC1A7; GLUL; SLC1A3; SNAP25;	GO:0001504~neurotransmitter uptake	4	9	44.4444444444444	0.00142483300962648	0.0181738169990489	1	1	0.839550883527119	0.999999733847336	0.165466355152845
down	BMP4; ERBB3; FOXF1; TBX5;	GO:0003197~endocardial cushion development	4	9	44.4444444444444	0.00142483300962648	0.0181738169990489	1	1	0.839550883527119	0.999999733847336	0.165466355152845
down	HPGD; PTGFR; NRK; PLA2G4C;	GO:0007567~parturition	4	9	44.4444444444444	0.00142483300962648	0.0181738169990489	1	1	0.839550883527119	0.999999733847336	0.165466355152845
down	PEX11A; PEX19; SEC16B; MFF;	GO:0016559~peroxisome fission	4	9	44.4444444444444	0.00142483300962648	0.0181738169990489	1	1	0.839550883527119	0.999999733847336	0.165466355152845
down	DLL1; TBX3; OSR1; SMO;	GO:0030857~negative regulation of epithelial cell differentiation	4	9	44.4444444444444	0.00142483300962648	0.0181738169990489	1	1	0.839550883527119	0.999999733847336	0.165466355152845
down	KLK8; TNFRSF21; CTSC; TMEM98;	GO:0031642~negative regulation of myelination	4	9	44.4444444444444	0.00142483300962648	0.0181738169990489	1	1	0.839550883527119	0.999999733847336	0.165466355152845
down	PLA2G4A; PLA2G7; PNPLA7; GDPD3;	GO:0034638~phosphatidylcholine catabolic process	4	9	44.4444444444444	0.00142483300962648	0.0181738169990489	1	1	0.839550883527119	0.999999733847336	0.165466355152845
down	ALOX15B; FABP5; PTGIS; LMO3;	GO:0035360~positive regulation of peroxisome proliferator activated receptor signaling pathway	4	9	44.4444444444444	0.00142483300962648	0.0181738169990489	1	1	0.839550883527119	0.999999733847336	0.165466355152845
down	FGFR1; HOXA1; TWIST1; SALL1;	GO:0042473~outer ear morphogenesis	4	9	44.4444444444444	0.00142483300962648	0.0181738169990489	1	1	0.839550883527119	0.999999733847336	0.165466355152845
down	EFEMP2; TNXB; MFAP4; EMILIN1;	GO:0048251~elastic fiber assembly	4	9	44.4444444444444	0.00142483300962648	0.0181738169990489	1	1	0.839550883527119	0.999999733847336	0.165466355152845
down	WASL; UBE2C; BIRC5; OIP5; EPB41L2; HAUS5; CDK1; CCNB1; RCC1; CCNO; NEK3; GPSM2; CDC20; PLK5; CDCA8; FIGN; PMF1; LLGL2; NEK9; CABLES1; TTC28; CDCA3; KIF13A; TRIOBP; FAM83D; FBXL7; TPX2; AURKC;	GO:0051301~cell division	28	347	8.06916426512968	0.00154679225091425	0.0194349444262883	1	1	0.857082533147377	0.999999733847336	0.176948486769968
down	ABCC9; CACNB3; CACNG7; KCNJ2; CACNA1C; SCN5A; SPTBN4; KCND2;	GO:0061337~cardiac conduction	8	47	17.0212765957447	0.001586570389285	0.0197258350744306	1	1	0.861430168547152	0.999999733847336	0.179596946105653
down	NRP1; EREG; EGFR; ANG; AR; MIF;	GO:0042327~positive regulation of phosphorylation	6	26	23.0769230769231	0.00159672124210319	0.0197258350744306	1	1	0.862174124943379	0.999999733847336	0.179596946105653
down	FOXE1; CTSK; DIO3; DUOX2; DUOX1;	GO:0006590~thyroid hormone generation	5	17	29.4117647058824	0.00159728104245538	0.0197258350744306	1	1	0.862174124943379	0.999999733847336	0.179596946105653
down	ALOX15B; AGT; CSF1; MSR1; IL18;	GO:0010744~positive regulation of macrophage derived foam cell differentiation	5	17	29.4117647058824	0.00159728104245538	0.0197258350744306	1	1	0.862174124943379	0.999999733847336	0.179596946105653
up	CYBA; NCF1; NCF2; CD52; NCF4; NCF1B; NCF1C;	GO:0045730~respiratory burst	7	13	53.8461538461538	0.00161383296737327	0.287060539071521	1	1	0.999999999999999	0.999999999999999	1
down	IRAK2; MAPK10; ROR2; MAPK8IP2; CDC42EP5; TAB3; TRIB1; TNFRSF19;	GO:0007254~JNK cascade	8	48	16.6666666666667	0.00178625350887807	0.0219522298621487	1	1	0.875837056207434	0.999999733847336	0.199867505156307
down	AGT; LHCGR; EDNRB; HRH1; P2RY2; P2RY1; ANO1; ADRA1A; ADRA1B;	GO:0007200~phospholipase C-activating G protein-coupled receptor signaling pathway	9	60	15	0.00181724901202862	0.0222789435916421	1	1	0.878054848664964	0.999999733847336	0.202842121330802
up	PIK3CD; CRLF1; F13A1; IL2RA; CD4; PF4; ITGB2; FCER2; HCK; ALOX5; CSF3; UBB; HSPA8; ITGAM; CCL5; OSM; MMP9; LIF; JUNB; IL11; FPR1; IL10; IL32; PRTN3; PTAFR; PTPN6; CSF2RB; CD80; FLT3; CCR2; IL12RB1; FASLG; CCR5; IL2; IL5RA; IRF4; BATF; FSCN1; PTPRN; CSF3R; IL22; IL26; IL20; CLCF1; F3; IFNA5; IFNAR2;	GO:0019221~cytokine-mediated signaling pathway	47	278	16.9064748201439	0.00187241993838461	0.319734428678555	1	1	0.999999999999999	0.999999999999999	1
down	MAF; S100A8; S100A9; FABP4; S1PR3; NFATC4;	GO:0001816~cytokine production	6	27	22.2222222222222	0.00188542200373121	0.0227285597633564	1	1	0.883071283985568	0.999999733847336	0.206935721984711
down	CCL21; CSF1; JUP; EPHA1; EMP2; SFRP1;	GO:0001954~positive regulation of cell-matrix adhesion	6	27	22.2222222222222	0.00188542200373121	0.0227285597633564	1	1	0.883071283985568	0.999999733847336	0.206935721984711
down	DLL1; GLI3; PBX1; PBX2; DLX2; TP63;	GO:0009954~proximal/distal pattern formation	6	27	22.2222222222222	0.00188542200373121	0.0227285597633564	1	1	0.883071283985568	0.999999733847336	0.206935721984711
down	RAPGEF3; AHR; DEFB1; ADCY2; EIF4EBP2; PDE3A;	GO:0019933~cAMP-mediated signaling	6	27	22.2222222222222	0.00188542200373121	0.0227285597633564	1	1	0.883071283985568	0.999999733847336	0.206935721984711
down	FGF10; BMP4; CDH1; SRD5A1; ISL1; SALL1;	GO:0021983~pituitary gland development	6	27	22.2222222222222	0.00188542200373121	0.0227285597633564	1	1	0.883071283985568	0.999999733847336	0.206935721984711
down	FGF10; FGF7; EMP2; ANK2; ANGPT1; GGA3;	GO:0034394~protein localization to cell surface	6	27	22.2222222222222	0.00188542200373121	0.0227285597633564	1	1	0.883071283985568	0.999999733847336	0.206935721984711
down	CDH5; CDH26; CDH18; CDH15; CDH10; CDH1;	GO:0044331~cell-cell adhesion mediated by cadherin	6	27	22.2222222222222	0.00188542200373121	0.0227285597633564	1	1	0.883071283985568	0.999999733847336	0.206935721984711
down	NR2F2; ADORA1; ADRA1A; NMU;	GO:0003084~positive regulation of systemic arterial blood pressure	4	10	40	0.00193111920038114	0.0229507837202944	1	1	0.886383712974942	0.999999733847336	0.208958994706347
down	BMP4; TGFBR2; FZD2; FZD1;	GO:0003149~membranous septum morphogenesis	4	10	40	0.00193111920038114	0.0229507837202944	1	1	0.886383712974942	0.999999733847336	0.208958994706347
down	JUP; SPTBN4; EPB41L3; SHANK1;	GO:0007016~cytoskeletal anchoring at plasma membrane	4	10	40	0.00193111920038114	0.0229507837202944	1	1	0.886383712974942	0.999999733847336	0.208958994706347
down	EMP1; EMP2; PMP22; LPAR1;	GO:0032060~bleb assembly	4	10	40	0.00193111920038114	0.0229507837202944	1	1	0.886383712974942	0.999999733847336	0.208958994706347
down	IGFBP4; IGFBP5; SERPINB1; NKX6-1;	GO:0044342~type B pancreatic cell proliferation	4	10	40	0.00193111920038114	0.0229507837202944	1	1	0.886383712974942	0.999999733847336	0.208958994706347
down	BMP4; BMP7; OSR2; OSR1;	GO:0060272~embryonic skeletal joint morphogenesis	4	10	40	0.00193111920038114	0.0229507837202944	1	1	0.886383712974942	0.999999733847336	0.208958994706347
down	TMPRSS2; F12; PCSK2; KLK6; PIDD1;	GO:0016540~protein autoprocessing	5	18	27.7777777777778	0.00197349685609094	0.0231279179121005	1	1	0.889616537689593	0.999999733847336	0.210571740619472
down	NRP1; SLIT2; EFNA5; ISL1; ISL2;	GO:0031290~retinal ganglion cell axon guidance	5	18	27.7777777777778	0.00197349685609094	0.0231279179121005	1	1	0.889616537689593	0.999999733847336	0.210571740619472
down	ROS1; GPAT3; FLCN; RFFL; FAM83D;	GO:0032006~regulation of TOR signaling	5	18	27.7777777777778	0.00197349685609094	0.0231279179121005	1	1	0.889616537689593	0.999999733847336	0.210571740619472
down	ACVR1B; ACVRL1; TGFBR2; SMAD3; GDF6;	GO:0032924~activin receptor signaling pathway	5	18	27.7777777777778	0.00197349685609094	0.0231279179121005	1	1	0.889616537689593	0.999999733847336	0.210571740619472
down	SLC1A3; DLG4; GRIK2; NMU; RIMS4;	GO:0050806~positive regulation of synaptic transmission	5	18	27.7777777777778	0.00197349685609094	0.0231279179121005	1	1	0.889616537689593	0.999999733847336	0.210571740619472
down	DLL1; KLF4; FGF1; SMAD1; BMPER;	GO:1903672~positive regulation of sprouting angiogenesis	5	18	27.7777777777778	0.00197349685609094	0.0231279179121005	1	1	0.889616537689593	0.999999733847336	0.210571740619472
down	DLL1; CXCL8; LAMA2; FUT2; IL18; LAMA4; SPINK5; CBLL1;	GO:0030155~regulation of cell adhesion	8	49	16.3265306122449	0.00200525010006969	0.0233528396156063	1	1	0.891939047068441	0.999999733847336	0.212619575396053
down	EGFR; SRD5A1; STAR;	GO:0016101~diterpenoid metabolic process	3	4	75	0.00204817025335846	0.0233528396156063	1	1	0.894824796077368	0.999999733847336	0.212619575396053
down	PTPRS; GRAMD4; RAB7B;	GO:0034164~negative regulation of toll-like receptor 9 signaling pathway	3	4	75	0.00204817025335846	0.0233528396156063	1	1	0.894824796077368	0.999999733847336	0.212619575396053
down	NRP1; NRP2; SEMA3A;	GO:0036486~ventral trunk neural crest cell migration	3	4	75	0.00204817025335846	0.0233528396156063	1	1	0.894824796077368	0.999999733847336	0.212619575396053
down	KLF4; ELANE; MAP2K5;	GO:0045415~negative regulation of interleukin-8 biosynthetic process	3	4	75	0.00204817025335846	0.0233528396156063	1	1	0.894824796077368	0.999999733847336	0.212619575396053
down	IGF1; HGF; ATOH8;	GO:0051450~myoblast proliferation	3	4	75	0.00204817025335846	0.0233528396156063	1	1	0.894824796077368	0.999999733847336	0.212619575396053
down	BMP4; BMP7; BMPER;	GO:0060393~regulation of pathway-restricted SMAD protein phosphorylation	3	4	75	0.00204817025335846	0.0233528396156063	1	1	0.894824796077368	0.999999733847336	0.212619575396053
down	BMP2; BMP7; BNC2;	GO:0060485~mesenchyme development	3	4	75	0.00204817025335846	0.0233528396156063	1	1	0.894824796077368	0.999999733847336	0.212619575396053
down	NRP1; NRP2; SEMA3A;	GO:0097490~sympathetic neuron projection extension	3	4	75	0.00204817025335846	0.0233528396156063	1	1	0.894824796077368	0.999999733847336	0.212619575396053
down	NRP1; NRP2; SEMA3A;	GO:0097491~sympathetic neuron projection guidance	3	4	75	0.00204817025335846	0.0233528396156063	1	1	0.894824796077368	0.999999733847336	0.212619575396053
down	ANXA8; ANXA1; ANXA8L1;	GO:1900138~negative regulation of phospholipase A2 activity	3	4	75	0.00204817025335846	0.0233528396156063	1	1	0.894824796077368	0.999999733847336	0.212619575396053
down	NRP1; NRP2; SEMA3A;	GO:1902285~semaphorin-plexin signaling pathway involved in neuron projection guidance	3	4	75	0.00204817025335846	0.0233528396156063	1	1	0.894824796077368	0.999999733847336	0.212619575396053
down	RAMP2; CLDN1; CDH5; RAB13; PARD3; POF1B; CRB3;	GO:0070830~bicellular tight junction assembly	7	38	18.4210526315789	0.00207125799822561	0.0235099419079495	1	1	0.896116898598656	0.999999733847336	0.214049937752048
down	JUP; DSP; KCNJ2; ANK2; DSC2; CACNA1C; SCN5A;	GO:0086091~regulation of heart rate by cardiac conduction	7	38	18.4210526315789	0.00207125799822561	0.0235099419079495	1	1	0.896116898598656	0.999999733847336	0.214049937752048
up	PIK3CD; NCR3; MEFV; PSTPIP1; TSPAN2; SEMA7A; IL18RAP; LY86; CALCA; ORM1; ITGB2; HCK; CYBA; CCL5; SCG2; SELE; ITGB6; BMP6; GAL; CXCR2; PTAFR; CD40LG; FCGR2B; CNR2; MAP2K3; CXCR3; NDST1; AIF1; NLRP6; ADAM8; FUT7; NAIP; GPR68; AOC3; THEMIS2; DAB2IP; NLRP9; NFAM1; PLD4; KLRG1; CD180; IL22; PROK2; MMP25; CELA1; LY96; PF4; CD14; CCR3; PPBP; PTGIR; CMKLR1; FPR1; TLR1; CCR5; FPR3; CCR2; XCL2; FPR2; IL2RA;	GO:0006954~inflammatory response	60	381	15.748031496063	0.00219719476861513	0.360762479508384	1	1	0.999999999999999	0.999999999999999	1
down	PLPP1; AZU1; HTR1B; BDKRB1; LRP1; PARD3;	GO:0007205~protein kinase C-activating G protein-coupled receptor signaling pathway	6	28	21.4285714285714	0.00221193480511594	0.024994368457809	1	1	0.904489722936602	0.999999733847336	0.227565131104673
down	EREG; EGFR; GAB1; GRB7; FAM83B; EPGN; FAM83A; SHC3;	GO:0007173~epidermal growth factor receptor signaling pathway	8	50	16	0.00224482756858235	0.02525306024256	1	1	0.906380686887322	0.999999733847336	0.229920430859974
down	CHRM2; SYP; HTR1B; ADRA1A; P2RY1; BACE1; FBXL20; RIMS4;	GO:2000300~regulation of synaptic vesicle exocytosis	8	50	16	0.00224482756858235	0.02525306024256	1	1	0.906380686887322	0.999999733847336	0.229920430859974
down	AGT; IL1B; BMP4; BMP7; CBLC; IRAK3; SPRY1;	GO:0043407~negative regulation of MAP kinase activity	7	39	17.9487179487179	0.00235885877093456	0.0263597248937842	1	1	0.912878344351674	0.999999733847336	0.239996232009734
down	KLF4; AGT; IL1B; ICAM1; PTX3; SMAD3; TRPV1;	GO:0045429~positive regulation of nitric oxide biosynthetic process	7	39	17.9487179487179	0.00235885877093456	0.0263597248937842	1	1	0.912878344351674	0.999999733847336	0.239996232009734
down	AGT; EFNA1; ERBB3; CD24; DLG4; NOX4; GPRC5B;	GO:0061098~positive regulation of protein tyrosine kinase activity	7	39	17.9487179487179	0.00235885877093456	0.0263597248937842	1	1	0.912878344351674	0.999999733847336	0.239996232009734
down	HOXA2; MSX2; SMAD3; CLEC5A; LIMD1;	GO:0002076~osteoblast development	5	19	26.3157894736842	0.00241051894057254	0.0265262116968015	1	1	0.915997197417564	0.999999733847336	0.241512037108782
down	DLX2; DLX3; OSR2; OSR1; CDX1;	GO:0009790~embryo development	5	19	26.3157894736842	0.00241051894057254	0.0265262116968015	1	1	0.915997197417564	0.999999733847336	0.241512037108782
down	ABCA1; PLTP; LRP1; NR1H3; ABCA12;	GO:0010875~positive regulation of cholesterol efflux	5	19	26.3157894736842	0.00241051894057254	0.0265262116968015	1	1	0.915997197417564	0.999999733847336	0.241512037108782
down	NRP1; IGF1; PDGFRB; SEMA6D; NOX4;	GO:0014911~positive regulation of smooth muscle cell migration	5	19	26.3157894736842	0.00241051894057254	0.0265262116968015	1	1	0.915997197417564	0.999999733847336	0.241512037108782
down	ACTC1; MYH14; MYO6; WASF2; WASL;	GO:0030048~actin filament-based movement	5	19	26.3157894736842	0.00241051894057254	0.0265262116968015	1	1	0.915997197417564	0.999999733847336	0.241512037108782
down	TBX3; PDGFRA; SRD5A1; LHCGR; ROR2;	GO:0030539~male genitalia development	5	19	26.3157894736842	0.00241051894057254	0.0265262116968015	1	1	0.915997197417564	0.999999733847336	0.241512037108782
down	ADCY6; NPR1; P2RY2; P2RY1; FOXC2;	GO:0097746~regulation of blood vessel diameter	5	19	26.3157894736842	0.00241051894057254	0.0265262116968015	1	1	0.915997197417564	0.999999733847336	0.241512037108782
down	ADGRF1; SDK1; NLGN1; NLGN2; SLITRK6; PLXND1; PCDHB5; SHANK1; CDH1;	GO:0007416~synapse assembly	9	63	14.2857142857143	0.00245014860660719	0.0267872307618462	1	1	0.917848197184715	0.999999733847336	0.243888525950978
up	RNASE2; CCL5; SPN; FPR1; ANOS1; CXCR2; FPR3; FPR2; PTAFR; L1CAM; CX3CR1; CCR6; NCKAP1L; CMTM7; CMTM3; CMKLR1; PROK2; CCR3; CXCR3; CCR8; FES; CXCR5; CXCR1; CCR2; CCR5;	GO:0006935~chemotaxis	25	122	20.4918032786885	0.00246614651808685	0.383369439719463	1	1	0.999999999999999	0.999999999999999	1
up	MATN3; ADAM12; COL4A1; PDGFA; ITGB3; ITGB2; SERPINE1; ITGA2B; ITGAM; ICAM2; ITGB4; ITGB6; COL9A1; BGN; TNC; COL8A2; ITGA3; ITGB7; LOX; ICAM3; COMP; ITGA1; LOXL1; MFAP5; ITGA7; LAMB3; LAMC2; COL19A1; LAMA3; SH3PXD2A; VWA1; ITGA11; ICAM5; NR2E1; COL17A1; MMP25; COL22A1; MMP10; MMP16; MMP9;	GO:0030198~extracellular matrix organization	40	230	17.3913043478261	0.00251448683816935	0.383369439719463	1	1	0.999999999999999	0.999999999999999	1
down	PTGES; CBR1; PTGDS; PTGIS;	GO:0019371~cyclooxygenase pathway	4	11	36.3636363636364	0.00254944728765816	0.0273402510614891	1	1	0.922712208013108	0.999999733847336	0.248923585636691
down	IL1B; ISL1; IL18; IL17D;	GO:0032725~positive regulation of granulocyte macrophage colony-stimulating factor production	4	11	36.3636363636364	0.00254944728765816	0.0273402510614891	1	1	0.922712208013108	0.999999733847336	0.248923585636691
down	EGFR; GLI3; HAND2; BNC2;	GO:0043586~tongue development	4	11	36.3636363636364	0.00254944728765816	0.0273402510614891	1	1	0.922712208013108	0.999999733847336	0.248923585636691
down	IRF6; EREG; KLK8; SDR16C5;	GO:0043616~keratinocyte proliferation	4	11	36.3636363636364	0.00254944728765816	0.0273402510614891	1	1	0.922712208013108	0.999999733847336	0.248923585636691
down	BMP4; ACVRL1; ATOH8; TMEM100;	GO:0045603~positive regulation of endothelial cell differentiation	4	11	36.3636363636364	0.00254944728765816	0.0273402510614891	1	1	0.922712208013108	0.999999733847336	0.248923585636691
down	KLK8; PTPRS; RGMA; KREMEN1;	GO:0048681~negative regulation of axon regeneration	4	11	36.3636363636364	0.00254944728765816	0.0273402510614891	1	1	0.922712208013108	0.999999733847336	0.248923585636691
down	FGFR1; BMP7; FGF7; ESRP2;	GO:0060445~branching involved in salivary gland morphogenesis	4	11	36.3636363636364	0.00254944728765816	0.0273402510614891	1	1	0.922712208013108	0.999999733847336	0.248923585636691
down	POR; STAR; EFNA5; PPARGC1A;	GO:0071372~cellular response to follicle-stimulating hormone stimulus	4	11	36.3636363636364	0.00254944728765816	0.0273402510614891	1	1	0.922712208013108	0.999999733847336	0.248923585636691
down	JUP; DSP; DSC2; CACNA1C;	GO:0098911~regulation of ventricular cardiac muscle cell action potential	4	11	36.3636363636364	0.00254944728765816	0.0273402510614891	1	1	0.922712208013108	0.999999733847336	0.248923585636691
down	NRP1; ENG; TGFBR2; NFATC4; FOXC2; PLXND1;	GO:0001569~branching involved in blood vessel morphogenesis	6	29	20.6896551724138	0.00257928241426897	0.0274272746831001	1	1	0.923892419396401	0.999999733847336	0.249715905790511
down	CDKN1C; ITGA8; DAB2; NPNT; FLCN; HIPK2;	GO:0030511~positive regulation of transforming growth factor beta receptor signaling pathway	6	29	20.6896551724138	0.00257928241426897	0.0274272746831001	1	1	0.923892419396401	0.999999733847336	0.249715905790511
down	GLI3; PTPRZ1; NKX6-1; GPR17; NTRK2; TRPC4;	GO:0048709~oligodendrocyte differentiation	6	29	20.6896551724138	0.00257928241426897	0.0274272746831001	1	1	0.923892419396401	0.999999733847336	0.249715905790511
down	CCL3; EDNRB; ADORA1; FABP5; MGLL; TMEM100;	GO:0051930~regulation of sensory perception of pain	6	29	20.6896551724138	0.00257928241426897	0.0274272746831001	1	1	0.923892419396401	0.999999733847336	0.249715905790511
up	HP; PPBP; SPN; IL10; GNLY; FPR2; CFP; CAMP; IRF8; CLEC4D; CLEC4E; IGHV3-48; IGHG2; IGLC3; IGHV1-46; IGHV3-13; IGHV1-24; TRBC1; TRBC2; IGHV3-30; IGHA2; IGLC2; IGHD; IGHV3-74; IGHV3-7; IGHV4-34; IGHV3-15; IGHV5-51; IGHV3-35; FCER1G; TRDC; IGKC; IGHM; IGHV2-26; MPO; IGHV3-11; IGHV1-3; IGHV3-33;	GO:0042742~defense response to bacterium	38	216	17.5925925925926	0.00266602345356881	0.392457038733974	1	1	0.999999999999999	0.999999999999999	1
down	MCC; PLK1; ITGA8; DLG4; NPNT; DZIP1; NLGN1;	GO:0045184~establishment of protein localization	7	40	17.5	0.00267624470015104	0.0283985545808044	1	1	0.928656910952412	0.999999733847336	0.258559075308217
down	ZEB2; GLI3; ANXA3; SRD5A1; XRCC1; ID4; DLX2; PTPRS; FGF13;	GO:0021766~hippocampus development	9	64	14.0625	0.00269610139446008	0.0285492833195343	1	1	0.92971532539074	0.999999733847336	0.259931408649954
down	NRP1; TNFRSF21; SEMA3A; CNTN4; NDN;	GO:0007413~axonal fasciculation	5	20	25	0.00291376043502667	0.0304078594159498	1	1	0.940063461186393	0.999999733847336	0.27685310498178
down	F12; PLAT; KRT1; SERPINB2; SERPING1;	GO:0042730~fibrinolysis	5	20	25	0.00291376043502667	0.0304078594159498	1	1	0.940063461186393	0.999999733847336	0.27685310498178
down	SYNGR1; AGT; SYP; DLG4; GRIK2;	GO:0048169~regulation of long-term neuronal synaptic plasticity	5	20	25	0.00291376043502667	0.0304078594159498	1	1	0.940063461186393	0.999999733847336	0.27685310498178
down	WASL; EGFR; IL1B; SPR; CYGB;	GO:0050999~regulation of nitric-oxide synthase activity	5	20	25	0.00291376043502667	0.0304078594159498	1	1	0.940063461186393	0.999999733847336	0.27685310498178
down	ANXA1; CCL2; ADRB3; LHCGR; CALCRL; HTR1B; HRH1; CHRM2; HTR7;	GO:0007187~G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger	9	65	13.8461538461538	0.00296117565455611	0.0307755107637097	1	1	0.942123213182688	0.999999733847336	0.280200444095189
down	SLC1A7; SLC1A3; SNAP25; VAMP2; NTRK2; TRPV1;	GO:0014047~glutamate secretion	6	30	20	0.00299054556961009	0.0308270319838787	1	1	0.943632710493952	0.999999733847336	0.280669527090514
down	PEX11A; NUDT7; FABP4; ALDH6A1; EBF2; PPARGC1A;	GO:0050873~brown fat cell differentiation	6	30	20	0.00299054556961009	0.0308270319838787	1	1	0.943632710493952	0.999999733847336	0.280669527090514
down	FGFR3; CDX1; SFRP4; OSR2; PAPPA2; RARG;	GO:0060349~bone morphogenesis	6	30	20	0.00299054556961009	0.0308270319838787	1	1	0.943632710493952	0.999999733847336	0.280669527090514
down	FGF10; AGT; TF; IGF1; CCL11; ZFP36L1;	GO:0070371~ERK1 and ERK2 cascade	6	30	20	0.00299054556961009	0.0308270319838787	1	1	0.943632710493952	0.999999733847336	0.280669527090514
down	MAL; CNTNAP1; EPB41L3;	GO:0002175~protein localization to paranode region of axon	3	5	60	0.00317857240582109	0.0319820104019967	1	1	0.952285576971122	0.999999733847336	0.291185208476332
down	STS; HSD17B14; HSD11B1;	GO:0006706~steroid catabolic process	3	5	60	0.00317857240582109	0.0319820104019967	1	1	0.952285576971122	0.999999733847336	0.291185208476332
down	FGFR4; LRP1; DDR2;	GO:0010715~regulation of extracellular matrix disassembly	3	5	60	0.00317857240582109	0.0319820104019967	1	1	0.952285576971122	0.999999733847336	0.291185208476332
down	SLIT3; SLIT2; ROBO1;	GO:0035385~Roundabout signaling pathway	3	5	60	0.00317857240582109	0.0319820104019967	1	1	0.952285576971122	0.999999733847336	0.291185208476332
down	EGFR; DUOXA1; DUOXA2;	GO:0042743~hydrogen peroxide metabolic process	3	5	60	0.00317857240582109	0.0319820104019967	1	1	0.952285576971122	0.999999733847336	0.291185208476332
down	BBOX1; SHMT1; ALDH9A1;	GO:0045329~carnitine biosynthetic process	3	5	60	0.00317857240582109	0.0319820104019967	1	1	0.952285576971122	0.999999733847336	0.291185208476332
down	NRP1; SEMA3A; PLXND1;	GO:0060666~dichotomous subdivision of terminal units involved in salivary gland branching	3	5	60	0.00317857240582109	0.0319820104019967	1	1	0.952285576971122	0.999999733847336	0.291185208476332
down	NRP1; NRP2; SEMA3A;	GO:0061551~trigeminal ganglion development	3	5	60	0.00317857240582109	0.0319820104019967	1	1	0.952285576971122	0.999999733847336	0.291185208476332
down	SLIT2; AOC1; SFRP1;	GO:0071504~cellular response to heparin	3	5	60	0.00317857240582109	0.0319820104019967	1	1	0.952285576971122	0.999999733847336	0.291185208476332
down	CFLAR; SERPINB7; PDGFD;	GO:0072126~positive regulation of glomerular mesangial cell proliferation	3	5	60	0.00317857240582109	0.0319820104019967	1	1	0.952285576971122	0.999999733847336	0.291185208476332
down	IL1B; IL1R1; IL18;	GO:2000556~positive regulation of T-helper 1 cell cytokine production	3	5	60	0.00317857240582109	0.0319820104019967	1	1	0.952285576971122	0.999999733847336	0.291185208476332
down	MAGI2; NLGN1; NLGN2;	GO:2000809~positive regulation of synaptic vesicle clustering	3	5	60	0.00317857240582109	0.0319820104019967	1	1	0.952285576971122	0.999999733847336	0.291185208476332
down	RBM47; BMP4; EEF2; HOXB3; PTPRZ1; SFRP1; PYGO1; PDGFRA; PDGFRB;	GO:0002244~hematopoietic progenitor cell differentiation	9	66	13.6363636363636	0.00324638342793782	0.0325312741709205	1	1	0.955217647690043	0.999999733847336	0.296186066241441
up	CYBA; NCF1; NCF2; SH3PXD2A; PREX1; NCF1B; NCF1C; NCF4;	GO:0006801~superoxide metabolic process	8	20	40	0.00327086327299819	0.45442065414652	1	1	0.999999999999999	0.999999999999999	1
down	SOX18; ACVRL1; CCBE1; FOXC2;	GO:0001946~lymphangiogenesis	4	12	33.3333333333333	0.00329112672764609	0.0325312741709205	1	1	0.957649471241409	0.999999733847336	0.296186066241441
down	HEXB; GNS; LUM; FMOD;	GO:0042340~keratan sulfate catabolic process	4	12	33.3333333333333	0.00329112672764609	0.0325312741709205	1	1	0.957649471241409	0.999999733847336	0.296186066241441
down	DIO3; HFE; DUOX2; DUOX1;	GO:0042446~hormone biosynthetic process	4	12	33.3333333333333	0.00329112672764609	0.0325312741709205	1	1	0.957649471241409	0.999999733847336	0.296186066241441
down	ANG; MPV17; SMAD1; RHCG;	GO:0042592~homeostatic process	4	12	33.3333333333333	0.00329112672764609	0.0325312741709205	1	1	0.957649471241409	0.999999733847336	0.296186066241441
down	NFIB; NRP1; GDNF; SMO;	GO:0071679~commissural neuron axon guidance	4	12	33.3333333333333	0.00329112672764609	0.0325312741709205	1	1	0.957649471241409	0.999999733847336	0.296186066241441
down	NRP1; SEMA3A; PLXNB1; PLXND1;	GO:1902287~semaphorin-plexin signaling pathway involved in axon guidance	4	12	33.3333333333333	0.00329112672764609	0.0325312741709205	1	1	0.957649471241409	0.999999733847336	0.296186066241441
down	PLXNB1; GABRA2; NLGN2; FGF13;	GO:1904862~inhibitory synapse assembly	4	12	33.3333333333333	0.00329112672764609	0.0325312741709205	1	1	0.957649471241409	0.999999733847336	0.296186066241441
down	RAMP2; CEACAM1; RIN2; TMEM100;	GO:2001214~positive regulation of vasculogenesis	4	12	33.3333333333333	0.00329112672764609	0.0325312741709205	1	1	0.957649471241409	0.999999733847336	0.296186066241441
up	ITGB2; ALOX5; SELE; CCR6; ADAM8; FUT7;	GO:0002523~leukocyte migration involved in inflammatory response	6	11	54.5454545454545	0.00333108313956898	0.45442065414652	1	1	0.999999999999999	0.999999999999999	1
down	SLC26A4; CA12; AQP1; CYB5RL; SLC26A9; SLC4A11; SLC26A10;	GO:0015701~bicarbonate transport	7	42	16.6666666666667	0.00340829207038595	0.0334368113878292	1	1	0.962759378956937	0.999999733847336	0.304430671254519
down	TSPAN15; EGFR; BMP7; DLX2; BEND6; JAG1; DLL1;	GO:0045746~negative regulation of Notch signaling pathway	7	42	16.6666666666667	0.00340829207038595	0.0334368113878292	1	1	0.962759378956937	0.999999733847336	0.304430671254519
down	ALOX15B; INHA; BMP2; BMP4; HPGD; BMP7; CAMK2N1;	GO:0045786~negative regulation of cell cycle	7	42	16.6666666666667	0.00340829207038595	0.0334368113878292	1	1	0.962759378956937	0.999999733847336	0.304430671254519
down	CCL21; PDGFRB; PDGFRA; FGFR3; ATG14; AMBRA1;	GO:0043552~positive regulation of phosphatidylinositol 3-kinase activity	6	31	19.3548387096774	0.00344885217492097	0.0334368113878292	1	1	0.964765672851655	0.999999733847336	0.304430671254519
down	NRP1; SLIT2; CLEC14A; MMRN2; ROBO1;	GO:0002042~cell migration involved in sprouting angiogenesis	5	21	23.8095238095238	0.00348865563282241	0.0334368113878292	1	1	0.966357610291808	0.999999733847336	0.304430671254519
down	FMO1; FMO2; CYP2J2; CYP2E1; CYP2S1;	GO:0006082~organic acid metabolic process	5	21	23.8095238095238	0.00348865563282241	0.0334368113878292	1	1	0.966357610291808	0.999999733847336	0.304430671254519
down	PLPP1; PLPP3; PLPP2; FUT3; FUT6;	GO:0006672~ceramide metabolic process	5	21	23.8095238095238	0.00348865563282241	0.0334368113878292	1	1	0.966357610291808	0.999999733847336	0.304430671254519
down	CYP2J2; CYP1B1; CYP4F12; CYP2E1; CYP2S1;	GO:0019373~epoxygenase P450 pathway	5	21	23.8095238095238	0.00348865563282241	0.0334368113878292	1	1	0.966357610291808	0.999999733847336	0.304430671254519
down	MITF; GLI3; EDNRB; HPS4; TYRP1;	GO:0030318~melanocyte differentiation	5	21	23.8095238095238	0.00348865563282241	0.0334368113878292	1	1	0.966357610291808	0.999999733847336	0.304430671254519
down	PDGFRB; PDGFRA; PBX1; SMAD3; SALL1;	GO:0030325~adrenal gland development	5	21	23.8095238095238	0.00348865563282241	0.0334368113878292	1	1	0.966357610291808	0.999999733847336	0.304430671254519
down	ALOX15; TYRO3; LRP1; MFGE8; NR1H3;	GO:0043277~apoptotic cell clearance	5	21	23.8095238095238	0.00348865563282241	0.0334368113878292	1	1	0.966357610291808	0.999999733847336	0.304430671254519
down	CLDN1; CLDN6; CXADR; SMAD3; SDK1;	GO:0045216~cell-cell junction organization	5	21	23.8095238095238	0.00348865563282241	0.0334368113878292	1	1	0.966357610291808	0.999999733847336	0.304430671254519
down	NRP1; ANXA1; HMOX1; FGFBP1; FOXC2;	GO:0090050~positive regulation of cell migration involved in sprouting angiogenesis	5	21	23.8095238095238	0.00348865563282241	0.0334368113878292	1	1	0.966357610291808	0.999999733847336	0.304430671254519
down	NOL3; IGF1; HGF; PPIF; HIGD1A;	GO:0090201~negative regulation of release of cytochrome c from mitochondria	5	21	23.8095238095238	0.00348865563282241	0.0334368113878292	1	1	0.966357610291808	0.999999733847336	0.304430671254519
down	CACNG7; MAPK8IP2; NLGN1; NLGN2; SHANK1;	GO:2000311~regulation of AMPA receptor activity	5	21	23.8095238095238	0.00348865563282241	0.0334368113878292	1	1	0.966357610291808	0.999999733847336	0.304430671254519
down	KLF4; CDK1; PDGFRB; AQP1; PPIF; LCN2; CYP1B1; PDGFD; ANXA1;	GO:0070301~cellular response to hydrogen peroxide	9	67	13.4328358208955	0.00355275858336879	0.0339867113723404	1	1	0.969653252251565	0.999999733847336	0.309437321543803
down	TBX3; DLX3; CEACAM1; AHR; TGFBR2; FOXF1; ANTXR1;	GO:0001568~blood vessel development	7	43	16.2790697674419	0.00382700738454489	0.0364721024515778	1	1	0.982042620750725	0.999999733847336	0.332065952779185
down	RHOD; SYNGR1; AKAP12; NLGN1; AP1S3; HPS4; AP1M2;	GO:0006605~protein targeting	7	43	16.2790697674419	0.00382700738454489	0.0364721024515778	1	1	0.982042620750725	0.999999733847336	0.332065952779185
down	TRPA1; XRCC1; S100P; CTSC; TIMP4; TIMP2;	GO:0010033~response to organic substance	6	32	18.75	0.00395736636846467	0.0375726645246523	1	1	0.987361953327188	0.999999733847336	0.342086192053116
down	ANG; IGF1; FGF1; TXN; NTF3; IL18;	GO:0032148~activation of protein kinase B activity	6	32	18.75	0.00395736636846467	0.0375726645246523	1	1	0.987361953327188	0.999999733847336	0.342086192053116
down	KRT16; KRT6C; PPL; DSP; EVPL;	GO:0045104~intermediate filament cytoskeleton organization	5	22	22.7272727272727	0.0041406300910074	0.0380613197355913	1	1	0.991954334505454	0.999999733847336	0.346535229736545
down	FGF10; SLIT2; BMP4; BMP7; RASIP1;	GO:0048754~branching morphogenesis of an epithelial tube	5	22	22.7272727272727	0.0041406300910074	0.0380613197355913	1	1	0.991954334505454	0.999999733847336	0.346535229736545
down	SLIT3; BMP2; TGFBR2; TBX5;	GO:0003181~atrioventricular valve morphogenesis	4	13	30.7692307692308	0.00416707776950742	0.0380613197355913	1	1	0.992437178320926	0.999999733847336	0.346535229736545
down	BMP4; ENG; MSX2; TMEM100;	GO:0003198~epithelial to mesenchymal transition involved in endocardial cushion formation	4	13	30.7692307692308	0.00416707776950742	0.0380613197355913	1	1	0.992437178320926	0.999999733847336	0.346535229736545
down	DNPEP; CPZ; CPM; CPXM1;	GO:0006518~peptide metabolic process	4	13	30.7692307692308	0.00416707776950742	0.0380613197355913	1	1	0.992437178320926	0.999999733847336	0.346535229736545
down	AKR1B15; STAR; HSD17B8; HSD17B14;	GO:0006703~estrogen biosynthetic process	4	13	30.7692307692308	0.00416707776950742	0.0380613197355913	1	1	0.992437178320926	0.999999733847336	0.346535229736545
down	FGF10; FGF7; TGM1; TP63;	GO:0010838~positive regulation of keratinocyte proliferation	4	13	30.7692307692308	0.00416707776950742	0.0380613197355913	1	1	0.992437178320926	0.999999733847336	0.346535229736545
down	PDGFRB; FGFR1; PDGFRA; NTF3;	GO:0010863~positive regulation of phospholipase C activity	4	13	30.7692307692308	0.00416707776950742	0.0380613197355913	1	1	0.992437178320926	0.999999733847336	0.346535229736545
down	KCNJ2; NIPAL1; NIPAL3; NIPAL2;	GO:0015693~magnesium ion transport	4	13	30.7692307692308	0.00416707776950742	0.0380613197355913	1	1	0.992437178320926	0.999999733847336	0.346535229736545
down	CCL2; AQP1; TNS2; ABCA12;	GO:0019725~cellular homeostasis	4	13	30.7692307692308	0.00416707776950742	0.0380613197355913	1	1	0.992437178320926	0.999999733847336	0.346535229736545
down	CCL21; CDC42EP5; CDC42EP4; C15orf62;	GO:0031274~positive regulation of pseudopodium assembly	4	13	30.7692307692308	0.00416707776950742	0.0380613197355913	1	1	0.992437178320926	0.999999733847336	0.346535229736545
down	NRP2; GAB1; VEGFC; VEGFD;	GO:0038084~vascular endothelial growth factor signaling pathway	4	13	30.7692307692308	0.00416707776950742	0.0380613197355913	1	1	0.992437178320926	0.999999733847336	0.346535229736545
down	ELOVL7; ELOVL3; ELOVL2; TECR;	GO:0042761~very long-chain fatty acid biosynthetic process	4	13	30.7692307692308	0.00416707776950742	0.0380613197355913	1	1	0.992437178320926	0.999999733847336	0.346535229736545
down	IGF1; AR; IGFBP4; IGFBP5;	GO:0043568~positive regulation of insulin-like growth factor receptor signaling pathway	4	13	30.7692307692308	0.00416707776950742	0.0380613197355913	1	1	0.992437178320926	0.999999733847336	0.346535229736545
down	ID4; DLX2; HES5; TMEM98;	GO:0048715~negative regulation of oligodendrocyte differentiation	4	13	30.7692307692308	0.00416707776950742	0.0380613197355913	1	1	0.992437178320926	0.999999733847336	0.346535229736545
down	TRPA1; CXCL12; CACNB3; BACE1;	GO:0050966~detection of mechanical stimulus involved in sensory perception of pain	4	13	30.7692307692308	0.00416707776950742	0.0380613197355913	1	1	0.992437178320926	0.999999733847336	0.346535229736545
down	JUP; ANO3; PIEZO2; PKD1L2;	GO:0050982~detection of mechanical stimulus	4	13	30.7692307692308	0.00416707776950742	0.0380613197355913	1	1	0.992437178320926	0.999999733847336	0.346535229736545
down	TBX3; CSF1; MSX2; CCL11;	GO:0060444~branching involved in mammary gland duct morphogenesis	4	13	30.7692307692308	0.00416707776950742	0.0380613197355913	1	1	0.992437178320926	0.999999733847336	0.346535229736545
down	EGFR; TWIST1; OSR2; GRHL3;	GO:0061029~eyelid development in camera-type eye	4	13	30.7692307692308	0.00416707776950742	0.0380613197355913	1	1	0.992437178320926	0.999999733847336	0.346535229736545
down	SPINT2; NID1; MMP11; NID2;	GO:0071711~basement membrane organization	4	13	30.7692307692308	0.00416707776950742	0.0380613197355913	1	1	0.992437178320926	0.999999733847336	0.346535229736545
down	ADORA1; KCNJ2; ANK2; SCN5A;	GO:0086004~regulation of cardiac muscle cell contraction	4	13	30.7692307692308	0.00416707776950742	0.0380613197355913	1	1	0.992437178320926	0.999999733847336	0.346535229736545
down	NRP1; FGF10; ANXA1; FGF7; CXADR; GAB1; ANTXR1; NRK;	GO:0031532~actin cytoskeleton reorganization	8	56	14.2857142857143	0.00418968922053242	0.0381987730196918	1	1	0.992956345266184	0.999999733847336	0.347786694628323
down	IGF1; FGFR3; ISL1; PTK6; IL18; CTF1; HES5; TSLP; STAP2;	GO:0042531~positive regulation of tyrosine phosphorylation of STAT protein	9	69	13.0434782608696	0.00423324848387907	0.0385263749406724	1	1	0.994414538708096	0.999999733847336	0.350769397480925
down	PDGFRA; HOXA5; MEGF8; OSR2; HOXB4; HOXB3; HOXA3;	GO:0048704~embryonic skeletal system morphogenesis	7	44	15.9090909090909	0.00428360621551249	0.0389145593427223	1	1	0.99543173852265	0.999999733847336	0.354303682993855
down	FXYD1; CHRM2; DES; CYP2J2; TBX2; HSPB7;	GO:0008016~regulation of heart contraction	6	33	18.1818181818182	0.00451927753603054	0.0397958327486821	1	1	0.999999733847336	0.999999733847336	0.362327374350764
down	IGF1; ERBB3; TYRO3; ZFP36L1; NYAP1; PREX2;	GO:0014065~phosphatidylinositol 3-kinase signaling	6	33	18.1818181818182	0.00451927753603054	0.0397958327486821	1	1	0.999999733847336	0.999999733847336	0.362327374350764
down	SH3PXD2B; IGF2; CSF1; DIO3; SMO; SPTBN4;	GO:0040018~positive regulation of multicellular organism growth	6	33	18.1818181818182	0.00451927753603054	0.0397958327486821	1	1	0.999999733847336	0.999999733847336	0.362327374350764
down	ZEB2; SLIT2; NTRK2; ROBO1; PLXNB1; PLXND1;	GO:0050772~positive regulation of axonogenesis	6	33	18.1818181818182	0.00451927753603054	0.0397958327486821	1	1	0.999999733847336	0.999999733847336	0.362327374350764
down	IL1A; IL1B; KITLG; ERBB3; LCN2; MKNK2;	GO:0097192~extrinsic apoptotic signaling pathway in absence of ligand	6	33	18.1818181818182	0.00451927753603054	0.0397958327486821	1	1	0.999999733847336	0.999999733847336	0.362327374350764
down	AGT; IGF1; HPGD; IGFBP5; HTR1B; ADAMTS1;	GO:1904707~positive regulation of vascular smooth muscle cell proliferation	6	33	18.1818181818182	0.00451927753603054	0.0397958327486821	1	1	0.999999733847336	0.999999733847336	0.362327374350764
up	SYT7; MYH9; MYH10; CAV3; DYSF; ANXA6;	GO:0001778~plasma membrane repair	6	12	50	0.00460496424906987	0.531313307548088	1	1	0.999999999999999	0.999999999999999	1
up	MYOZ1; PGM5; LMOD1; TMOD1; LMOD3; LMOD2;	GO:0030239~myofibril assembly	6	12	50	0.00460496424906987	0.531313307548088	1	1	0.999999999999999	0.999999999999999	1
up	IL2RA; LYN; CTLA4; HLA-G; FCGR2B; PDCD1;	GO:0050777~negative regulation of immune response	6	12	50	0.00460496424906987	0.531313307548088	1	1	0.999999999999999	0.999999999999999	1
down	FGFR1; ATP6V1B1; ITGA8; PRRX1; FOXG1; ROR2; MAFB; MYO6;	GO:0042472~inner ear morphogenesis	8	57	14.0350877192982	0.00461154966697486	0.0397958327486821	1	1	0.999999733847336	0.999999733847336	0.362327374350764
down	SQSTM1; ATG14; AMBRA1;	GO:0000423~mitophagy	3	6	50	0.00462485722104067	0.0397958327486821	1	1	0.999999733847336	0.999999733847336	0.362327374350764
down	IL33; HMOX1; ADORA1;	GO:0002686~negative regulation of leukocyte migration	3	6	50	0.00462485722104067	0.0397958327486821	1	1	0.999999733847336	0.999999733847336	0.362327374350764
down	BMP4; FZD2; FZD1;	GO:0003150~muscular septum morphogenesis	3	6	50	0.00462485722104067	0.0397958327486821	1	1	0.999999733847336	0.999999733847336	0.362327374350764
down	POR; CROT; CPT1C;	GO:0009437~carnitine metabolic process	3	6	50	0.00462485722104067	0.0397958327486821	1	1	0.999999733847336	0.999999733847336	0.362327374350764
down	F12; CLEC3B; HPN;	GO:0010756~positive regulation of plasminogen activation	3	6	50	0.00462485722104067	0.0397958327486821	1	1	0.999999733847336	0.999999733847336	0.362327374350764
down	LHCGR; HRH1; P2RY1;	GO:0032962~positive regulation of inositol trisphosphate biosynthetic process	3	6	50	0.00462485722104067	0.0397958327486821	1	1	0.999999733847336	0.999999733847336	0.362327374350764
down	PLPP3; ADAM9; NPNT;	GO:0033631~cell-cell adhesion mediated by integrin	3	6	50	0.00462485722104067	0.0397958327486821	1	1	0.999999733847336	0.999999733847336	0.362327374350764
down	HAND2; GPNMB; DDR2;	GO:0034103~regulation of tissue remodeling	3	6	50	0.00462485722104067	0.0397958327486821	1	1	0.999999733847336	0.999999733847336	0.362327374350764
down	SMAD6; ABCA1; ADAM9;	GO:0034616~response to laminar fluid shear stress	3	6	50	0.00462485722104067	0.0397958327486821	1	1	0.999999733847336	0.999999733847336	0.362327374350764
down	ALDH7A1; SLC44A1; BHMT;	GO:0042426~choline catabolic process	3	6	50	0.00462485722104067	0.0397958327486821	1	1	0.999999733847336	0.999999733847336	0.362327374350764
down	ALOX15B; ALOX12B; ALOX15;	GO:0051122~hepoxilin biosynthetic process	3	6	50	0.00462485722104067	0.0397958327486821	1	1	0.999999733847336	0.999999733847336	0.362327374350764
down	FOXE1; FZD2; FZD1;	GO:0060022~hard palate development	3	6	50	0.00462485722104067	0.0397958327486821	1	1	0.999999733847336	0.999999733847336	0.362327374350764
down	CAPN1; IGFBP5; ELF3;	GO:0060056~mammary gland involution	3	6	50	0.00462485722104067	0.0397958327486821	1	1	0.999999733847336	0.999999733847336	0.362327374350764
down	BMP4; MSX2; TWIST1;	GO:0060363~cranial suture morphogenesis	3	6	50	0.00462485722104067	0.0397958327486821	1	1	0.999999733847336	0.999999733847336	0.362327374350764
down	FOXP2; WNT2; FGF7;	GO:0060501~positive regulation of epithelial cell proliferation involved in lung morphogenesis	3	6	50	0.00462485722104067	0.0397958327486821	1	1	0.999999733847336	0.999999733847336	0.362327374350764
down	BMP4; BMP7; SFRP1;	GO:0060687~regulation of branching involved in prostate gland morphogenesis	3	6	50	0.00462485722104067	0.0397958327486821	1	1	0.999999733847336	0.999999733847336	0.362327374350764
down	JUP; DSP; DSC2;	GO:0086073~bundle of His cell-Purkinje myocyte adhesion involved in cell communication	3	6	50	0.00462485722104067	0.0397958327486821	1	1	0.999999733847336	0.999999733847336	0.362327374350764
down	NLGN1; NLGN2; LRRC4;	GO:0097119~postsynaptic density protein 95 clustering	3	6	50	0.00462485722104067	0.0397958327486821	1	1	0.999999733847336	0.999999733847336	0.362327374350764
down	SQSTM1; ATG14; AMBRA1;	GO:0098780~response to mitochondrial depolarisation	3	6	50	0.00462485722104067	0.0397958327486821	1	1	0.999999733847336	0.999999733847336	0.362327374350764
down	EGFR; ROR2; CEMIP;	GO:1900020~positive regulation of protein kinase C activity	3	6	50	0.00462485722104067	0.0397958327486821	1	1	0.999999733847336	0.999999733847336	0.362327374350764
down	NRP1; NRP2; SEMA3A;	GO:1901166~neural crest cell migration involved in autonomic nervous system development	3	6	50	0.00462485722104067	0.0397958327486821	1	1	0.999999733847336	0.999999733847336	0.362327374350764
down	FGF1; LRRK1; NLGN1;	GO:1902533~positive regulation of intracellular signal transduction	3	6	50	0.00462485722104067	0.0397958327486821	1	1	0.999999733847336	0.999999733847336	0.362327374350764
down	GJB6; GJB2; GJB4;	GO:1990349~gap junction-mediated intercellular transport	3	6	50	0.00462485722104067	0.0397958327486821	1	1	0.999999733847336	0.999999733847336	0.362327374350764
down	OVOL1; FBLN1; KDF1;	GO:2000647~negative regulation of stem cell proliferation	3	6	50	0.00462485722104067	0.0397958327486821	1	1	0.999999733847336	0.999999733847336	0.362327374350764
up	MYO1G; ITGB7; ZAP70; GPR15; CCR6;	GO:0072678~T cell migration	5	8	62.5	0.00483805143618721	0.543516883712715	1	1	0.999999999999999	0.999999999999999	1
down	ARHGAP33; INMT; EPHX1; CCL3; CDH1; AHR; ADAMTS13; SLC6A14; PON2;	GO:0009636~response to toxic substance	9	71	12.6760563380282	0.00501130620814061	0.0429747158867881	1	1	0.999999733847336	0.999999733847336	0.391270012341824
down	SMO; TBX18; TBX3; TBX5; TBX4; TBX2;	GO:0001708~cell fate specification	6	34	17.6470588235294	0.00513778933843934	0.0434549556091907	1	1	0.999999733847336	0.999999733847336	0.39564242989559
down	PLVAP; TCF21; TWIST2; HAND2; TWIST1; COLEC10;	GO:0032502~developmental process	6	34	17.6470588235294	0.00513778933843934	0.0434549556091907	1	1	0.999999733847336	0.999999733847336	0.39564242989559
down	ZEB2; SASH1; ROR2; DVL3; FZD4; FZD10;	GO:0043507~positive regulation of JUN kinase activity	6	34	17.6470588235294	0.00513778933843934	0.0434549556091907	1	1	0.999999733847336	0.999999733847336	0.39564242989559
up	TRPM2; CCL5; CXCR1; CXCR2; CCR2; CCR5; CCR6;	GO:0002407~dendritic cell chemotaxis	7	17	41.1764705882353	0.00516364669523717	0.565220711332499	1	1	0.999999999999999	0.999999999999999	1
down	FABP4; PPARG; SLC27A3; PLIN2;	GO:0015909~long-chain fatty acid transport	4	14	28.5714285714286	0.00518775257025184	0.0434549556091907	1	1	0.999999733847336	0.999999733847336	0.39564242989559
down	ASPA; ID4; CNTNAP1; HES5;	GO:0022010~central nervous system myelination	4	14	28.5714285714286	0.00518775257025184	0.0434549556091907	1	1	0.999999733847336	0.999999733847336	0.39564242989559
down	CYP7B1; ISL1; KANK2; TP63;	GO:0033147~negative regulation of intracellular estrogen receptor signaling pathway	4	14	28.5714285714286	0.00518775257025184	0.0434549556091907	1	1	0.999999733847336	0.999999733847336	0.39564242989559
down	PDGFRB; JAG1; LRP1; TBX2;	GO:0035909~aorta morphogenesis	4	14	28.5714285714286	0.00518775257025184	0.0434549556091907	1	1	0.999999733847336	0.999999733847336	0.39564242989559
down	AKR1C1; CYP1B1; SDR16C5; RDH13;	GO:0042574~retinal metabolic process	4	14	28.5714285714286	0.00518775257025184	0.0434549556091907	1	1	0.999999733847336	0.999999733847336	0.39564242989559
down	IL1A; ICAM1; CDK1; SOD3;	GO:0046688~response to copper ion	4	14	28.5714285714286	0.00518775257025184	0.0434549556091907	1	1	0.999999733847336	0.999999733847336	0.39564242989559
down	SCNN1A; SCNN1B; SCN7A; CYP4F12;	GO:0055078~sodium ion homeostasis	4	14	28.5714285714286	0.00518775257025184	0.0434549556091907	1	1	0.999999733847336	0.999999733847336	0.39564242989559
down	SOX15; PRDM1; GJB5; NR2F2;	GO:0060707~trophoblast giant cell differentiation	4	14	28.5714285714286	0.00518775257025184	0.0434549556091907	1	1	0.999999733847336	0.999999733847336	0.39564242989559
down	MEIS2; ANXA3; P2RY1; LUM;	GO:0070848~response to growth factor	4	14	28.5714285714286	0.00518775257025184	0.0434549556091907	1	1	0.999999733847336	0.999999733847336	0.39564242989559
down	CLDN1; ICAM1; RAP2B; PTPRS;	GO:0090557~establishment of endothelial intestinal barrier	4	14	28.5714285714286	0.00518775257025184	0.0434549556091907	1	1	0.999999733847336	0.999999733847336	0.39564242989559
down	SLC26A4; SLC26A9; SLC26A10; SLC25A10;	GO:1902358~sulfate transmembrane transport	4	14	28.5714285714286	0.00518775257025184	0.0434549556091907	1	1	0.999999733847336	0.999999733847336	0.39564242989559
down	TACC2; CCNB1; RCC1; GPSM2; EFHC1; AURKB; AURKC;	GO:0007052~mitotic spindle organization	7	46	15.2173913043478	0.00531887233947448	0.0444795102428569	1	1	0.999999733847336	0.999999733847336	0.404970647567011
down	TRPA1; TK1; SHMT1; ALDH9A1; KCNJ2; TRPV1; CBY1; PFKM;	GO:0051289~protein homotetramerization	8	59	13.5593220338983	0.00555225806065296	0.0462779793141223	1	1	0.999999733847336	0.999999733847336	0.421345090101178
down	NTF3; ANGPT1; SFRP4; MAGI2; TBC1D5;	GO:0002092~positive regulation of receptor internalization	5	24	20.8333333333333	0.00569730500012722	0.0469446779048003	1	1	0.999999733847336	0.999999733847336	0.42741515154126
down	HPN; EFNA1; FOXA1; SFRP1; TBX5;	GO:0010719~negative regulation of epithelial to mesenchymal transition	5	24	20.8333333333333	0.00569730500012722	0.0469446779048003	1	1	0.999999733847336	0.999999733847336	0.42741515154126
down	NPR1; EDNRB; AQP1; PRKG1; PDE3A;	GO:0019934~cGMP-mediated signaling	5	24	20.8333333333333	0.00569730500012722	0.0469446779048003	1	1	0.999999733847336	0.999999733847336	0.42741515154126
down	DLL1; TBX3; CXCL14; BMP4; IL18;	GO:0045662~negative regulation of myoblast differentiation	5	24	20.8333333333333	0.00569730500012722	0.0469446779048003	1	1	0.999999733847336	0.999999733847336	0.42741515154126
down	BDKRB2; PLA2G4A; PLA2G4F; PLA2G3; ANXA1;	GO:0050482~arachidonic acid secretion	5	24	20.8333333333333	0.00569730500012722	0.0469446779048003	1	1	0.999999733847336	0.999999733847336	0.42741515154126
down	HPN; HOXA1; FZD2; GRHL3; FRZB;	GO:0090103~cochlea morphogenesis	5	24	20.8333333333333	0.00569730500012722	0.0469446779048003	1	1	0.999999733847336	0.999999733847336	0.42741515154126
down	CLDN4; CLDN1; ANXA1; DUOX2; DUOX1;	GO:0090303~positive regulation of wound healing	5	24	20.8333333333333	0.00569730500012722	0.0469446779048003	1	1	0.999999733847336	0.999999733847336	0.42741515154126
down	EREG; SPRY1; STAM2; EGFR; EPGN; CBLC;	GO:0042059~negative regulation of epidermal growth factor receptor signaling pathway	6	35	17.1428571428571	0.00581610881423877	0.0475358667001943	1	1	0.999999733847336	0.999999733847336	0.432797722257481
down	GRIA1; GRIK4; FGF14; KCND2; GABRA2; GABRE;	GO:0060078~regulation of postsynaptic membrane potential	6	35	17.1428571428571	0.00581610881423877	0.0475358667001943	1	1	0.999999733847336	0.999999733847336	0.432797722257481
down	SMAD6; BMP2; SMAD3; KLF5; SMAD1; ATOH8;	GO:1902895~positive regulation of pri-miRNA transcription by RNA polymerase II	6	35	17.1428571428571	0.00581610881423877	0.0475358667001943	1	1	0.999999733847336	0.999999733847336	0.432797722257481
down	FGF10; IL1A; IL1B; HSPA1B; GDNF; MAP2K5;	GO:2001240~negative regulation of extrinsic apoptotic signaling pathway in absence of ligand	6	35	17.1428571428571	0.00581610881423877	0.0475358667001943	1	1	0.999999733847336	0.999999733847336	0.432797722257481
down	S100A8; S100A9; SIAH1; FLCN; IL20RA; PLAGL2;	GO:2001244~positive regulation of intrinsic apoptotic signaling pathway	6	35	17.1428571428571	0.00581610881423877	0.0475358667001943	1	1	0.999999733847336	0.999999733847336	0.432797722257481
up	PIK3CD; PRKCB; MS4A1; CD79A; CD22; CXCR5; ZAP70; FCRL1; LAT2;	GO:0042113~B cell activation	9	28	32.1428571428571	0.00601268736693539	0.641704059236179	1	1	0.999999999999999	0.999999999999999	1
down	GCNT3; GALNT3; MUC15; GALNT15; MUCL1; MUC4; B3GNT5; B3GNT3;	GO:0016266~O-glycan processing	8	60	13.3333333333333	0.00607414103344472	0.0494049699837831	1	1	0.999999733847336	0.999999733847336	0.449815265009003
down	CTSV; BCHE; ANXA3; ALAD; IL1RN; ALDH3A1; HSD11B2; ADAM9;	GO:0051384~response to glucocorticoid	8	60	13.3333333333333	0.00607414103344472	0.0494049699837831	1	1	0.999999733847336	0.999999733847336	0.449815265009003
up	RGS13; RGS14; PLEK; CCL5; RGS2; RGS4;	GO:0045744~negative regulation of G protein-coupled receptor signaling pathway	6	13	46.1538461538462	0.00620392980611795	0.644917933669795	1	1	0.999999999999999	0.999999999999999	1
down	ELOVL7; SCD5; ELOVL3; ELOVL2;	GO:0006636~unsaturated fatty acid biosynthetic process	4	15	26.6666666666667	0.00636306958299127	0.0495756619207223	1	1	0.999999733847336	0.999999733847336	0.451369356406578
down	EPB41L3; RHOV; RHOU; RHOBTB3;	GO:0030865~cortical cytoskeleton organization	4	15	26.6666666666667	0.00636306958299127	0.0495756619207223	1	1	0.999999733847336	0.999999733847336	0.451369356406578
down	BMP7; FOXF2; TBX2; HIPK2;	GO:0048596~embryonic camera-type eye morphogenesis	4	15	26.6666666666667	0.00636306958299127	0.0495756619207223	1	1	0.999999733847336	0.999999733847336	0.451369356406578
down	IL1B; ADAM9; SH3D19; PACSIN3;	GO:0051044~positive regulation of membrane protein ectodomain proteolysis	4	15	26.6666666666667	0.00636306958299127	0.0495756619207223	1	1	0.999999733847336	0.999999733847336	0.451369356406578
down	OBSL1; PDGFRB; PDGFRA; ACTC1;	GO:0055003~cardiac myofibril assembly	4	15	26.6666666666667	0.00636306958299127	0.0495756619207223	1	1	0.999999733847336	0.999999733847336	0.451369356406578
down	GLI3; DLG4; MYH14; SHANK1;	GO:0071625~vocalization behavior	4	15	26.6666666666667	0.00636306958299127	0.0495756619207223	1	1	0.999999733847336	0.999999733847336	0.451369356406578
down	KLF4; MEOX2; MAP2K5; MMRN2;	GO:0090051~negative regulation of cell migration involved in sprouting angiogenesis	4	15	26.6666666666667	0.00636306958299127	0.0495756619207223	1	1	0.999999733847336	0.999999733847336	0.451369356406578
down	KLF4; KLF5; ANO1; KLF15;	GO:1901653~cellular response to peptide	4	15	26.6666666666667	0.00636306958299127	0.0495756619207223	1	1	0.999999733847336	0.999999733847336	0.451369356406578
down	PDGFRB; HGF; FGFR4; NOX4;	GO:2000573~positive regulation of DNA biosynthetic process	4	15	26.6666666666667	0.00636306958299127	0.0495756619207223	1	1	0.999999733847336	0.999999733847336	0.451369356406578
down	BMP4; ACVRL1; BMPER;	GO:0002043~blood vessel endothelial cell proliferation involved in sprouting angiogenesis	3	7	42.8571428571429	0.00640920753003993	0.0495756619207223	1	1	0.999999733847336	0.999999733847336	0.451369356406578
down	PTGES; S100A8; CCL11;	GO:0002544~chronic inflammatory response	3	7	42.8571428571429	0.00640920753003993	0.0495756619207223	1	1	0.999999733847336	0.999999733847336	0.451369356406578
down	SMAD6; EFNA1; TWIST1;	GO:0003183~mitral valve morphogenesis	3	7	42.8571428571429	0.00640920753003993	0.0495756619207223	1	1	0.999999733847336	0.999999733847336	0.451369356406578
down	FMO1; CYP1B1; FMO2;	GO:0009404~toxin metabolic process	3	7	42.8571428571429	0.00640920753003993	0.0495756619207223	1	1	0.999999733847336	0.999999733847336	0.451369356406578
down	ALAD; STAR; LCN2;	GO:0009635~response to herbicide	3	7	42.8571428571429	0.00640920753003993	0.0495756619207223	1	1	0.999999733847336	0.999999733847336	0.451369356406578
down	ADAM9; D2HGDH; FIBIN;	GO:0010042~response to manganese ion	3	7	42.8571428571429	0.00640920753003993	0.0495756619207223	1	1	0.999999733847336	0.999999733847336	0.451369356406578
down	CFLAR; ACTN3; PPARGC1A;	GO:0014732~skeletal muscle atrophy	3	7	42.8571428571429	0.00640920753003993	0.0495756619207223	1	1	0.999999733847336	0.999999733847336	0.451369356406578
down	AQP7; AQP1; AQP3;	GO:0015793~glycerol transport	3	7	42.8571428571429	0.00640920753003993	0.0495756619207223	1	1	0.999999733847336	0.999999733847336	0.451369356406578
down	ELOVL7; ELOVL3; ELOVL2;	GO:0019367~fatty acid elongation, saturated fatty acid	3	7	42.8571428571429	0.00640920753003993	0.0495756619207223	1	1	0.999999733847336	0.999999733847336	0.451369356406578
down	ELOVL3; ELOVL2; ELOVL7;	GO:0034625~fatty acid elongation, monounsaturated fatty acid	3	7	42.8571428571429	0.00640920753003993	0.0495756619207223	1	1	0.999999733847336	0.999999733847336	0.451369356406578
down	ELOVL7; ELOVL3; ELOVL2;	GO:0034626~fatty acid elongation, polyunsaturated fatty acid	3	7	42.8571428571429	0.00640920753003993	0.0495756619207223	1	1	0.999999733847336	0.999999733847336	0.451369356406578
down	IL1A; IL1B; KITLG;	GO:0035234~ectopic germ cell programmed cell death	3	7	42.8571428571429	0.00640920753003993	0.0495756619207223	1	1	0.999999733847336	0.999999733847336	0.451369356406578
down	BMP2; BMP4; APCDD1;	GO:0042487~regulation of odontogenesis of dentin-containing tooth	3	7	42.8571428571429	0.00640920753003993	0.0495756619207223	1	1	0.999999733847336	0.999999733847336	0.451369356406578
down	NRP1; CXCL12; MEGF8;	GO:0048842~positive regulation of axon extension involved in axon guidance	3	7	42.8571428571429	0.00640920753003993	0.0495756619207223	1	1	0.999999733847336	0.999999733847336	0.451369356406578
down	FOXN1; KRT17; HPSE;	GO:0051798~positive regulation of hair follicle development	3	7	42.8571428571429	0.00640920753003993	0.0495756619207223	1	1	0.999999733847336	0.999999733847336	0.451369356406578
down	FGF10; SPRY1; BMP4;	GO:0060449~bud elongation involved in lung branching	3	7	42.8571428571429	0.00640920753003993	0.0495756619207223	1	1	0.999999733847336	0.999999733847336	0.451369356406578
down	GLI3; ACVRL1; HOXA1;	GO:0060840~artery development	3	7	42.8571428571429	0.00640920753003993	0.0495756619207223	1	1	0.999999733847336	0.999999733847336	0.451369356406578
down	PDGFRB; PDGFRA; ACVRL1;	GO:0061298~retina vasculature development in camera-type eye	3	7	42.8571428571429	0.00640920753003993	0.0495756619207223	1	1	0.999999733847336	0.999999733847336	0.451369356406578
down	SLIT3; SLIT2; ROBO1;	GO:0070100~negative regulation of chemokine-mediated signaling pathway	3	7	42.8571428571429	0.00640920753003993	0.0495756619207223	1	1	0.999999733847336	0.999999733847336	0.451369356406578
down	CD24; FOXC2; KLF15;	GO:0072112~glomerular visceral epithelial cell differentiation	3	7	42.8571428571429	0.00640920753003993	0.0495756619207223	1	1	0.999999733847336	0.999999733847336	0.451369356406578
down	IL33; IL1B; IL18;	GO:0150078~positive regulation of neuroinflammatory response	3	7	42.8571428571429	0.00640920753003993	0.0495756619207223	1	1	0.999999733847336	0.999999733847336	0.451369356406578
down	RHOD; AZU1; CXCL12; ANGPT1; FLCN; CHRD; EPB41L4B;	GO:0045785~positive regulation of cell adhesion	7	48	14.5833333333333	0.00653109731541857	0.0504412424161761	1	1	0.999999733847336	0.999999733847336	0.459250169208953
down	AR; GDNF; ISL1; DLX2; HSF4; FGFR1;	GO:0045597~positive regulation of cell differentiation	6	36	16.6666666666667	0.00655743561541333	0.0505673393793172	1	1	0.999999733847336	0.999999733847336	0.460398238702989
down	PIGZ; PIGO; TMEM246; PGAP2; CWH43;	GO:0006506~GPI anchor biosynthetic process	5	25	20	0.00661256241109909	0.0507599585690904	1	1	0.999999733847336	0.999999733847336	0.462151970198466
down	SERPINB7; VIM; PDGFRB; BMP4; ENG;	GO:0032967~positive regulation of collagen biosynthetic process	5	25	20	0.00661256241109909	0.0507599585690904	1	1	0.999999733847336	0.999999733847336	0.462151970198466
down	MT1A; MT1G; MT1H; MT1X; MT1M;	GO:0071294~cellular response to zinc ion	5	25	20	0.00661256241109909	0.0507599585690904	1	1	0.999999733847336	0.999999733847336	0.462151970198466
down	DLL1; RAMP2; AGT; HMOX1; NPR1; EDNRB; ACVRL1; PPARG;	GO:0008217~regulation of blood pressure	8	61	13.1147540983607	0.0066324219541446	0.0508351491508109	1	1	0.999999733847336	0.999999733847336	0.462836554592584
down	CFAP69; OVOL1; TDRD6; CTSV; CLDN11; GJB3; CRTAP; ROS1; AR; CCNB1; CSNK2A2; TBP; NME5; TYRO3; CCNI; GAMT; WFDC2; RGN; TMEM119; NKAPL; DZIP1; SIAH1; MNS1; SPATA20; MOV10L1; TP63; CEP131; AURKC; GGT5;	GO:0007283~spermatogenesis	29	407	7.12530712530713	0.00667483759183918	0.051082734358151	1	1	0.999999733847336	0.999999733847336	0.465090732779284
up	HLA-B; HLA-C; HLA-G; HLA-F; B2M;	GO:0002480~antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent	5	9	55.5555555555556	0.00695159305131909	0.674462516729118	1	1	0.999999999999999	0.999999999999999	1
up	LY86; BMP6; SCIMP; CD180; LY96;	GO:0031666~positive regulation of lipopolysaccharide-mediated signaling pathway	5	9	55.5555555555556	0.00695159305131909	0.674462516729118	1	1	0.999999999999999	0.999999999999999	1
down	NRP1; KLK8; VWF; FGF7; SLC1A3; ZFP36L1; KLK6; TMPRSS4;	GO:0009611~response to wounding	8	62	12.9032258064516	0.00722864736126616	0.0550707357794199	1	1	0.999999733847336	0.999999733847336	0.501400114542964
down	ADGRB2; EFNA5; ASIC2; NTRK2; NLGN1; NLGN2; SLITRK6; LRRC4B;	GO:0051965~positive regulation of synapse assembly	8	62	12.9032258064516	0.00722864736126616	0.0550707357794199	1	1	0.999999733847336	0.999999733847336	0.501400114542964
down	CCL21; FGFR1; SOX18; PPARG; HES5; EPAS1;	GO:0048469~cell maturation	6	37	16.2162162162162	0.00736495143107319	0.0557726681834343	1	1	0.999999733847336	0.999999733847336	0.507790967739187
down	CFLAR; EGFR; SRD5A1; MSX2; SFRP1; PPARGC1A;	GO:0071392~cellular response to estradiol stimulus	6	37	16.2162162162162	0.00736495143107319	0.0557726681834343	1	1	0.999999733847336	0.999999733847336	0.507790967739187
down	PLA2G4A; PLA2G4E; PLA2G4F; PLA2G3; PLA2G4C;	GO:0036152~phosphatidylethanolamine acyl-chain remodeling	5	26	19.2307692307692	0.00762596319703901	0.0573814453582658	1	1	0.999999733847336	0.999999733847336	0.522438330777254
down	ADCY6; ADCY3; GLP2R; GJB2; ADCY2;	GO:0071377~cellular response to glucagon stimulus	5	26	19.2307692307692	0.00762596319703901	0.0573814453582658	1	1	0.999999733847336	0.999999733847336	0.522438330777254
down	SASH1; IL1B; BMP2; HAND2; GDF6;	GO:1900745~positive regulation of p38MAPK cascade	5	26	19.2307692307692	0.00762596319703901	0.0573814453582658	1	1	0.999999733847336	0.999999733847336	0.522438330777254
down	CACNB3; DLG4; NLGN1; NLGN2; SHANK1;	GO:2000463~positive regulation of excitatory postsynaptic potential	5	26	19.2307692307692	0.00762596319703901	0.0573814453582658	1	1	0.999999733847336	0.999999733847336	0.522438330777254
up	MRAS; FSCN2; TYROBP; PDGFA; PFN1; CFL1; CORO1A; RHOG; DMTN; KANK1; FSCN1; FGD3; PALLD; RHOJ; DIAPH3; SHROOM4; PDLIM2; SMTN; PDLIM4; PDLIM5; MICALL1; FHL3; MICAL3; CSRP1; RAC2; MICAL2; SHROOM3; VASP;	GO:0030036~actin cytoskeleton organization	28	157	17.8343949044586	0.00763081806966703	0.708173094334969	1	1	0.999999999999999	0.999999999999999	1
down	BMP4; WLS; SIX2; CDX1;	GO:0009948~anterior/posterior axis specification	4	16	25	0.00770235991940293	0.0573814453582658	1	1	0.999999733847336	0.999999733847336	0.522438330777254
down	KLF4; AGT; CSF1; NR1H3;	GO:0032270~positive regulation of cellular protein metabolic process	4	16	25	0.00770235991940293	0.0573814453582658	1	1	0.999999733847336	0.999999733847336	0.522438330777254
down	EDNRB; HTR1B; BDKRB2; HTR7;	GO:0042310~vasoconstriction	4	16	25	0.00770235991940293	0.0573814453582658	1	1	0.999999733847336	0.999999733847336	0.522438330777254
down	INHA; BMP4; BMP7; CDKN1C;	GO:0042326~negative regulation of phosphorylation	4	16	25	0.00770235991940293	0.0573814453582658	1	1	0.999999733847336	0.999999733847336	0.522438330777254
down	DLL1; FOXA1; ISL1; ISL2;	GO:0048665~neuron fate specification	4	16	25	0.00770235991940293	0.0573814453582658	1	1	0.999999733847336	0.999999733847336	0.522438330777254
down	ADORA1; CXCL12; ANO1; TRPV1;	GO:0050965~detection of temperature stimulus involved in sensory perception of pain	4	16	25	0.00770235991940293	0.0573814453582658	1	1	0.999999733847336	0.999999733847336	0.522438330777254
down	ICAM1; PTGIS; PID1; PPARGC1A;	GO:0071354~cellular response to interleukin-6	4	16	25	0.00770235991940293	0.0573814453582658	1	1	0.999999733847336	0.999999733847336	0.522438330777254
up	S1PR4; CALCA; GJA1; OXTR; CD52; GLP1R; CAV3; IL2; PROK2; TRPC5; NPTN; FPR2; ADRA1D; FPR3; CMKLR1; CXCR2; CXCR3; CCR8; CCR6; CCR5; FPR1; CXCR5; PTGIR; CCR2; CCR3; CXCR1; CX3CR1;	GO:0007204~positive regulation of cytosolic calcium ion concentration	27	150	18	0.0078289059888248	0.711097865240278	1	1	0.999999999999999	0.999999999999999	1
down	IL1A; FGF1; HMOX1; HSPA1B; ANO1; SCARA5; TRPV1; HSF4;	GO:0034605~cellular response to heat	8	63	12.6984126984127	0.00786437043005206	0.0585021134642017	1	1	0.999999733847336	0.999999733847336	0.532641628567419
down	DLL1; FGF10; JAG1; ELF3; HES5; MESP1; TP63;	GO:0045747~positive regulation of Notch signaling pathway	7	50	14	0.00793744763141013	0.0589588940974303	1	1	0.999999733847336	0.999999733847336	0.536800459180091
down	HS3ST1; PDGFRB; SDC2; GCNT2; HS6ST2; GPC6;	GO:0006024~glycosaminoglycan biosynthetic process	6	38	15.7894736842105	0.00824180964702115	0.0610401474004455	1	1	0.999999733847336	0.999999733847336	0.555749554915883
down	CFLAR; ICAM1; HMOX1; HGF; RFFL; FAIM2;	GO:1902042~negative regulation of extrinsic apoptotic signaling pathway via death domain receptors	6	38	15.7894736842105	0.00824180964702115	0.0610401474004455	1	1	0.999999733847336	0.999999733847336	0.555749554915883
down	ACVRL1; FUT2; ANGPT1;	GO:0001936~regulation of endothelial cell proliferation	3	8	37.5	0.00854949282813511	0.0616906975355863	1	1	0.999999733847336	0.999999733847336	0.561672590220551
down	ECM1; IL36RN; IRAK3;	GO:0001960~negative regulation of cytokine-mediated signaling pathway	3	8	37.5	0.00854949282813511	0.0616906975355863	1	1	0.999999733847336	0.999999733847336	0.561672590220551
down	CXCL8; CXCL2; CD24;	GO:0002237~response to molecule of bacterial origin	3	8	37.5	0.00854949282813511	0.0616906975355863	1	1	0.999999733847336	0.999999733847336	0.561672590220551
down	PLPP1; PLPP3; PLPP2;	GO:0006670~sphingosine metabolic process	3	8	37.5	0.00854949282813511	0.0616906975355863	1	1	0.999999733847336	0.999999733847336	0.561672590220551
down	INMT; VCAM1; AOC1;	GO:0009308~amine metabolic process	3	8	37.5	0.00854949282813511	0.0616906975355863	1	1	0.999999733847336	0.999999733847336	0.561672590220551
down	KLF4; SPINK5; OVOL1;	GO:0009913~epidermal cell differentiation	3	8	37.5	0.00854949282813511	0.0616906975355863	1	1	0.999999733847336	0.999999733847336	0.561672590220551
down	GJB6; GJB2; GJD3;	GO:0016264~gap junction assembly	3	8	37.5	0.00854949282813511	0.0616906975355863	1	1	0.999999733847336	0.999999733847336	0.561672590220551
down	EGFR; EFHC1; FGF13;	GO:0021795~cerebral cortex cell migration	3	8	37.5	0.00854949282813511	0.0616906975355863	1	1	0.999999733847336	0.999999733847336	0.561672590220551
down	NRP1; RAB13; CORO1B;	GO:0035767~endothelial cell chemotaxis	3	8	37.5	0.00854949282813511	0.0616906975355863	1	1	0.999999733847336	0.999999733847336	0.561672590220551
down	MAOA; MAOB; PRIMA1;	GO:0042135~neurotransmitter catabolic process	3	8	37.5	0.00854949282813511	0.0616906975355863	1	1	0.999999733847336	0.999999733847336	0.561672590220551
down	MAOA; MAOB; MOXD1;	GO:0042420~dopamine catabolic process	3	8	37.5	0.00854949282813511	0.0616906975355863	1	1	0.999999733847336	0.999999733847336	0.561672590220551
down	USP2; GPR176; GPR157;	GO:0048512~circadian behavior	3	8	37.5	0.00854949282813511	0.0616906975355863	1	1	0.999999733847336	0.999999733847336	0.561672590220551
down	MAOB; DUOX2; DUOX1;	GO:0050665~hydrogen peroxide biosynthetic process	3	8	37.5	0.00854949282813511	0.0616906975355863	1	1	0.999999733847336	0.999999733847336	0.561672590220551
down	AQP1; SCNN1A; SCNN1B;	GO:0050891~multicellular organismal water homeostasis	3	8	37.5	0.00854949282813511	0.0616906975355863	1	1	0.999999733847336	0.999999733847336	0.561672590220551
down	PLA2G4A; STAR; PLA2G4F;	GO:0071236~cellular response to antibiotic	3	8	37.5	0.00854949282813511	0.0616906975355863	1	1	0.999999733847336	0.999999733847336	0.561672590220551
down	DLL1; JAG1; SIX2;	GO:0072006~nephron development	3	8	37.5	0.00854949282813511	0.0616906975355863	1	1	0.999999733847336	0.999999733847336	0.561672590220551
down	"NAMPT; CACNB3; AQP3;"	GO:0090650~cellular response to oxygen-glucose deprivation	3	8	37.5	0.00854949282813511	0.0616906975355863	1	1	0.999999733847336	0.999999733847336	0.561672590220551
down	DLG4; DVL3; FZD4;	GO:0150012~positive regulation of neuron projection arborization	3	8	37.5	0.00854949282813511	0.0616906975355863	1	1	0.999999733847336	0.999999733847336	0.561672590220551
down	CYP7B1; CH25H; STAR; ACOX2; CYP39A1;	GO:0006699~bile acid biosynthetic process	5	27	18.5185185185185	0.00874248948497047	0.0621993971465011	1	1	0.999999733847336	0.999999733847336	0.566304125273982
down	NRP1; RAMP2; ANXA1; MT1G; GAS1;	GO:0035924~cellular response to vascular endothelial growth factor stimulus	5	27	18.5185185185185	0.00874248948497047	0.0621993971465011	1	1	0.999999733847336	0.999999733847336	0.566304125273982
down	PLA2G4A; PLA2G4E; PLA2G4F; PLA2G3; PLA2G4C;	GO:0036151~phosphatidylcholine acyl-chain remodeling	5	27	18.5185185185185	0.00874248948497047	0.0621993971465011	1	1	0.999999733847336	0.999999733847336	0.566304125273982
down	CXCL8; CCL2; STAR; ZFP36L1; SFRP1;	GO:0044344~cellular response to fibroblast growth factor stimulus	5	27	18.5185185185185	0.00874248948497047	0.0621993971465011	1	1	0.999999733847336	0.999999733847336	0.566304125273982
down	SMAD6; PRDM1; BMP4; MEGF8; PLXND1;	GO:0060976~coronary vasculature development	5	27	18.5185185185185	0.00874248948497047	0.0621993971465011	1	1	0.999999733847336	0.999999733847336	0.566304125273982
down	AGT; PDGFRB; TGFBR2; PID1; NOX4;	GO:2000379~positive regulation of reactive oxygen species metabolic process	5	27	18.5185185185185	0.00874248948497047	0.0621993971465011	1	1	0.999999733847336	0.999999733847336	0.566304125273982
up	LST1; ATP10A; F2; S100B; ITGB2; FES; HCK; VIL1; TPM1; FGR; EPB42; CORO1A; MYH9; MYH10; DMTN; ITGA7; ARHGAP15; FGD3; BVES; SHROOM3; FBLIM1; FERMT2; PLXNB3; RHOG; RAC2; CDC42EP3; PLXNA4; RHOJ;	GO:0008360~regulation of cell shape	28	159	17.6100628930818	0.00880487720552425	0.767102465109858	1	1	0.999999999999999	0.999999999999999	1
down	ANXA8; RAB5B; SQSTM1; ALS2CL; RNF26; ANXA8L1;	GO:0007032~endosome organization	6	39	15.3846153846154	0.00919112528536692	0.0621993971465011	1	1	0.999999733847336	0.999999733847336	0.566304125273982
down	RGS12; RGS5; ERBB3; PTK6; RGS22; DDIT4L;	GO:0009968~negative regulation of signal transduction	6	39	15.3846153846154	0.00919112528536692	0.0621993971465011	1	1	0.999999733847336	0.999999733847336	0.566304125273982
down	DLL1; HOXA2; JAG1; EBF2;	GO:0001709~cell fate determination	4	17	23.5294117647059	0.00921432448871651	0.0621993971465011	1	1	0.999999733847336	0.999999733847336	0.566304125273982
down	LTA4H; ALOX15; GGT5; PTGR1;	GO:0006691~leukotriene metabolic process	4	17	23.5294117647059	0.00921432448871651	0.0621993971465011	1	1	0.999999733847336	0.999999733847336	0.566304125273982
down	PIR; BMP4; MT1G; PPARG;	GO:0030224~monocyte differentiation	4	17	23.5294117647059	0.00921432448871651	0.0621993971465011	1	1	0.999999733847336	0.999999733847336	0.566304125273982
down	C1R; F12; PRSS3; C1RL;	GO:0031638~zymogen activation	4	17	23.5294117647059	0.00921432448871651	0.0621993971465011	1	1	0.999999733847336	0.999999733847336	0.566304125273982
down	MEIS1; THPO; ZNF385A; WASF2;	GO:0035855~megakaryocyte development	4	17	23.5294117647059	0.00921432448871651	0.0621993971465011	1	1	0.999999733847336	0.999999733847336	0.566304125273982
down	LTA4H; ADAMTS13; NPEPPS; TRHDE;	GO:0043171~peptide catabolic process	4	17	23.5294117647059	0.00921432448871651	0.0621993971465011	1	1	0.999999733847336	0.999999733847336	0.566304125273982
down	NFATC4; SDHAF4; COX15; PPARGC1A;	GO:0045333~cellular respiration	4	17	23.5294117647059	0.00921432448871651	0.0621993971465011	1	1	0.999999733847336	0.999999733847336	0.566304125273982
down	CCL21; PDGFRB; RARRES2; CCL26;	GO:0050921~positive regulation of chemotaxis	4	17	23.5294117647059	0.00921432448871651	0.0621993971465011	1	1	0.999999733847336	0.999999733847336	0.566304125273982
down	NOL3; CLDN1; HGSNAT; CHP1;	GO:0051259~protein complex oligomerization	4	17	23.5294117647059	0.00921432448871651	0.0621993971465011	1	1	0.999999733847336	0.999999733847336	0.566304125273982
down	BMP2; BMP4; SOX5; SMAD1;	GO:0061036~positive regulation of cartilage development	4	17	23.5294117647059	0.00921432448871651	0.0621993971465011	1	1	0.999999733847336	0.999999733847336	0.566304125273982
down	DCLK1; TRIM29; FLCN; TMEM98;	GO:1900181~negative regulation of protein localization to nucleus	4	17	23.5294117647059	0.00921432448871651	0.0621993971465011	1	1	0.999999733847336	0.999999733847336	0.566304125273982
down	NR2F1; BMP4; RARG; BMP7; NR2F2; PPARG; NR1H3;	GO:0043401~steroid hormone mediated signaling pathway	7	52	13.4615384615385	0.00955508556369422	0.0638395994473803	1	1	0.999999733847336	0.999999733847336	0.581237603279951
up	IL18RAP; EOMES; SPN; AVPR2; LILRB1;	GO:0032609~interferon-gamma production	5	10	50	0.00963394284185259	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
up	ACTN4; F13A1; SERPINA1; ORM1; PPBP; PF4; PDGFA; ITGB3; SERPINE1; LYN; ITGA2B; PLEK; ACTN1; VCL; ORM2; FLNA; TIMP3; MANF; CTSW; TGFB2; FERMT3; SCG3; POTEKP;	GO:0002576~platelet degranulation	23	124	18.5483870967742	0.00994496192667493	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
down	PENK; TXN; CXCL12; CCL11; BACE1;	GO:0009314~response to radiation	5	28	17.8571428571429	0.00996696582095069	0.0661539347721707	1	1	0.999999733847336	0.999999733847336	0.602308830684441
down	CCNB1; TGFBR2; FOXF1; FAT4; CLMP;	GO:0048565~digestive tract development	5	28	17.8571428571429	0.00996696582095069	0.0661539347721707	1	1	0.999999733847336	0.999999733847336	0.602308830684441
down	S100A8; S100A9; NLRP10; SPON2; RNASE7;	GO:0050832~defense response to fungus	5	28	17.8571428571429	0.00996696582095069	0.0661539347721707	1	1	0.999999733847336	0.999999733847336	0.602308830684441
down	CHP1; SLC4A11; SLC9A5; SLC9A8; SLC9A3;	GO:0051453~regulation of intracellular pH	5	28	17.8571428571429	0.00996696582095069	0.0661539347721707	1	1	0.999999733847336	0.999999733847336	0.602308830684441
down	BMP2; HGF; BMP7; FOXF2; DDX17; FAM83D;	GO:0001837~epithelial to mesenchymal transition	6	40	15	0.010215965262484	0.0672761936646764	1	1	0.999999733847336	0.999999733847336	0.612526612039371
down	HEXB; STS; GM2A; ASAH1; SUMF1; GLTP;	GO:0006687~glycosphingolipid metabolic process	6	40	15	0.010215965262484	0.0672761936646764	1	1	0.999999733847336	0.999999733847336	0.612526612039371
down	IL1B; FBLN1; TGFBR2; EMP2; PTGIS; TPPP3;	GO:0007566~embryo implantation	6	40	15	0.010215965262484	0.0672761936646764	1	1	0.999999733847336	0.999999733847336	0.612526612039371
down	CDK1; GLI3; CDH1; JUP; SMAD3; SMO;	GO:0042307~positive regulation of protein import into nucleus	6	40	15	0.010215965262484	0.0672761936646764	1	1	0.999999733847336	0.999999733847336	0.612526612039371
down	TNFRSF21; ERBB3; ATN1; GRIK2; SIAH1; TP63;	GO:0051402~neuron apoptotic process	6	40	15	0.010215965262484	0.0672761936646764	1	1	0.999999733847336	0.999999733847336	0.612526612039371
up	WNT9A; DHH; SIGLEC6; EFNA2; SH2D1A; TSHB; GHRH; LTA; PDGFA; WNT1; ITGB2; INHBA; PTHLH; CCL5; EDN3; GJA1; CD33; SSTR3; PTGIR; FASLG; CX3CR1; PGF; CCR5; IL2; LTB; GRAP; IHH; ZYX; BHLHA15; LILRB2; FCRL2; IL26; SIRPG; ADRA1D; FGFBP2; FJX1; DRD3;	GO:0007267~cell-cell signaling	37	230	16.0869565217391	0.0103561694427613	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
down	CSF1; EEF2; GJB2; PPIF; SQSTM1; FAIM2; PPARGC1A;	GO:0002931~response to ischemia	7	53	13.2075471698113	0.0104484592915798	0.0686283067383218	1	1	0.999999733847336	0.999999733847336	0.624837136683826
down	DLL1; JAG1; ANGPT1; FLCN; TWSG1; MKNK2; MECOM;	GO:0030097~hemopoiesis	7	53	13.2075471698113	0.0104484592915798	0.0686283067383218	1	1	0.999999733847336	0.999999733847336	0.624837136683826
down	NECTIN1; HEPH; HEPHL1; CP;	GO:0006826~iron ion transport	4	18	22.2222222222222	0.0109070008101209	0.0699153386896268	1	1	0.999999733847336	0.999999733847336	0.636555120085927
down	BMP2; BMP4; SCN5A; HES5;	GO:0021537~telencephalon development	4	18	22.2222222222222	0.0109070008101209	0.0699153386896268	1	1	0.999999733847336	0.999999733847336	0.636555120085927
down	NFIB; BMP7; SMAD1; WLS;	GO:0030902~hindbrain development	4	18	22.2222222222222	0.0109070008101209	0.0699153386896268	1	1	0.999999733847336	0.999999733847336	0.636555120085927
down	VIM; DSP; DES; KRT17;	GO:0045109~intermediate filament organization	4	18	22.2222222222222	0.0109070008101209	0.0699153386896268	1	1	0.999999733847336	0.999999733847336	0.636555120085927
down	NPNT; NMU; ADRA1B; ADRA1A;	GO:0045987~positive regulation of smooth muscle contraction	4	18	22.2222222222222	0.0109070008101209	0.0699153386896268	1	1	0.999999733847336	0.999999733847336	0.636555120085927
down	BMP7; TBX2; SGCG; SGCD;	GO:0048738~cardiac muscle tissue development	4	18	22.2222222222222	0.0109070008101209	0.0699153386896268	1	1	0.999999733847336	0.999999733847336	0.636555120085927
down	SULT2B1; TPST1; SULT1C4; ABHD14B;	GO:0050427~3'-phosphoadenosine 5'-phosphosulfate metabolic process	4	18	22.2222222222222	0.0109070008101209	0.0699153386896268	1	1	0.999999733847336	0.999999733847336	0.636555120085927
down	CXCL12; PLA2G7; CXCL17; S100A14;	GO:0090026~positive regulation of monocyte chemotaxis	4	18	22.2222222222222	0.0109070008101209	0.0699153386896268	1	1	0.999999733847336	0.999999733847336	0.636555120085927
down	AGT; GDNF; WNT2B; SMO;	GO:0090190~positive regulation of branching involved in ureteric bud morphogenesis	4	18	22.2222222222222	0.0109070008101209	0.0699153386896268	1	1	0.999999733847336	0.999999733847336	0.636555120085927
down	KRT1; MASP1; COLEC10;	GO:0001867~complement activation, lectin pathway	3	9	33.3333333333333	0.011059662564445	0.0699153386896268	1	1	0.999999733847336	0.999999733847336	0.636555120085927
down	VWF; ZNF385A; HPS4;	GO:0007599~hemostasis	3	9	33.3333333333333	0.011059662564445	0.0699153386896268	1	1	0.999999733847336	0.999999733847336	0.636555120085927
down	CES2; AADAC; AADACL2;	GO:0009056~catabolic process	3	9	33.3333333333333	0.011059662564445	0.0699153386896268	1	1	0.999999733847336	0.999999733847336	0.636555120085927
down	ABCA1; PPARG; NR1H3;	GO:0010887~negative regulation of cholesterol storage	3	9	33.3333333333333	0.011059662564445	0.0699153386896268	1	1	0.999999733847336	0.999999733847336	0.636555120085927
down	PLSCR1; PLSCR4; TMEM256-PLSCR3;	GO:0017121~plasma membrane phospholipid scrambling	3	9	33.3333333333333	0.011059662564445	0.0699153386896268	1	1	0.999999733847336	0.999999733847336	0.636555120085927
down	NRP1; NRP2; SEMA3A;	GO:0021612~facial nerve structural organization	3	9	33.3333333333333	0.011059662564445	0.0699153386896268	1	1	0.999999733847336	0.999999733847336	0.636555120085927
down	PLXNB1; SMAD3; SFRP1;	GO:0033689~negative regulation of osteoblast proliferation	3	9	33.3333333333333	0.011059662564445	0.0699153386896268	1	1	0.999999733847336	0.999999733847336	0.636555120085927
down	PLTP; ABCA12; GLTP;	GO:0035627~ceramide transport	3	9	33.3333333333333	0.011059662564445	0.0699153386896268	1	1	0.999999733847336	0.999999733847336	0.636555120085927
down	NR1H3; LRFN5; VSIG4;	GO:0043031~negative regulation of macrophage activation	3	9	33.3333333333333	0.011059662564445	0.0699153386896268	1	1	0.999999733847336	0.999999733847336	0.636555120085927
down	AKR1B10; AKR1C2; AKR1C1;	GO:0044597~daunorubicin metabolic process	3	9	33.3333333333333	0.011059662564445	0.0699153386896268	1	1	0.999999733847336	0.999999733847336	0.636555120085927
down	AKR1B10; AKR1C2; AKR1C1;	GO:0044598~doxorubicin metabolic process	3	9	33.3333333333333	0.011059662564445	0.0699153386896268	1	1	0.999999733847336	0.999999733847336	0.636555120085927
down	HMGCL; HMGCS2; HMGCLL1;	GO:0046951~ketone body biosynthetic process	3	9	33.3333333333333	0.011059662564445	0.0699153386896268	1	1	0.999999733847336	0.999999733847336	0.636555120085927
down	BMP2; SMAD3; TBX5;	GO:0060039~pericardium development	3	9	33.3333333333333	0.011059662564445	0.0699153386896268	1	1	0.999999733847336	0.999999733847336	0.636555120085927
down	NRP1; RAB25; VAMP2;	GO:0060627~regulation of vesicle-mediated transport	3	9	33.3333333333333	0.011059662564445	0.0699153386896268	1	1	0.999999733847336	0.999999733847336	0.636555120085927
down	WNT2; WNT2B; HIPK2;	GO:0061072~iris morphogenesis	3	9	33.3333333333333	0.011059662564445	0.0699153386896268	1	1	0.999999733847336	0.999999733847336	0.636555120085927
down	NRP1; NRP2; SEMA3A;	GO:0061549~sympathetic ganglion development	3	9	33.3333333333333	0.011059662564445	0.0699153386896268	1	1	0.999999733847336	0.999999733847336	0.636555120085927
down	RAMP2; LAMB2; LAMB1;	GO:0070831~basement membrane assembly	3	9	33.3333333333333	0.011059662564445	0.0699153386896268	1	1	0.999999733847336	0.999999733847336	0.636555120085927
down	HMOX1; PPIF; MKNK2;	GO:0071243~cellular response to arsenic-containing substance	3	9	33.3333333333333	0.011059662564445	0.0699153386896268	1	1	0.999999733847336	0.999999733847336	0.636555120085927
down	BMP4; JAG1; MAGI2;	GO:0072015~glomerular visceral epithelial cell development	3	9	33.3333333333333	0.011059662564445	0.0699153386896268	1	1	0.999999733847336	0.999999733847336	0.636555120085927
down	DAB2; RSPO3; PLEKHA4;	GO:2000096~positive regulation of Wnt signaling pathway, planar cell polarity pathway	3	9	33.3333333333333	0.011059662564445	0.0699153386896268	1	1	0.999999733847336	0.999999733847336	0.636555120085927
down	CFLAR; FGF1; HPN;	GO:2000347~positive regulation of hepatocyte proliferation	3	9	33.3333333333333	0.011059662564445	0.0699153386896268	1	1	0.999999733847336	0.999999733847336	0.636555120085927
down	FDXR; PBX1; LSS; SRD5A1; STAR;	GO:0006694~steroid biosynthetic process	5	29	17.2413793103448	0.0113040401340571	0.0708475604780098	1	1	0.999999733847336	0.999999733847336	0.645042678947441
down	GRIK2; MYH14; KCND2; SCN5A; SCN7A;	GO:0019228~neuronal action potential	5	29	17.2413793103448	0.0113040401340571	0.0708475604780098	1	1	0.999999733847336	0.999999733847336	0.645042678947441
down	EPB41L2; RAB13; EHD2; EPB41L3; LLGL2;	GO:0030866~cortical actin cytoskeleton organization	5	29	17.2413793103448	0.0113040401340571	0.0708475604780098	1	1	0.999999733847336	0.999999733847336	0.645042678947441
down	EGFR; TIMP2; GAS1; SMAD3; CDKN1C;	GO:0045930~negative regulation of mitotic cell cycle	5	29	17.2413793103448	0.0113040401340571	0.0708475604780098	1	1	0.999999733847336	0.999999733847336	0.645042678947441
down	EGFR; IL1B; ROS1; CEACAM1; FAM83D;	GO:0070372~regulation of ERK1 and ERK2 cascade	5	29	17.2413793103448	0.0113040401340571	0.0708475604780098	1	1	0.999999733847336	0.999999733847336	0.645042678947441
down	IL1RAPL2; LRRC4B; FZD1; GPC6; LRFN5;	GO:1905606~regulation of presynapse assembly	5	29	17.2413793103448	0.0113040401340571	0.0708475604780098	1	1	0.999999733847336	0.999999733847336	0.645042678947441
down	WNT2; TGFBR2; SIX5; WNT2B; SLITRK6; CRYGN;	GO:0002088~lens development in camera-type eye	6	41	14.6341463414634	0.0113193390033169	0.0708475604780098	1	1	0.999999733847336	0.999999733847336	0.645042678947441
down	IGF1; ICAM1; VCAM1; NAMPT; BACE1; LRP1;	GO:1904646~cellular response to amyloid-beta	6	41	14.6341463414634	0.0113193390033169	0.0708475604780098	1	1	0.999999733847336	0.999999733847336	0.645042678947441
down	EGFR; S100A8; HPN; S100A9; SFN; KRT17; MAP2K5; SFRP1; CXCL16;	GO:0030307~positive regulation of cell growth	9	82	10.9756097560976	0.0114429002413758	0.0715322885138482	1	1	0.999999733847336	0.999999733847336	0.651276892286724
down	RAMP2; CXCL8; CD9; GRIA1; LRP1; CALCRL;	GO:0031623~receptor internalization	6	42	14.2857142857143	0.0125041894398406	0.0779736553834995	1	1	0.999999733847336	0.999999733847336	0.709923322928084
down	AGT; ROS1; CEACAM1; IGFBP4; IGFBP5; LTBP4; PAPPA2; EPB41L3;	GO:0001558~regulation of cell growth	8	69	11.5942028985507	0.0125952611504413	0.0784447152538582	1	1	0.999999733847336	0.999999733847336	0.714212161085258
up	TYROBP; IFNG; HSPB1; SPN; TNFRSF8; CCR2; TLR1;	GO:0042535~positive regulation of tumor necrosis factor biosynthetic process	7	21	33.3333333333333	0.012691754182835	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
down	MT1X; MT1A; MT1H; MT1G; MT1M;	GO:0006882~cellular zinc ion homeostasis	5	30	16.6666666666667	0.0127581664206917	0.0784822200315503	1	1	0.999999733847336	0.999999733847336	0.714553629191042
down	THY1; GRIK2; MAGI2; DLG4; TMEFF1;	GO:0043113~receptor clustering	5	30	16.6666666666667	0.0127581664206917	0.0784822200315503	1	1	0.999999733847336	0.999999733847336	0.714553629191042
down	IGF1; TXN; PPARG; ISL1; HIPK2;	GO:0043388~positive regulation of DNA binding	5	30	16.6666666666667	0.0127581664206917	0.0784822200315503	1	1	0.999999733847336	0.999999733847336	0.714553629191042
down	HMOX1; HAND2; TFAP4; WFIKKN2; SMO;	GO:0043392~negative regulation of DNA binding	5	30	16.6666666666667	0.0127581664206917	0.0784822200315503	1	1	0.999999733847336	0.999999733847336	0.714553629191042
down	EGFR; ICAM1; ADRA1A; HRH1; ADRA1B;	GO:0045907~positive regulation of vasoconstriction	5	30	16.6666666666667	0.0127581664206917	0.0784822200315503	1	1	0.999999733847336	0.999999733847336	0.714553629191042
down	NRP1; PDGFRB; PDGFRA; PDGFD; PLAT;	GO:0048008~platelet-derived growth factor receptor signaling pathway	5	30	16.6666666666667	0.0127581664206917	0.0784822200315503	1	1	0.999999733847336	0.999999733847336	0.714553629191042
down	KRIT1; RAMP2; ICAM1; ANGPT1; ANGPTL4;	GO:2000352~negative regulation of endothelial cell apoptotic process	5	30	16.6666666666667	0.0127581664206917	0.0784822200315503	1	1	0.999999733847336	0.999999733847336	0.714553629191042
down	ELOVL7; ELOVL3; ELOVL2; TECR;	GO:0035338~long-chain fatty-acyl-CoA biosynthetic process	4	19	21.0526315789474	0.0127877384846498	0.0784822200315503	1	1	0.999999733847336	0.999999733847336	0.714553629191042
down	PLA2G4A; PLA2G4E; PLA2G4F; PLA2G4C;	GO:0036149~phosphatidylinositol acyl-chain remodeling	4	19	21.0526315789474	0.0127877384846498	0.0784822200315503	1	1	0.999999733847336	0.999999733847336	0.714553629191042
down	FGFR4; PLK1; ASPH; PERP;	GO:0045862~positive regulation of proteolysis	4	19	21.0526315789474	0.0127877384846498	0.0784822200315503	1	1	0.999999733847336	0.999999733847336	0.714553629191042
down	EGFR; PDGFRB; EFNA1; PDGFD;	GO:0050730~regulation of peptidyl-tyrosine phosphorylation	4	19	21.0526315789474	0.0127877384846498	0.0784822200315503	1	1	0.999999733847336	0.999999733847336	0.714553629191042
down	POR; NKX6-1; ZFP36L1; CYP11A1;	GO:0071375~cellular response to peptide hormone stimulus	4	19	21.0526315789474	0.0127877384846498	0.0784822200315503	1	1	0.999999733847336	0.999999733847336	0.714553629191042
up	MICAL2; VIL1; CFL1; MICAL3; TWF2;	GO:0030042~actin filament depolymerization	5	11	45.4545454545455	0.0129497547528955	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
down	PIR; MEIS2; FOXN1; KLF4; MAF; NFIC; TBP; SOX5; AHR; NKX6-1; ELF3; KLF5; TRIM29; NFATC4; NFIX; NFIL3; PMF1; EPAS1; EHF; HIF3A;	GO:0006366~transcription by RNA polymerase II	20	266	7.5187969924812	0.0131593144369082	0.0805669057222101	1	1	0.999999733847336	0.999999733847336	0.733533975636196
up	CLEC4D; CLEC4E; FCER1G;	GO:0002292~T cell differentiation involved in immune response	3	3	100	0.0131693126681387	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
up	HLA-G; LILRB2; LILRB1;	GO:0002767~immune response-inhibiting cell surface receptor signaling pathway	3	3	100	0.0131693126681387	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
up	LYN; LILRB2; LILRB1;	GO:0002774~Fc receptor mediated inhibitory signaling pathway	3	3	100	0.0131693126681387	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
up	CLEC4D; CLEC4E; FCER1G;	GO:0038094~Fc-gamma receptor signaling pathway	3	3	100	0.0131693126681387	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
up	CD4; CD74; CD1D;	GO:0045058~T cell selection	3	3	100	0.0131693126681387	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
up	LILRA5; LILRB1; TLR8;	GO:2001183~negative regulation of interleukin-12 secretion	3	3	100	0.0131693126681387	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
up	IFNG; ITGB2; ITGAM; FPR2; SNCA; AIF1; TLR8; TLR7;	GO:0001774~microglial cell activation	8	27	29.6296296296296	0.0137614631845319	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
down	ACADS; HADHB; HADH; ACAD10; CPT1C; CROT;	GO:0006635~fatty acid beta-oxidation	6	43	13.953488372093	0.0137733844216428	0.0812941349220588	1	1	0.999999733847336	0.999999733847336	0.740155147460803
down	CDK1; ANXA3; HGF; TGFBR2; PPARG; CXCL12;	GO:0031100~animal organ regeneration	6	43	13.953488372093	0.0137733844216428	0.0812941349220588	1	1	0.999999733847336	0.999999733847336	0.740155147460803
down	ABCC9; KCNK5; KCNJ2; KCNJ8; ATP12A; SLC12A6;	GO:1990573~potassium ion import across plasma membrane	6	43	13.953488372093	0.0137733844216428	0.0812941349220588	1	1	0.999999733847336	0.999999733847336	0.740155147460803
down	TCF21; PRDM1; FOXF1;	GO:0001763~morphogenesis of a branching structure	3	10	30	0.0139501114309061	0.0812941349220588	1	1	0.999999733847336	0.999999733847336	0.740155147460803
down	ADCY6; ADCY3; ADCY2;	GO:0006171~cAMP biosynthetic process	3	10	30	0.0139501114309061	0.0812941349220588	1	1	0.999999733847336	0.999999733847336	0.740155147460803
down	HSD11B1; HSD11B2; CYP11A1;	GO:0006704~glucocorticoid biosynthetic process	3	10	30	0.0139501114309061	0.0812941349220588	1	1	0.999999733847336	0.999999733847336	0.740155147460803
down	EGFR; FOXF1; SMO;	GO:0007494~midgut development	3	10	30	0.0139501114309061	0.0812941349220588	1	1	0.999999733847336	0.999999733847336	0.740155147460803
down	ACTN3; SCN5A; SGCA;	GO:0014894~response to denervation involved in regulation of muscle adaptation	3	10	30	0.0139501114309061	0.0812941349220588	1	1	0.999999733847336	0.999999733847336	0.740155147460803
down	SLC26A4; SLC26A9; SLC26A10;	GO:0019532~oxalate transport	3	10	30	0.0139501114309061	0.0812941349220588	1	1	0.999999733847336	0.999999733847336	0.740155147460803
down	BMP4; FOXA1; SMO;	GO:0021904~dorsal/ventral neural tube patterning	3	10	30	0.0139501114309061	0.0812941349220588	1	1	0.999999733847336	0.999999733847336	0.740155147460803
down	ALOX15B; GLI3; ANXA1;	GO:0030850~prostate gland development	3	10	30	0.0139501114309061	0.0812941349220588	1	1	0.999999733847336	0.999999733847336	0.740155147460803
down	MAF; SIX2; SCIN;	GO:0032330~regulation of chondrocyte differentiation	3	10	30	0.0139501114309061	0.0812941349220588	1	1	0.999999733847336	0.999999733847336	0.740155147460803
down	PPARG; CYGB; EMILIN1;	GO:0032966~negative regulation of collagen biosynthetic process	3	10	30	0.0139501114309061	0.0812941349220588	1	1	0.999999733847336	0.999999733847336	0.740155147460803
down	KLF4; IL1RN; MAP2K5;	GO:0034115~negative regulation of heterotypic cell-cell adhesion	3	10	30	0.0139501114309061	0.0812941349220588	1	1	0.999999733847336	0.999999733847336	0.740155147460803
down	TBX3; GDF5; TBX5;	GO:0035136~forelimb morphogenesis	3	10	30	0.0139501114309061	0.0812941349220588	1	1	0.999999733847336	0.999999733847336	0.740155147460803
down	SRD5A1; AKR1C2; AKR1C1;	GO:0042448~progesterone metabolic process	3	10	30	0.0139501114309061	0.0812941349220588	1	1	0.999999733847336	0.999999733847336	0.740155147460803
down	HOXA5; ZFP36L1; MAFB;	GO:0045647~negative regulation of erythrocyte differentiation	3	10	30	0.0139501114309061	0.0812941349220588	1	1	0.999999733847336	0.999999733847336	0.740155147460803
down	THPO; RAB7B; SCIN;	GO:0045654~positive regulation of megakaryocyte differentiation	3	10	30	0.0139501114309061	0.0812941349220588	1	1	0.999999733847336	0.999999733847336	0.740155147460803
down	EREG; ADORA1; EPGN;	GO:0045741~positive regulation of epidermal growth factor-activated receptor activity	3	10	30	0.0139501114309061	0.0812941349220588	1	1	0.999999733847336	0.999999733847336	0.740155147460803
down	HAND2; NTRK2; ISL2;	GO:0048935~peripheral nervous system neuron development	3	10	30	0.0139501114309061	0.0812941349220588	1	1	0.999999733847336	0.999999733847336	0.740155147460803
down	CCL3; HTR1B; HOXA1;	GO:0050795~regulation of behavior	3	10	30	0.0139501114309061	0.0812941349220588	1	1	0.999999733847336	0.999999733847336	0.740155147460803
down	KLF4; WFS1; MAP2K5;	GO:0051247~positive regulation of protein metabolic process	3	10	30	0.0139501114309061	0.0812941349220588	1	1	0.999999733847336	0.999999733847336	0.740155147460803
down	PSCA; SLURP1; LYPD6B;	GO:0099601~regulation of neurotransmitter receptor activity	3	10	30	0.0139501114309061	0.0812941349220588	1	1	0.999999733847336	0.999999733847336	0.740155147460803
up	CACNA1H; CALCA; TPM1; GLP1R; TNNT2; KCNQ1; CAV3; KCNJ12; FOXN4;	GO:0008016~regulation of heart contraction	9	33	27.2727272727273	0.0141084737122755	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
down	FGF10; SPRY1; PLK1; GPSM2; SAPCD2;	GO:0000132~establishment of mitotic spindle orientation	5	31	16.1290322580645	0.0143335891386364	0.0812941349220588	1	1	0.999999733847336	0.999999733847336	0.740155147460803
down	AGT; ANK2; SCN5A; SEMA3A; EPAS1;	GO:0002027~regulation of heart rate	5	31	16.1290322580645	0.0143335891386364	0.0812941349220588	1	1	0.999999733847336	0.999999733847336	0.740155147460803
down	KRT14; S100A8; ALAD; D2HGDH; GGH;	GO:0010043~response to zinc ion	5	31	16.1290322580645	0.0143335891386364	0.0812941349220588	1	1	0.999999733847336	0.999999733847336	0.740155147460803
down	LEPROT; CSNK2A2; NPEPPS; RHOU; HPS4;	GO:1903955~positive regulation of protein targeting to mitochondrion	5	31	16.1290322580645	0.0143335891386364	0.0812941349220588	1	1	0.999999733847336	0.999999733847336	0.740155147460803
up	TRAV19; PIK3CD; CD4; TRBV12-3; TRAV8-4; TRAC; TRBC1; HLA-DQA2; CD3D; TRBV7-9; TRAV29DV5; HLA-DQB2; LCK; CD3G; CD247; PSMB8; PSMB9; PSMB10; ZAP70; PSMB3; HLA-DRB5; TRAT1; SKAP1; PSMA8; CARD11; THEMIS2; PRAM1; HHLA2; CTLA4;	GO:0050852~T cell receptor signaling pathway	29	174	16.6666666666667	0.0144865239308015	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
down	ANXA1; ANXA3; ADORA1; LRP1; CD93; TYRO3; ELANE;	GO:0006909~phagocytosis	7	57	12.280701754386	0.0146342521537794	0.0812941349220588	1	1	0.999999733847336	0.999999733847336	0.740155147460803
down	IGF1; PDGFRB; FGFR1; PDGFRA; PLCD1; PLCB1; PLCD3;	GO:0048015~phosphatidylinositol-mediated signaling	7	57	12.280701754386	0.0146342521537794	0.0812941349220588	1	1	0.999999733847336	0.999999733847336	0.740155147460803
down	PTGES; EGFR; PENK; ADAM9; D2HGDH; AQP3; S100A16;	GO:0051592~response to calcium ion	7	57	12.280701754386	0.0146342521537794	0.0812941349220588	1	1	0.999999733847336	0.999999733847336	0.740155147460803
up	CD22; FCGR2B; FCRL3; CD300A;	GO:0050859~negative regulation of B cell receptor signaling pathway	4	7	57.1428571428571	0.0147334926660581	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
up	HP; SLC4A1; GZMA; GZMK;	GO:0051354~negative regulation of oxidoreductase activity	4	7	57.1428571428571	0.0147334926660581	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
up	TMOD1; LMOD1; LMOD3; LMOD2;	GO:0051694~pointed-end actin filament capping	4	7	57.1428571428571	0.0147334926660581	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
down	EREG; ANG; CCNB1; PDE3A;	GO:0001556~oocyte maturation	4	20	20	0.0148631823934453	0.0812941349220588	1	1	0.999999733847336	0.999999733847336	0.740155147460803
down	CTDNEP1; SMAD1; SPIN4; SPIN2A;	GO:0007276~gamete generation	4	20	20	0.0148631823934453	0.0812941349220588	1	1	0.999999733847336	0.999999733847336	0.740155147460803
down	LAMC1; BMP4; PAX9; SMAD3;	GO:0007492~endoderm development	4	20	20	0.0148631823934453	0.0812941349220588	1	1	0.999999733847336	0.999999733847336	0.740155147460803
down	AGT; IGF1; ADRA1A; HAND2;	GO:0010613~positive regulation of cardiac muscle hypertrophy	4	20	20	0.0148631823934453	0.0812941349220588	1	1	0.999999733847336	0.999999733847336	0.740155147460803
down	BMP4; RARG; GDF5; CHADL;	GO:0032331~negative regulation of chondrocyte differentiation	4	20	20	0.0148631823934453	0.0812941349220588	1	1	0.999999733847336	0.999999733847336	0.740155147460803
down	FOXE1; FGF10; HOXA3; PBX1; HAND2; MAFB;	GO:0048538~thymus development	6	44	13.6363636363636	0.0151297085629808	0.0813846197567795	1	1	0.999999733847336	0.999999733847336	0.740978980769933
down	THBD; ALDH3A1; CNGA3; MMP19; DUOX2; DUOX1;	GO:0051591~response to cAMP	6	44	13.6363636363636	0.0151297085629808	0.0813846197567795	1	1	0.999999733847336	0.999999733847336	0.740978980769933
down	FOXN1; CXCL12; MST1R; COLEC12; CLEC1A; DUOX2; DUOX1; NOX4;	GO:0006952~defense response	8	72	11.1111111111111	0.0156191886156983	0.0838390241210332	1	1	0.999999733847336	0.999999733847336	0.763325488619415
down	S100A8; S100A9; PPARG; SMAD3; BEX3; PIDD1; ROBO1; CFLAR; CASP12;	GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process	9	87	10.3448275862069	0.0158528546079879	0.0850029390923004	1	1	0.999999733847336	0.999999733847336	0.773922534249042
down	PLK1; CHP1; TPPP3; CAPN6; NAV1;	GO:0001578~microtubule bundle formation	5	32	15.625	0.016034329289125	0.0852519970940739	1	1	0.999999733847336	0.999999733847336	0.776190121722673
down	KCNK5; HMOX1; ATP6V1B1; SCNN1B; CLCNKB;	GO:0007588~excretion	5	32	15.625	0.016034329289125	0.0852519970940739	1	1	0.999999733847336	0.999999733847336	0.776190121722673
down	AR; NR2F1; NR2F2; AHR; NR1H3;	GO:0030522~intracellular receptor signaling pathway	5	32	15.625	0.016034329289125	0.0852519970940739	1	1	0.999999733847336	0.999999733847336	0.776190121722673
down	ACTC1; MYH14; EPB41L4B; EPB41L2; EPB41L3;	GO:0031032~actomyosin structure organization	5	32	15.625	0.016034329289125	0.0852519970940739	1	1	0.999999733847336	0.999999733847336	0.776190121722673
down	IL1B; TNS2; PID1; TSC2; GRB7;	GO:0046627~negative regulation of insulin receptor signaling pathway	5	32	15.625	0.016034329289125	0.0852519970940739	1	1	0.999999733847336	0.999999733847336	0.776190121722673
down	CTSK; CTSF; CTSV; CTSC; SCPEP1;	GO:0051603~proteolysis involved in cellular protein catabolic process	5	32	15.625	0.016034329289125	0.0852519970940739	1	1	0.999999733847336	0.999999733847336	0.776190121722673
down	NR2F2; MEOX2; RSPO2; KREMEN1; SALL1;	GO:0060173~limb development	5	32	15.625	0.016034329289125	0.0852519970940739	1	1	0.999999733847336	0.999999733847336	0.776190121722673
down	FGF10; EGFR; PLCB1; ADAMTS1; ANXA1;	GO:1900087~positive regulation of G1/S transition of mitotic cell cycle	5	32	15.625	0.016034329289125	0.0852519970940739	1	1	0.999999733847336	0.999999733847336	0.776190121722673
up	PIK3CD; CD4; CD3D; LCK; ZAP70; IL2; PREX1; TBX21; CD3G;	GO:0030217~T cell differentiation	9	34	26.4705882352941	0.0163998128718211	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
down	SNAP25; VAMP2; NFATC4; NTRK2; NLGN1; SHANK1;	GO:0060291~long-term synaptic potentiation	6	45	13.3333333333333	0.0165758555426818	0.0880385345384709	1	1	0.999999733847336	0.999999733847336	0.801560587071006
down	SULT2B1; CYP7B1; ABCA1; APOC1; CYP11A1; FDXR; STAR; CH25H;	GO:0008203~cholesterol metabolic process	8	73	10.958904109589	0.0167347486040615	0.0887890915957089	1	1	0.999999733847336	0.999999733847336	0.808394151016428
up	ITGB4; LAMB3; LAMC2; LAMA3; COL17A1;	GO:0031581~hemidesmosome assembly	5	12	41.6666666666667	0.0169575345917505	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
up	MEFV; IL10; SLAMF1; TIGIT; CMKLR1;	GO:0032695~negative regulation of interleukin-12 production	5	12	41.6666666666667	0.0169575345917505	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
down	DLL1; FGF10; LEFTY1; FOXF1; ARMC4; NPHP3; BICC1;	GO:0007368~determination of left/right symmetry	7	59	11.864406779661	0.0171227118673184	0.0898953728850586	1	1	0.999999733847336	0.999999733847336	0.818466461788131
down	EGFR; GM2A; PTPRZ1; CCL11; LHX8; SHC3; ZNF385A;	GO:0007611~learning or memory	7	59	11.864406779661	0.0171227118673184	0.0898953728850586	1	1	0.999999733847336	0.999999733847336	0.818466461788131
down	SCEL; OSR2; CAMSAP3; RAI2;	GO:0009792~embryo development ending in birth or egg hatching	4	21	19.047619047619	0.0171392627665062	0.0898953728850586	1	1	0.999999733847336	0.999999733847336	0.818466461788131
down	HSPB6; CFLAR; HAND2; AMBRA1;	GO:0010667~negative regulation of cardiac muscle cell apoptotic process	4	21	19.047619047619	0.0171392627665062	0.0898953728850586	1	1	0.999999733847336	0.999999733847336	0.818466461788131
down	VEGFD; FOXA1; RSPO2; SFRP1;	GO:0071542~dopaminergic neuron differentiation	4	21	19.047619047619	0.0171392627665062	0.0898953728850586	1	1	0.999999733847336	0.999999733847336	0.818466461788131
down	S100A8; S100A9; ELANE;	GO:0002523~leukocyte migration involved in inflammatory response	3	11	27.2727272727273	0.0172280184028384	0.0898953728850586	1	1	0.999999733847336	0.999999733847336	0.818466461788131
down	KITLG; BDKRB1; CCL8;	GO:0002687~positive regulation of leukocyte migration	3	11	27.2727272727273	0.0172280184028384	0.0898953728850586	1	1	0.999999733847336	0.999999733847336	0.818466461788131
down	BMP4; ISL1; MESP1;	GO:0003139~secondary heart field specification	3	11	27.2727272727273	0.0172280184028384	0.0898953728850586	1	1	0.999999733847336	0.999999733847336	0.818466461788131
down	CCL3; CCL26; CXCL16;	GO:0010818~T cell chemotaxis	3	11	27.2727272727273	0.0172280184028384	0.0898953728850586	1	1	0.999999733847336	0.999999733847336	0.818466461788131
down	VEGFC; KDF1; TBX18;	GO:0016331~morphogenesis of embryonic epithelium	3	11	27.2727272727273	0.0172280184028384	0.0898953728850586	1	1	0.999999733847336	0.999999733847336	0.818466461788131
down	LTA4H; PLA2G4A; MGST2;	GO:0019370~leukotriene biosynthetic process	3	11	27.2727272727273	0.0172280184028384	0.0898953728850586	1	1	0.999999733847336	0.999999733847336	0.818466461788131
down	AR; MGST1; PDGFRA;	GO:0033327~Leydig cell differentiation	3	11	27.2727272727273	0.0172280184028384	0.0898953728850586	1	1	0.999999733847336	0.999999733847336	0.818466461788131
down	FUT3; FUT2; FUT6;	GO:0036065~fucosylation	3	11	27.2727272727273	0.0172280184028384	0.0898953728850586	1	1	0.999999733847336	0.999999733847336	0.818466461788131
down	JAG1; SCUBE1; MESP1;	GO:0045446~endothelial cell differentiation	3	11	27.2727272727273	0.0172280184028384	0.0898953728850586	1	1	0.999999733847336	0.999999733847336	0.818466461788131
down	SLURP1; CNTNAP1; PRRT2;	GO:0050884~neuromuscular process controlling posture	3	11	27.2727272727273	0.0172280184028384	0.0898953728850586	1	1	0.999999733847336	0.999999733847336	0.818466461788131
down	CA12; ATP6V1B1; SLC12A6;	GO:0055064~chloride ion homeostasis	3	11	27.2727272727273	0.0172280184028384	0.0898953728850586	1	1	0.999999733847336	0.999999733847336	0.818466461788131
down	TSC2; STON1; PACSIN3; RAB5B; OPHN1;	GO:0030100~regulation of endocytosis	5	33	15.1515151515152	0.017864172155986	0.092735800164322	1	1	0.999999733847336	0.999999733847336	0.844327575554218
down	PDGFRB; LPAR1; ROBO1; LPAR4; GPR17;	GO:0035025~positive regulation of Rho protein signal transduction	5	33	15.1515151515152	0.017864172155986	0.092735800164322	1	1	0.999999733847336	0.999999733847336	0.844327575554218
down	SH3PXD2B; PDGFRB; FGFR1; HOXC8; TBX4;	GO:0048705~skeletal system morphogenesis	5	33	15.1515151515152	0.017864172155986	0.092735800164322	1	1	0.999999733847336	0.999999733847336	0.844327575554218
down	DLL1; IL1B; HOXB3; HES5; HES2;	GO:0050767~regulation of neurogenesis	5	33	15.1515151515152	0.017864172155986	0.092735800164322	1	1	0.999999733847336	0.999999733847336	0.844327575554218
down	IRAK2; IL1B; IL1R1; IRAK3; ANXA1;	GO:0070555~response to interleukin-1	5	33	15.1515151515152	0.017864172155986	0.092735800164322	1	1	0.999999733847336	0.999999733847336	0.844327575554218
down	TSC2; SQSTM1; DUOXA1; DUOXA2; CADM3; SPTSSA; CBY1; PARD3;	GO:0008104~protein localization	8	74	10.8108108108108	0.0179065204092195	0.0928601997812809	1	1	0.999999733847336	0.999999733847336	0.845460191294855
down	BMP7; PRKG1; IGSF9; EGFLAM; TMEFF1; NTN3;	GO:0016358~dendrite development	6	46	13.0434782608696	0.0181144208735433	0.0936498872387587	1	1	0.999999733847336	0.999999733847336	0.852650024080429
down	DCLK1; NR2F2; PRKG1; TWSG1; CHRD; PPARGC1A;	GO:0030900~forebrain development	6	46	13.0434782608696	0.0181144208735433	0.0936498872387587	1	1	0.999999733847336	0.999999733847336	0.852650024080429
down	PTGES; PDGFRB; RARG; GJB2; PPARG; AQP3;	GO:0032526~response to retinoic acid	6	46	13.0434782608696	0.0181144208735433	0.0936498872387587	1	1	0.999999733847336	0.999999733847336	0.852650024080429
up	LILRA5; ORM1; LPL; ORM2; NLRP12; LILRA2; TLR8; NLRP7; HMGB1P1;	GO:0050718~positive regulation of interleukin-1 beta secretion	9	35	25.7142857142857	0.0189517830870862	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
down	TMEM8B; PLK1; FOXG1; TTLL12; TTC28; MAP4K4; NRK; MAP2K5; PAK6;	GO:0007346~regulation of mitotic cell cycle	9	90	10	0.0190338741933637	0.0983027592542739	1	1	0.999999733847336	0.999999733847336	0.895012824005192
up	HLA-B; HLA-F; IL12RB1; B2M; CD1D; HLA-C; CD1C; HLA-G;	GO:0001916~positive regulation of T cell mediated cytotoxicity	8	29	27.5862068965517	0.0191095463880019	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
up	VIL1; HCLS1; AIF1; CORO7; LMOD2; PREX1; DIAPH3; MSRB1;	GO:0030041~actin filament polymerization	8	29	27.5862068965517	0.0191095463880019	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
down	CLDN4; EGFR; HTR7; NAMPT; NTRK2; HEBP1; PPARGC1A; NFIL3;	GO:0007623~circadian rhythm	8	75	10.6666666666667	0.0191359174374044	0.0987288242863428	1	1	0.999999733847336	0.999999733847336	0.898891999630115
down	ADORA1; NMU; PPARGC1A; ADRB3;	GO:0001659~temperature homeostasis	4	22	18.1818181818182	0.0196211913362758	0.100615875573126	1	1	0.999999733847336	0.999999733847336	0.91607295277974
down	FGF10; BMP7; SMAD3; SMAD1;	GO:0009880~embryonic pattern specification	4	22	18.1818181818182	0.0196211913362758	0.100615875573126	1	1	0.999999733847336	0.999999733847336	0.91607295277974
down	SMAD6; PRDM1; PLXND1; ROBO1;	GO:0035904~aorta development	4	22	18.1818181818182	0.0196211913362758	0.100615875573126	1	1	0.999999733847336	0.999999733847336	0.91607295277974
down	FGF10; CCNB1; ADAM15; KLK6;	GO:0042246~tissue regeneration	4	22	18.1818181818182	0.0196211913362758	0.100615875573126	1	1	0.999999733847336	0.999999733847336	0.91607295277974
down	PLAT; CSTA; CSTB; CAMK2N1;	GO:0045861~negative regulation of proteolysis	4	22	18.1818181818182	0.0196211913362758	0.100615875573126	1	1	0.999999733847336	0.999999733847336	0.91607295277974
down	WFS1; ATP6V1B1; SGCD; S100A14;	GO:0055074~calcium ion homeostasis	4	22	18.1818181818182	0.0196211913362758	0.100615875573126	1	1	0.999999733847336	0.999999733847336	0.91607295277974
down	EREG; BMP7; CXCL12; TRPV1; TIMP4; ANXA1;	GO:0043434~response to peptide hormone	6	47	12.7659574468085	0.0197478951544184	0.101060403672713	1	1	0.999999733847336	0.999999733847336	0.920120228286338
down	IMPA2; INPP1; PLCD1; PLCD3; ITPKC; PLCB1;	GO:0043647~inositol phosphate metabolic process	6	47	12.7659574468085	0.0197478951544184	0.101060403672713	1	1	0.999999733847336	0.999999733847336	0.920120228286338
down	MUSK; LAMB2; CACNB3; PDZRN3; TMEFF1;	GO:0007528~neuromuscular junction development	5	34	14.7058823529412	0.0198266566589262	0.10115600281236	1	1	0.999999733847336	0.999999733847336	0.920990625583395
down	IRAK2; IL1B; CCL3; CCL2; IL18;	GO:0031663~lipopolysaccharide-mediated signaling pathway	5	34	14.7058823529412	0.0198266566589262	0.10115600281236	1	1	0.999999733847336	0.999999733847336	0.920990625583395
down	CTDNEP1; BMP4; BMP7; SMO; PYGO1;	GO:0034504~protein localization to nucleus	5	34	14.7058823529412	0.0198266566589262	0.10115600281236	1	1	0.999999733847336	0.999999733847336	0.920990625583395
down	ADCY3; AR; GNPDA1; MST1R; MFGE8; LHFPL2; FETUB;	GO:0007338~single fertilization	7	61	11.4754098360656	0.0198953719116953	0.101404160974746	1	1	0.999999733847336	0.999999733847336	0.923250020328788
up	SELE; PTAFR; CCR2; FUT7;	GO:1903238~positive regulation of leukocyte tethering or rolling	4	8	50	0.0204882675199723	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
up	ITGB2; LYN; CD14; ITGAM; SCIMP; LY96;	GO:0034142~toll-like receptor 4 signaling pathway	6	18	33.3333333333333	0.0205411932055102	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
up	FLNA; VASP; ACTB; LIMS2; FBLIM1; FERMT2;	GO:0034329~cell junction assembly	6	18	33.3333333333333	0.0205411932055102	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
up	KCNQ1; CAV3; KCNH2; PKP2; SCN3B; KCNE4;	GO:0086005~ventricular cardiac muscle cell action potential	6	18	33.3333333333333	0.0205411932055102	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
down	SRD5A1; OSR1; OSR2;	GO:0001655~urogenital system development	3	12	25	0.0208976611816423	0.101841855640042	1	1	0.999999733847336	0.999999733847336	0.927235079765683
down	DLL1; BMP4; SMO;	GO:0003323~type B pancreatic cell development	3	12	25	0.0208976611816423	0.101841855640042	1	1	0.999999733847336	0.999999733847336	0.927235079765683
down	TKT; PGD; DERA;	GO:0006098~pentose-phosphate shunt	3	12	25	0.0208976611816423	0.101841855640042	1	1	0.999999733847336	0.999999733847336	0.927235079765683
down	FBXO27; FBXO17; NCCRP1;	GO:0006516~glycoprotein catabolic process	3	12	25	0.0208976611816423	0.101841855640042	1	1	0.999999733847336	0.999999733847336	0.927235079765683
down	CYP11A1; FDXR; STAR;	GO:0006700~C21-steroid hormone biosynthetic process	3	12	25	0.0208976611816423	0.101841855640042	1	1	0.999999733847336	0.999999733847336	0.927235079765683
down	CSF1; PBX1; SIX2;	GO:0030278~regulation of ossification	3	12	25	0.0208976611816423	0.101841855640042	1	1	0.999999733847336	0.999999733847336	0.927235079765683
down	KRT14; LAMC1; KRT5;	GO:0031581~hemidesmosome assembly	3	12	25	0.0208976611816423	0.101841855640042	1	1	0.999999733847336	0.999999733847336	0.927235079765683
down	PPIF; OXA1L; PXK;	GO:0032780~negative regulation of ATPase activity	3	12	25	0.0208976611816423	0.101841855640042	1	1	0.999999733847336	0.999999733847336	0.927235079765683
down	BMP2; TMEM119; HPSE;	GO:0033690~positive regulation of osteoblast proliferation	3	12	25	0.0208976611816423	0.101841855640042	1	1	0.999999733847336	0.999999733847336	0.927235079765683
down	ABCA1; APOC1; ABCA12;	GO:0033700~phospholipid efflux	3	12	25	0.0208976611816423	0.101841855640042	1	1	0.999999733847336	0.999999733847336	0.927235079765683
down	CXCL8; CXCL6; IL18;	GO:0042119~neutrophil activation	3	12	25	0.0208976611816423	0.101841855640042	1	1	0.999999733847336	0.999999733847336	0.927235079765683
down	UNC119B; PPARG; LRP1;	GO:0042953~lipoprotein transport	3	12	25	0.0208976611816423	0.101841855640042	1	1	0.999999733847336	0.999999733847336	0.927235079765683
down	CCL3; TFAP4; POU2F3;	GO:0043922~negative regulation by host of viral transcription	3	12	25	0.0208976611816423	0.101841855640042	1	1	0.999999733847336	0.999999733847336	0.927235079765683
down	SCD5; HSD17B8; PPT2;	GO:0046949~fatty-acyl-CoA biosynthetic process	3	12	25	0.0208976611816423	0.101841855640042	1	1	0.999999733847336	0.999999733847336	0.927235079765683
down	IRF6; MAF; HSF4;	GO:0048468~cell development	3	12	25	0.0208976611816423	0.101841855640042	1	1	0.999999733847336	0.999999733847336	0.927235079765683
down	NTF3; LRRK1; SFRP1;	GO:0050732~negative regulation of peptidyl-tyrosine phosphorylation	3	12	25	0.0208976611816423	0.101841855640042	1	1	0.999999733847336	0.999999733847336	0.927235079765683
down	MAGEL2; SCIN; WASL;	GO:0051127~positive regulation of actin nucleation	3	12	25	0.0208976611816423	0.101841855640042	1	1	0.999999733847336	0.999999733847336	0.927235079765683
down	ADRA1A; CACNB3; CACNA1C;	GO:0060402~calcium ion transport into cytosol	3	12	25	0.0208976611816423	0.101841855640042	1	1	0.999999733847336	0.999999733847336	0.927235079765683
down	SPINT1; NR2F2; ITGB8;	GO:0060674~placenta blood vessel development	3	12	25	0.0208976611816423	0.101841855640042	1	1	0.999999733847336	0.999999733847336	0.927235079765683
down	KCNJ2; CACNA1C; SCN5A;	GO:0086012~membrane depolarization during cardiac muscle cell action potential	3	12	25	0.0208976611816423	0.101841855640042	1	1	0.999999733847336	0.999999733847336	0.927235079765683
down	CEACAM1; CD9; PRKG1;	GO:0090331~negative regulation of platelet aggregation	3	12	25	0.0208976611816423	0.101841855640042	1	1	0.999999733847336	0.999999733847336	0.927235079765683
down	UBE2C; PLK1; CDC20;	GO:1904668~positive regulation of ubiquitin protein ligase activity	3	12	25	0.0208976611816423	0.101841855640042	1	1	0.999999733847336	0.999999733847336	0.927235079765683
down	SPINT2; TACSTD2; FBLN1;	GO:2000146~negative regulation of cell motility	3	12	25	0.0208976611816423	0.101841855640042	1	1	0.999999733847336	0.999999733847336	0.927235079765683
up	CD14; TLR1; SCIMP;	GO:0038123~toll-like receptor TLR1:TLR2 signaling pathway	3	4	75	0.0214549486162602	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
up	ITGB2; ITGAM; PTAFR;	GO:0043315~positive regulation of neutrophil degranulation	3	4	75	0.0214549486162602	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
up	ACTA1; MYOZ1; MYOZ2;	GO:0043503~skeletal muscle fiber adaptation	3	4	75	0.0214549486162602	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
up	LST1; GAL; IL2;	GO:0050672~negative regulation of lymphocyte proliferation	3	4	75	0.0214549486162602	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
down	CHL1; CSTB; GDNF; CXCL12; PREX2; SLITRK6;	GO:0008344~adult locomotory behavior	6	48	12.5	0.0214786578126078	0.101841855640042	1	1	0.999999733847336	0.999999733847336	0.927235079765683
down	HGF; ADRA1A; NAMPT; RASIP1; TAB3; DAPL1;	GO:0010507~negative regulation of autophagy	6	48	12.5	0.0214786578126078	0.101841855640042	1	1	0.999999733847336	0.999999733847336	0.927235079765683
down	FOXP2; PTPRS; SCN5A; LPAR1; FAIM2; PPARGC1A;	GO:0021549~cerebellum development	6	48	12.5	0.0214786578126078	0.101841855640042	1	1	0.999999733847336	0.999999733847336	0.927235079765683
up	CR1; FPR3; FPR1; CMKLR1; FPR2;	GO:0002430~complement receptor mediated signaling pathway	5	13	38.4615384615385	0.02170852318508	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
up	TPM1; MYL9; TNNT2; KCNA1; ANXA6;	GO:0006937~regulation of muscle contraction	5	13	38.4615384615385	0.02170852318508	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
up	CD74; CD27; FCGR2B; TLR8; FCER1G;	GO:0016064~immunoglobulin mediated immune response	5	13	38.4615384615385	0.02170852318508	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
up	CCR2; CARD11; SLC46A2; TBX21; PRELID1;	GO:0045580~regulation of T cell differentiation	5	13	38.4615384615385	0.02170852318508	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
down	SLPI; DNAJB2; CARD18; DAB2; NFATC4; EFHB; WFIKKN2; AURKB;	GO:0032091~negative regulation of protein binding	8	77	10.3896103896104	0.0217730923661951	0.101841855640042	1	1	0.999999733847336	0.999999733847336	0.927235079765683
up	SEMA7A; L1CAM; TWF2; ISLR2; TNFRSF12A; TRPC5; MACF1; TRPV2; HCLS1;	GO:0045773~positive regulation of axon extension	9	36	25	0.0217793371652492	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
down	KLK8; HMOX1; EMP1; EMP2; PMP22;	GO:0008219~cell death	5	35	14.2857142857143	0.0219250662759739	0.101841855640042	1	1	0.999999733847336	0.999999733847336	0.927235079765683
up	PF4; IL10; CORO1A; CXCR5; CNR2; SBDS; PPBP;	GO:0030595~leukocyte chemotaxis	7	24	29.1666666666667	0.0220346872788949	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
down	GLI3; VEGFC; FOXG1; SMO;	GO:0002052~positive regulation of neuroblast proliferation	4	23	17.3913043478261	0.0223134628571149	0.102180689837976	1	1	0.999999733847336	0.999999733847336	0.930320048637997
down	HOXA3; SVEP1; MESP1; NOX4;	GO:0010467~gene expression	4	23	17.3913043478261	0.0223134628571149	0.102180689837976	1	1	0.999999733847336	0.999999733847336	0.930320048637997
down	TSPAN12; SDK1; RDH13; HIPK2;	GO:0010842~retina layer formation	4	23	17.3913043478261	0.0223134628571149	0.102180689837976	1	1	0.999999733847336	0.999999733847336	0.930320048637997
down	FABP4; FABP5; MGLL; PNPLA3;	GO:0019433~triglyceride catabolic process	4	23	17.3913043478261	0.0223134628571149	0.102180689837976	1	1	0.999999733847336	0.999999733847336	0.930320048637997
down	HEXB; GM2A; PLIN2; LDAH;	GO:0019915~lipid storage	4	23	17.3913043478261	0.0223134628571149	0.102180689837976	1	1	0.999999733847336	0.999999733847336	0.930320048637997
down	OPHN1; KANK2; ARHGEF25; EPS8L1;	GO:0035023~regulation of Rho protein signal transduction	4	23	17.3913043478261	0.0223134628571149	0.102180689837976	1	1	0.999999733847336	0.999999733847336	0.930320048637997
down	VCAM1; AZU1; PTGFR; DEFB1;	GO:0035584~calcium-mediated signaling using intracellular calcium source	4	23	17.3913043478261	0.0223134628571149	0.102180689837976	1	1	0.999999733847336	0.999999733847336	0.930320048637997
down	IGF2; IGF1; CD24; IL18;	GO:0042104~positive regulation of activated T cell proliferation	4	23	17.3913043478261	0.0223134628571149	0.102180689837976	1	1	0.999999733847336	0.999999733847336	0.930320048637997
down	GLI3; GAS1; SMAD3; KDF1;	GO:0048589~developmental growth	4	23	17.3913043478261	0.0223134628571149	0.102180689837976	1	1	0.999999733847336	0.999999733847336	0.930320048637997
down	DLL1; PRRX1; JAG1; HES5;	GO:0097150~neuronal stem cell population maintenance	4	23	17.3913043478261	0.0223134628571149	0.102180689837976	1	1	0.999999733847336	0.999999733847336	0.930320048637997
down	HSPA1B; PLK1; CHMP4C; RCC1;	GO:1901673~regulation of mitotic spindle assembly	4	23	17.3913043478261	0.0223134628571149	0.102180689837976	1	1	0.999999733847336	0.999999733847336	0.930320048637997
down	ABCA1; POR; ALDH3A1; HMGCL; TGFBR2; PPARG; STAR;	GO:0007584~response to nutrient	7	63	11.1111111111111	0.022966596677104	0.10498124870231	1	1	0.999999733847336	0.999999733847336	0.955818174193931
down	FGF10; KLF4; LDB2; EPHA1; PBX1; SFRP1; SALL1;	GO:0035019~somatic stem cell population maintenance	7	63	11.1111111111111	0.022966596677104	0.10498124870231	1	1	0.999999733847336	0.999999733847336	0.955818174193931
down	PTPRZ1; CNTN4; PARD3; SPTBN4; NUMBL; SLITRK6; ISL2; ISL1;	GO:0007409~axonogenesis	8	78	10.2564102564103	0.0231835413520567	0.105781452004732	1	1	0.999999733847336	0.999999733847336	0.963103750132107
down	ANXA1; ALOX15; DUOXA1; DUOXA2; MGLL; CASP12; IL1R1; IL1RL2;	GO:0050727~regulation of inflammatory response	8	78	10.2564102564103	0.0231835413520567	0.105781452004732	1	1	0.999999733847336	0.999999733847336	0.963103750132107
down	IGF1; GPNMB; TWIST1; HAVCR2; NFKBIL1; IRAK3;	GO:0032720~negative regulation of tumor necrosis factor production	6	49	12.2448979591837	0.0233089713428126	0.106161960552341	1	1	0.999999733847336	0.999999733847336	0.966568149629511
down	CHL1; CBR3; LHCGR; ADORA1; HOXA1; TMPRSS11E;	GO:0050890~cognition	6	49	12.2448979591837	0.0233089713428126	0.106161960552341	1	1	0.999999733847336	0.999999733847336	0.966568149629511
up	ACTN1; RAC2; ARHGAP25; CAV3; TMSB10; PACSIN1; SHROOM4; SHROOM3; LMOD3; MYO1G; RHOG; TMOD1; RHOJ; LMOD1; CORO1A; MYO7B; CORO7; TPM1; MYOM3; LMOD2; MYO1F;	GO:0007015~actin filament organization	21	121	17.3553719008264	0.0238661248432648	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
down	CFLAR; CEACAM1; SRD5A1; PPARG; STAR; RAB13; VAMP2; ZFP36L1; WDTC1;	GO:0032869~cellular response to insulin stimulus	9	94	9.57446808510638	0.0239620315856273	0.109038037422526	1	1	0.999999733847336	0.999999733847336	0.992753840663689
down	TRPA1; PPARG; ACOT11; PPARGC1A; SLC25A27;	GO:0009409~response to cold	5	36	13.8888888888889	0.0241624214789571	0.109653540781862	1	1	0.999999733847336	0.999999733847336	0.998357787124636
down	KLF4; FGFR1; HES5; LTBP4; KLK6;	GO:0045595~regulation of cell differentiation	5	36	13.8888888888889	0.0241624214789571	0.109653540781862	1	1	0.999999733847336	0.999999733847336	0.998357787124636
down	NRP1; VEGFD; NRP2; VEGFC; SHC2; FOXC2; WASF2;	GO:0048010~vascular endothelial growth factor receptor signaling pathway	7	64	10.9375	0.0246184026729364	0.110593450927858	1	1	0.999999733847336	0.999999733847336	1
down	EGFR; AGT; IL1B; ENG; AQP1; LTBR; KCNJ2; PIEZO2;	GO:0071260~cellular response to mechanical stimulus	8	79	10.126582278481	0.024656953037404	0.110593450927858	1	1	0.999999733847336	0.999999733847336	1
up	SLC4A1; SLC4A2; LRRC8A; SLC26A7; SLC26A8; SLC17A3;	GO:0006820~anion transport	6	19	31.5789473684211	0.0249433117949521	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
up	TYROBP; GNAI2; ITGB2; ITGAM; CYBA; FPR2;	GO:0032930~positive regulation of superoxide anion generation	6	19	31.5789473684211	0.0249433117949521	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
up	SELL; SPN; SELE; ITGB7; CX3CR1; SELPLG;	GO:0050901~leukocyte tethering or rolling	6	19	31.5789473684211	0.0249433117949521	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
down	GPNMB; TWSG1; NDRG2;	GO:0001818~negative regulation of cytokine production	3	13	23.0769230769231	0.0249607075940919	0.110593450927858	1	1	0.999999733847336	0.999999733847336	1
down	ADORA1; NLGN1; NLGN2;	GO:0002087~regulation of respiratory gaseous exchange by nervous system process	3	13	23.0769230769231	0.0249607075940919	0.110593450927858	1	1	0.999999733847336	0.999999733847336	1
down	BMP4; ISL1; JAG1;	GO:0003215~cardiac right ventricle morphogenesis	3	13	23.0769230769231	0.0249607075940919	0.110593450927858	1	1	0.999999733847336	0.999999733847336	1
down	QPRT; KYNU; NAPRT;	GO:0009435~NAD biosynthetic process	3	13	23.0769230769231	0.0249607075940919	0.110593450927858	1	1	0.999999733847336	0.999999733847336	1
down	ABCA1; PPARG; NR1H3;	GO:0010745~negative regulation of macrophage derived foam cell differentiation	3	13	23.0769230769231	0.0249607075940919	0.110593450927858	1	1	0.999999733847336	0.999999733847336	1
down	CTDNEP1; NR1H3; RGN;	GO:0010867~positive regulation of triglyceride biosynthetic process	3	13	23.0769230769231	0.0249607075940919	0.110593450927858	1	1	0.999999733847336	0.999999733847336	1
down	PTPRS; RTN4RL2; LPAR1;	GO:0022038~corpus callosum development	3	13	23.0769230769231	0.0249607075940919	0.110593450927858	1	1	0.999999733847336	0.999999733847336	1
down	PRRT2; SNAP25; SNAP29;	GO:0031629~synaptic vesicle fusion to presynaptic active zone membrane	3	13	23.0769230769231	0.0249607075940919	0.110593450927858	1	1	0.999999733847336	0.999999733847336	1
down	ADRA1A; NLGN1; NLGN2;	GO:0032230~positive regulation of synaptic transmission, GABAergic	3	13	23.0769230769231	0.0249607075940919	0.110593450927858	1	1	0.999999733847336	0.999999733847336	1
down	TNXB; TNS2; P3H3;	GO:0032963~collagen metabolic process	3	13	23.0769230769231	0.0249607075940919	0.110593450927858	1	1	0.999999733847336	0.999999733847336	1
down	PENK; DLG4; NLGN2;	GO:0035641~locomotory exploration behavior	3	13	23.0769230769231	0.0249607075940919	0.110593450927858	1	1	0.999999733847336	0.999999733847336	1
down	CSF1; ROR2; TRIB1;	GO:0045651~positive regulation of macrophage differentiation	3	13	23.0769230769231	0.0249607075940919	0.110593450927858	1	1	0.999999733847336	0.999999733847336	1
down	APOC1; CEACAM1; WDTC1;	GO:0045717~negative regulation of fatty acid biosynthetic process	3	13	23.0769230769231	0.0249607075940919	0.110593450927858	1	1	0.999999733847336	0.999999733847336	1
down	PLPP1; PLPP3; PLPP2;	GO:0046839~phospholipid dephosphorylation	3	13	23.0769230769231	0.0249607075940919	0.110593450927858	1	1	0.999999733847336	0.999999733847336	1
down	IGF1; TSC2; PLCB1;	GO:0048009~insulin-like growth factor receptor signaling pathway	3	13	23.0769230769231	0.0249607075940919	0.110593450927858	1	1	0.999999733847336	0.999999733847336	1
down	FGF10; HGF; EHF;	GO:0050673~epithelial cell proliferation	3	13	23.0769230769231	0.0249607075940919	0.110593450927858	1	1	0.999999733847336	0.999999733847336	1
down	FGF10; FOXF1; NFATC4;	GO:0051145~smooth muscle cell differentiation	3	13	23.0769230769231	0.0249607075940919	0.110593450927858	1	1	0.999999733847336	0.999999733847336	1
down	ACTC1; SGCD; SGCG;	GO:0060047~heart contraction	3	13	23.0769230769231	0.0249607075940919	0.110593450927858	1	1	0.999999733847336	0.999999733847336	1
down	WNT2; BMP2; ADAM15;	GO:0060317~cardiac epithelial to mesenchymal transition	3	13	23.0769230769231	0.0249607075940919	0.110593450927858	1	1	0.999999733847336	0.999999733847336	1
down	BMP2; TGFBR2; GDF6;	GO:0060389~pathway-restricted SMAD protein phosphorylation	3	13	23.0769230769231	0.0249607075940919	0.110593450927858	1	1	0.999999733847336	0.999999733847336	1
down	ISL1; TBX5; SMO;	GO:0060413~atrial septum morphogenesis	3	13	23.0769230769231	0.0249607075940919	0.110593450927858	1	1	0.999999733847336	0.999999733847336	1
down	IRF6; HOXA5; SMO;	GO:0060644~mammary gland epithelial cell differentiation	3	13	23.0769230769231	0.0249607075940919	0.110593450927858	1	1	0.999999733847336	0.999999733847336	1
down	NLGN1; NLGN2; FZD1;	GO:0099054~presynapse assembly	3	13	23.0769230769231	0.0249607075940919	0.110593450927858	1	1	0.999999733847336	0.999999733847336	1
down	HTR1B; ADORA1; P2RY1;	GO:0099509~regulation of presynaptic cytosolic calcium ion concentration	3	13	23.0769230769231	0.0249607075940919	0.110593450927858	1	1	0.999999733847336	0.999999733847336	1
down	TACSTD2; FBLN1; EFNA5;	GO:1900025~negative regulation of substrate adhesion-dependent cell spreading	3	13	23.0769230769231	0.0249607075940919	0.110593450927858	1	1	0.999999733847336	0.999999733847336	1
down	VEGFC; RAP2B; GPNMB; PDGFD;	GO:0031954~positive regulation of protein autophosphorylation	4	24	16.6666666666667	0.0252198613321772	0.111152720149753	1	1	0.999999733847336	0.999999733847336	1
down	CYP2E1; LTA4H; HPGD; ALOX15;	GO:0042759~long-chain fatty acid biosynthetic process	4	24	16.6666666666667	0.0252198613321772	0.111152720149753	1	1	0.999999733847336	0.999999733847336	1
down	CD24; ROR2; NTRK2; MUSK;	GO:0043408~regulation of MAPK cascade	4	24	16.6666666666667	0.0252198613321772	0.111152720149753	1	1	0.999999733847336	0.999999733847336	1
down	CCL3; SFRP1; TMEM178A; MAFB;	GO:0045671~negative regulation of osteoclast differentiation	4	24	16.6666666666667	0.0252198613321772	0.111152720149753	1	1	0.999999733847336	0.999999733847336	1
down	HRH1; SCTR; EIF4EBP2; CNTN4; FGF14; RIMS4;	GO:0048167~regulation of synaptic plasticity	6	50	12	0.0252409760466772	0.111152720149753	1	1	0.999999733847336	0.999999733847336	1
down	NR2F2; NR2F1; SIX2; SIX5; TFAP2C; ROR2;	GO:0048856~anatomical structure development	6	50	12	0.0252409760466772	0.111152720149753	1	1	0.999999733847336	0.999999733847336	1
down	CCL21; TRPA1; TRPV1; PLCD1; PLCB1; PLCD3;	GO:0051209~release of sequestered calcium ion into cytosol	6	50	12	0.0252409760466772	0.111152720149753	1	1	0.999999733847336	0.999999733847336	1
up	RS1; ADAM12; PSTPIP1; NUAK1; CD4; ITGB3; ITGB2; HCK; ITGAM; SELL; ITGB4; VCL; ITGB6; CDH2; CD22; ANOS1; IL32; TNC; FPR2; ITGB7; L1CAM; THBS2; MYH10; GP5; MCAM; CX3CR1; CXCR3; CCR3; CCR8; IL2; SPOCK1; FAP; SLAMF1; LAMC2; SELPLG; ADGRE1; NEDD9; MYBPC3; COL19A1; PGM5; AOC3; FREM2; THEMIS2; OLFM4; CSF3R; FERMT1; NTM; SIRPG; CD300A; ITGA11; CLEC4A; NINJ2; SIGLEC6; SIGLEC10; ICAM2; SIGLEC14; FES; SIGLEC9; CD33; ICAM3; ICAM5; NINJ1;	GO:0007155~cell adhesion	62	454	13.6563876651982	0.0253115995118952	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
up	WNT1; RAC2; FSCN1; CARMIL2; TWF2; FRMD7; AKIRIN1;	GO:0010592~positive regulation of lamellipodium assembly	7	25	28	0.0259910060809304	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
down	CFLAR; ADORA1; DAPK1; PTGIS; CASP12; IFI27; DAPL1;	GO:0097190~apoptotic signaling pathway	7	65	10.7692307692308	0.0263497993129149	0.115934526419454	1	1	0.999999733847336	0.999999733847336	1
down	DLX3; GJB3; ANG; DCN; PPARG;	GO:0001890~placenta development	5	37	13.5135135135135	0.0265414736227511	0.116473486766738	1	1	0.999999733847336	0.999999733847336	1
down	ROR2; FZD2; MOV10; PLCB1; FZD4;	GO:0007223~Wnt signaling pathway, calcium modulating pathway	5	37	13.5135135135135	0.0265414736227511	0.116473486766738	1	1	0.999999733847336	0.999999733847336	1
down	SYP; NLGN2; NLGN1; OPHN1; FCHO2;	GO:0048488~synaptic vesicle endocytosis	5	37	13.5135135135135	0.0265414736227511	0.116473486766738	1	1	0.999999733847336	0.999999733847336	1
down	CCL3; MIF; ISL1; NFATC4; TWIST1; SPON2;	GO:0032760~positive regulation of tumor necrosis factor production	6	51	11.7647058823529	0.0272766852720476	0.119595952525271	1	1	0.999999733847336	0.999999733847336	1
up	IGHD; ORM1; ORM2; HMGB1P1;	GO:0050716~positive regulation of interleukin-1 secretion	4	9	44.4444444444444	0.0274439191127827	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
up	SEMA7A; CD74; HLA-G; LILRB1;	GO:0060907~positive regulation of macrophage cytokine production	4	9	44.4444444444444	0.0274439191127827	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
up	DYSF; CAV3; PLPP4; FCRL3;	GO:0090279~regulation of calcium ion import	4	9	44.4444444444444	0.0274439191127827	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
down	CYP4B1; CYP2J2; CYP2S1; CYP2E1;	GO:0042738~exogenous drug catabolic process	4	25	16	0.0283434703452992	0.122027138262921	1	1	0.999999733847336	0.999999733847336	1
down	CTSV; GJB2; PTGIS; TPPP3;	GO:0046697~decidualization	4	25	16	0.0283434703452992	0.122027138262921	1	1	0.999999733847336	0.999999733847336	1
down	ALAD; MRC1; NFIL3; ADAMTS13;	GO:0071353~cellular response to interleukin-4	4	25	16	0.0283434703452992	0.122027138262921	1	1	0.999999733847336	0.999999733847336	1
down	CTSK; SQSTM1; AMBRA1; PPARGC1A; MAP1LC3C;	GO:0000422~autophagy of mitochondrion	5	38	13.1578947368421	0.0290647002269491	0.122027138262921	1	1	0.999999733847336	0.999999733847336	1
down	ANG; INHA; ICAM1; KITLG; MMP19;	GO:0001541~ovarian follicle development	5	38	13.1578947368421	0.0290647002269491	0.122027138262921	1	1	0.999999733847336	0.999999733847336	1
down	VIM; DES; TNNT3; ACTC1; ACTN3;	GO:0030049~muscle filament sliding	5	38	13.1578947368421	0.0290647002269491	0.122027138262921	1	1	0.999999733847336	0.999999733847336	1
down	SLC9A3; SLC9A5; SLC24A3; SLC9A8; SLC13A3;	GO:0098656~anion transmembrane transport	5	38	13.1578947368421	0.0290647002269491	0.122027138262921	1	1	0.999999733847336	0.999999733847336	1
down	HOXA5; CCBE1; NDN;	GO:0003016~respiratory system process	3	14	21.4285714285714	0.029416485413623	0.122027138262921	1	1	0.999999733847336	0.999999733847336	1
down	ADRA1A; HAND2; SCUBE1;	GO:0007512~adult heart development	3	14	21.4285714285714	0.029416485413623	0.122027138262921	1	1	0.999999733847336	0.999999733847336	1
down	SFN; SLURP1; KDF1;	GO:0010839~negative regulation of keratinocyte proliferation	3	14	21.4285714285714	0.029416485413623	0.122027138262921	1	1	0.999999733847336	0.999999733847336	1
down	KLF4; TSC2; TWIST1;	GO:0014067~negative regulation of phosphatidylinositol 3-kinase signaling	3	14	21.4285714285714	0.029416485413623	0.122027138262921	1	1	0.999999733847336	0.999999733847336	1
down	DCN; HEXB; IDUA;	GO:0030207~chondroitin sulfate catabolic process	3	14	21.4285714285714	0.029416485413623	0.122027138262921	1	1	0.999999733847336	0.999999733847336	1
down	"NAMPT; PTGIS; NAPRT;"	GO:0034356~NAD biosynthesis via nicotinamide riboside salvage pathway	3	14	21.4285714285714	0.029416485413623	0.122027138262921	1	1	0.999999733847336	0.999999733847336	1
down	SLC37A2; ADAMTS8; SLC25A10;	GO:0035435~phosphate ion transmembrane transport	3	14	21.4285714285714	0.029416485413623	0.122027138262921	1	1	0.999999733847336	0.999999733847336	1
down	P2RY2; P2RY1; GPR87;	GO:0035589~G protein-coupled purinergic nucleotide receptor signaling pathway	3	14	21.4285714285714	0.029416485413623	0.122027138262921	1	1	0.999999733847336	0.999999733847336	1
down	AGT; NPR1; EDNRB;	GO:0035815~positive regulation of renal sodium excretion	3	14	21.4285714285714	0.029416485413623	0.122027138262921	1	1	0.999999733847336	0.999999733847336	1
down	ALDH9A1; FOXA1; KLK6;	GO:0042445~hormone metabolic process	3	14	21.4285714285714	0.029416485413623	0.122027138262921	1	1	0.999999733847336	0.999999733847336	1
down	FGF10; FABP4; PPARG;	GO:0050872~white fat cell differentiation	3	14	21.4285714285714	0.029416485413623	0.122027138262921	1	1	0.999999733847336	0.999999733847336	1
down	SCNN1A; SCNN1B; SCNN1D;	GO:0050909~sensory perception of taste	3	14	21.4285714285714	0.029416485413623	0.122027138262921	1	1	0.999999733847336	0.999999733847336	1
down	IGF2; IGFBP5; POPDC3;	GO:0051146~striated muscle cell differentiation	3	14	21.4285714285714	0.029416485413623	0.122027138262921	1	1	0.999999733847336	0.999999733847336	1
down	DLL1; MNS1; SMO;	GO:0070986~left/right axis specification	3	14	21.4285714285714	0.029416485413623	0.122027138262921	1	1	0.999999733847336	0.999999733847336	1
down	CDH1; FABP4; NFATC4;	GO:0071285~cellular response to lithium ion	3	14	21.4285714285714	0.029416485413623	0.122027138262921	1	1	0.999999733847336	0.999999733847336	1
down	NFIB; BMP4; NFATC4;	GO:1902894~negative regulation of pri-miRNA transcription by RNA polymerase II	3	14	21.4285714285714	0.029416485413623	0.122027138262921	1	1	0.999999733847336	0.999999733847336	1
down	KCNK2; ACVRL1; RGN;	GO:2000279~negative regulation of DNA biosynthetic process	3	14	21.4285714285714	0.029416485413623	0.122027138262921	1	1	0.999999733847336	0.999999733847336	1
up	PDGFA; NCKAP1L; RHOJ; PARVG; RHOG; RAC2;	GO:0030031~cell projection assembly	6	20	30	0.0299315607493054	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
down	FOXP2; PRDM1; BMP4; SCUBE1; NDN; STK36; PLAGL2;	GO:0009791~post-embryonic development	7	67	10.4477611940298	0.0300573323856671	0.122139650748194	1	1	0.999999733847336	0.999999733847336	1
down	SPINT2; PARD3; RHOD; RHOU; RHOV; RHOBTB3;	GO:0007163~establishment or maintenance of cell polarity	6	53	11.3207547169811	0.0316666108419014	0.12814207829228	1	1	0.999999733847336	0.999999733847336	1
down	CCL21; EREG; CSF1; AZU1; VEGFC; DDR2;	GO:0045860~positive regulation of protein kinase activity	6	53	11.3207547169811	0.0316666108419014	0.12814207829228	1	1	0.999999733847336	0.999999733847336	1
down	EGFR; LGALS3; LRP1; SQSTM1; ARHGEF16; CLIP3;	GO:1903078~positive regulation of protein localization to plasma membrane	6	53	11.3207547169811	0.0316666108419014	0.12814207829228	1	1	0.999999733847336	0.999999733847336	1
down	AGT; SNAP25; RIN1; SHANK1;	GO:0008306~associative learning	4	26	15.3846153846154	0.0316866869505164	0.12814207829228	1	1	0.999999733847336	0.999999733847336	1
down	GNA15; GPR157; LPAR1; LPAR4; GPR17;	GO:0051482~positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway	5	39	12.8205128205128	0.0317343015832541	0.128231965837613	1	1	0.999999733847336	0.999999733847336	1
up	FCGR2B; ZPBP2; FCRL3;	GO:0002638~negative regulation of immunoglobulin production	3	5	60	0.0319702279464725	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
up	TSKU; PLXNA4; NR2E1;	GO:0021960~anterior commissure morphogenesis	3	5	60	0.0319702279464725	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
up	PCMT1; MSRB3; MSRB1;	GO:0030091~protein repair	3	5	60	0.0319702279464725	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
up	UNC13B; RGS14; UNC13C;	GO:0031914~negative regulation of synaptic plasticity	3	5	60	0.0319702279464725	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
up	CNR2; CD300LF; CD84;	GO:0033004~negative regulation of mast cell activation	3	5	60	0.0319702279464725	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
up	CHRM4; HTR1D; FBXO7;	GO:0040012~regulation of locomotion	3	5	60	0.0319702279464725	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
up	ACTA2; ACTG2; ACTA1;	GO:0090131~mesenchyme migration	3	5	60	0.0319702279464725	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
up	SYT6; UNC13C; UNC13B;	GO:0099525~presynaptic dense core vesicle exocytosis	3	5	60	0.0319702279464725	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
up	ALOX5; ALOX5AP; LTC4S;	GO:2001301~lipoxin biosynthetic process	3	5	60	0.0319702279464725	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
down	ALDH2; POR; SRD5A1; MAOB; AOX1; ASPH; NOX4;	GO:0022900~electron transport chain	7	68	10.2941176470588	0.0320362689720018	0.129245363081135	1	1	0.999999733847336	0.999999733847336	1
down	SMAD6; TGFBR2; HTRA3; SMAD3; PEG10; WFIKKN2; EMILIN1;	GO:0030512~negative regulation of transforming growth factor beta receptor signaling pathway	7	68	10.2941176470588	0.0320362689720018	0.129245363081135	1	1	0.999999733847336	0.999999733847336	1
down	DCLK1; PLXNB1; MAP4K4; CXCL1; HMOX1; CXCL8; IGFBP5; ADRA1A; ADRA1B; DAPK1; SQSTM1; TNS2; DEPTOR; ACOT11; DVL3; SDCBP2; MKNK2; PLA2G4C; MOK; PPP1R1A; MAPK10; IRAK3; IRAK2; PPP1R1B;	GO:0035556~intracellular signal transduction	24	371	6.46900269541779	0.0328077581977866	0.132252184083815	1	1	0.999999733847336	0.999999733847336	1
up	LIF; PTPN6; NCKAP1L; TGFB2; FERMT1;	GO:0033630~positive regulation of cell adhesion mediated by integrin	5	15	33.3333333333333	0.033604132562515	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
up	IFNG; IL2RA; CTLA4; CR1; IL2;	GO:0045589~regulation of regulatory T cell differentiation	5	15	33.3333333333333	0.033604132562515	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
down	WFS1; HMOX1; HAND2; TWIST1; SFRP4; TRIB1; GLIS2;	GO:0043433~negative regulation of DNA-binding transcription factor activity	7	69	10.1449275362319	0.0341003912991662	0.135625810143119	1	1	0.999999733847336	0.999999733847336	1
down	GGT5; GGT6; MGST2;	GO:0006750~glutathione biosynthetic process	3	15	20	0.0342622319823045	0.135625810143119	1	1	0.999999733847336	0.999999733847336	1
down	CP; HEPHL1; HEPH;	GO:0006825~copper ion transport	3	15	20	0.0342622319823045	0.135625810143119	1	1	0.999999733847336	0.999999733847336	1
down	NFIB; FGF5; KLF15;	GO:0010001~glial cell differentiation	3	15	20	0.0342622319823045	0.135625810143119	1	1	0.999999733847336	0.999999733847336	1
down	CSF1; CXCL17; RARRES2;	GO:0010759~positive regulation of macrophage chemotaxis	3	15	20	0.0342622319823045	0.135625810143119	1	1	0.999999733847336	0.999999733847336	1
down	IL1R2; GAS1; TMEM98;	GO:0010955~negative regulation of protein processing	3	15	20	0.0342622319823045	0.135625810143119	1	1	0.999999733847336	0.999999733847336	1
down	SPINT2; CDH1; JAG1;	GO:0022408~negative regulation of cell-cell adhesion	3	15	20	0.0342622319823045	0.135625810143119	1	1	0.999999733847336	0.999999733847336	1
down	ACOX2; ACOXL; CROT;	GO:0033540~fatty acid beta-oxidation using acyl-CoA oxidase	3	15	20	0.0342622319823045	0.135625810143119	1	1	0.999999733847336	0.999999733847336	1
down	CCL21; ADAM9; FOXC2;	GO:0033630~positive regulation of cell adhesion mediated by integrin	3	15	20	0.0342622319823045	0.135625810143119	1	1	0.999999733847336	0.999999733847336	1
down	TYRO3; NFKBIL1; IRAK3;	GO:0034122~negative regulation of toll-like receptor signaling pathway	3	15	20	0.0342622319823045	0.135625810143119	1	1	0.999999733847336	0.999999733847336	1
down	SOX18; TBX2; FOXC2;	GO:0035050~embryonic heart tube development	3	15	20	0.0342622319823045	0.135625810143119	1	1	0.999999733847336	0.999999733847336	1
down	WFS1; MECOM; KANK2;	GO:0043069~negative regulation of programmed cell death	3	15	20	0.0342622319823045	0.135625810143119	1	1	0.999999733847336	0.999999733847336	1
down	SYNGR1; SYP; GRIK2;	GO:0048172~regulation of short-term neuronal synaptic plasticity	3	15	20	0.0342622319823045	0.135625810143119	1	1	0.999999733847336	0.999999733847336	1
down	IL1B; APOC1; ADORA1;	GO:0050995~negative regulation of lipid catabolic process	3	15	20	0.0342622319823045	0.135625810143119	1	1	0.999999733847336	0.999999733847336	1
down	KRT1; KRT10; HSD17B8;	GO:0051290~protein heterotetramerization	3	15	20	0.0342622319823045	0.135625810143119	1	1	0.999999733847336	0.999999733847336	1
down	CCL2; NAMPT; AKAP12;	GO:0051770~positive regulation of nitric-oxide synthase biosynthetic process	3	15	20	0.0342622319823045	0.135625810143119	1	1	0.999999733847336	0.999999733847336	1
down	HTR1B; ADORA1; GRIK2;	GO:0051967~negative regulation of synaptic transmission, glutamatergic	3	15	20	0.0342622319823045	0.135625810143119	1	1	0.999999733847336	0.999999733847336	1
down	BMP4; DAB2; RBPMS;	GO:0060391~positive regulation of SMAD protein signal transduction	3	15	20	0.0342622319823045	0.135625810143119	1	1	0.999999733847336	0.999999733847336	1
down	TCF21; DAB2; SFRP1;	GO:0060766~negative regulation of androgen receptor signaling pathway	3	15	20	0.0342622319823045	0.135625810143119	1	1	0.999999733847336	0.999999733847336	1
down	FRZB; SMO; MEOX2;	GO:0061053~somite development	3	15	20	0.0342622319823045	0.135625810143119	1	1	0.999999733847336	0.999999733847336	1
down	AZU1; FIBIN; PLVAP;	GO:0070528~protein kinase C signaling	3	15	20	0.0342622319823045	0.135625810143119	1	1	0.999999733847336	0.999999733847336	1
down	NIPAL1; NIPAL3; NIPAL2;	GO:1903830~magnesium ion transmembrane transport	3	15	20	0.0342622319823045	0.135625810143119	1	1	0.999999733847336	0.999999733847336	1
down	NKX6-1; IGSF10; SCRT1;	GO:2001222~regulation of neuron migration	3	15	20	0.0342622319823045	0.135625810143119	1	1	0.999999733847336	0.999999733847336	1
down	ADCY6; ADCY3; ADRB3; LHCGR; ADCY2;	GO:0007190~activation of adenylate cyclase activity	5	40	12.5	0.0345521986205564	0.136559589383748	1	1	0.999999733847336	0.999999733847336	1
down	PENK; HMOX1; STAR; NKX6-1; PPP1R1B;	GO:0035094~response to nicotine	5	40	12.5	0.0345521986205564	0.136559589383748	1	1	0.999999733847336	0.999999733847336	1
down	CXCL8; CCL3; EDNRB; SGCD; ACKR4; CALML6; CALML3; CCRL2;	GO:0019722~calcium-mediated signaling	8	85	9.41176470588235	0.0348863208426372	0.137772327268304	1	1	0.999999733847336	0.999999733847336	1
down	CDK1; CCNB1; PBX1; DBF4B;	GO:0010971~positive regulation of G2/M transition of mitotic cell cycle	4	27	14.8148148148148	0.0352512386177342	0.138887680388592	1	1	0.999999733847336	0.999999733847336	1
down	GLI3; KIF7; MEGF8; GLIS2;	GO:0045879~negative regulation of smoothened signaling pathway	4	27	14.8148148148148	0.0352512386177342	0.138887680388592	1	1	0.999999733847336	0.999999733847336	1
down	ADORA1; NR1H3; IL18; ANGPTL4;	GO:0070328~triglyceride homeostasis	4	27	14.8148148148148	0.0352512386177342	0.138887680388592	1	1	0.999999733847336	0.999999733847336	1
up	PTPN6; NFAM1; FCRL3; CARD11;	GO:0045577~regulation of B cell differentiation	4	10	40	0.0356408495373621	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
up	SYT7; HCK; FGR; OLFM4;	GO:0050764~regulation of phagocytosis	4	10	40	0.0356408495373621	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
down	RAMP2; STAM2; CLTB; AP3S2; WLS; MLPH; KIF13A; GGA3; MYO6; RAB25; TBC1D3E; RAB38; TBC1D8; GRTP1; RAB7B; RAB5B; TBC1D5; TBC1D12; SGSM2; RAB13; TSNARE1;	GO:0006886~intracellular protein transport	21	317	6.62460567823344	0.0356847709176291	0.140376774069272	1	1	0.999999733847336	0.999999733847336	1
down	RAMP2; BMP2; BMP4; LRP1; HFE; HIPK2; PLXND1;	GO:0032092~positive regulation of protein binding	7	70	10	0.0362509043140928	0.142492854233839	1	1	0.999999733847336	0.999999733847336	1
up	CD3EAP; DOK2; CD4; LYN; CD7; CD8B; TRAT1; RASGRP4; SLA; FLT4; NEDD9; FGR; FES; HCK; LTK; CLNK; BLK; NGF; FLT3; LCK;	GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway	20	120	16.6666666666667	0.0372149666263549	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
down	PLK1; FLCN; KIF13A; AURKC; AURKB;	GO:0032465~regulation of cytokinesis	5	41	12.1951219512195	0.037520031956861	0.143408184207386	1	1	0.999999733847336	0.999999733847336	1
down	HMGCL; PPARG; PDK4; TBC1D5; PPARGC1A;	GO:0042594~response to starvation	5	41	12.1951219512195	0.037520031956861	0.143408184207386	1	1	0.999999733847336	0.999999733847336	1
down	WFS1; FOXRED2; FBXO17; NCCRP1; FBXO27; DNAJB2; UBE4B;	GO:0030433~ubiquitin-dependent ERAD pathway	7	71	9.85915492957746	0.038488930962182	0.143408184207386	1	1	0.999999733847336	0.999999733847336	1
down	CNGA3; ATP13A5; ANO1; PIEZO2;	GO:0006812~cation transport	4	28	14.2857142857143	0.039038202779539	0.143408184207386	1	1	0.999999733847336	0.999999733847336	1
down	MID1; FGF13; TPX2; CAMSAP3;	GO:0007026~negative regulation of microtubule depolymerization	4	28	14.2857142857143	0.039038202779539	0.143408184207386	1	1	0.999999733847336	0.999999733847336	1
down	ADRB3; ADRA1B; ADRA1A; SHANK1;	GO:0007610~behavior	4	28	14.2857142857143	0.039038202779539	0.143408184207386	1	1	0.999999733847336	0.999999733847336	1
down	CLDN4; EFNA5; ZMYM3; SH3D19;	GO:0022604~regulation of cell morphogenesis	4	28	14.2857142857143	0.039038202779539	0.143408184207386	1	1	0.999999733847336	0.999999733847336	1
down	WNT2; SERPINF1; STAR; NUMBL;	GO:0050769~positive regulation of neurogenesis	4	28	14.2857142857143	0.039038202779539	0.143408184207386	1	1	0.999999733847336	0.999999733847336	1
down	H6PD; IGF2; FABP5; PDK4; GDPGP1; WDTC1;	GO:0006006~glucose metabolic process	6	56	10.7142857142857	0.0390718841444636	0.143408184207386	1	1	0.999999733847336	0.999999733847336	1
down	CDK1; CCNB1; SFN; ZNF385A; PIDD1; PLAGL1;	GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest	6	56	10.7142857142857	0.0390718841444636	0.143408184207386	1	1	0.999999733847336	0.999999733847336	1
up	SRPX2; ITGB2; KRT18; PKHD1; ICAM2; CDH2; CD33; COL8A2; ICAM3; PPP1CA; ADAM8; COL19A1; CNN3; FBLIM1; PDLIM5; PKP2; ROPN1B; TENM2; ICAM5; LAMA3; LIMS2; CELSR1; FAT3; ICOS;	GO:0098609~cell-cell adhesion	24	152	15.7894736842105	0.0393897861568004	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
down	TCF21; SOX18; B9D1;	GO:0001944~vasculature development	3	16	18.75	0.0394933249321865	0.143408184207386	1	1	0.999999733847336	0.999999733847336	1
down	AR; RAB25; POF1B;	GO:0003382~epithelial cell morphogenesis	3	16	18.75	0.0394933249321865	0.143408184207386	1	1	0.999999733847336	0.999999733847336	1
down	CNTN4; NLGN1; NLGN2;	GO:0007158~neuron cell-cell adhesion	3	16	18.75	0.0394933249321865	0.143408184207386	1	1	0.999999733847336	0.999999733847336	1
down	GRIK2; GRIK4; PLCB1;	GO:0007215~glutamate receptor signaling pathway	3	16	18.75	0.0394933249321865	0.143408184207386	1	1	0.999999733847336	0.999999733847336	1
down	CYP2E1; MGST1; MGST2;	GO:0010243~response to organonitrogen compound	3	16	18.75	0.0394933249321865	0.143408184207386	1	1	0.999999733847336	0.999999733847336	1
down	TACSTD2; MCC; SEMA3A;	GO:0010633~negative regulation of epithelial cell migration	3	16	18.75	0.0394933249321865	0.143408184207386	1	1	0.999999733847336	0.999999733847336	1
down	SCN5A; CNKSR3; PRSS8;	GO:0010765~positive regulation of sodium ion transport	3	16	18.75	0.0394933249321865	0.143408184207386	1	1	0.999999733847336	0.999999733847336	1
down	AGT; BDKRB2; ASIC2;	GO:0019229~regulation of vasoconstriction	3	16	18.75	0.0394933249321865	0.143408184207386	1	1	0.999999733847336	0.999999733847336	1
down	HEXB; CEMIP; CHP1;	GO:0030214~hyaluronan catabolic process	3	16	18.75	0.0394933249321865	0.143408184207386	1	1	0.999999733847336	0.999999733847336	1
down	PLCD3; PLCD1; PLCB1;	GO:0032959~inositol trisphosphate biosynthetic process	3	16	18.75	0.0394933249321865	0.143408184207386	1	1	0.999999733847336	0.999999733847336	1
down	BMP7; CYP24A1; AQP3;	GO:0033280~response to vitamin D	3	16	18.75	0.0394933249321865	0.143408184207386	1	1	0.999999733847336	0.999999733847336	1
down	NOX4; DUOX2; DUOX1;	GO:0042554~superoxide anion generation	3	16	18.75	0.0394933249321865	0.143408184207386	1	1	0.999999733847336	0.999999733847336	1
down	FZD2; KLK6; KLK5;	GO:0045745~positive regulation of G protein-coupled receptor signaling pathway	3	16	18.75	0.0394933249321865	0.143408184207386	1	1	0.999999733847336	0.999999733847336	1
down	MEIS1; HOXB3; HOXB4;	GO:0060216~definitive hemopoiesis	3	16	18.75	0.0394933249321865	0.143408184207386	1	1	0.999999733847336	0.999999733847336	1
down	CNTN4; VSTM2L; IGSF9;	GO:0070593~dendrite self-avoidance	3	16	18.75	0.0394933249321865	0.143408184207386	1	1	0.999999733847336	0.999999733847336	1
down	ADCY6; PPARG; SFRP1;	GO:0071380~cellular response to prostaglandin E stimulus	3	16	18.75	0.0394933249321865	0.143408184207386	1	1	0.999999733847336	0.999999733847336	1
down	KCNJ2; CACNA1C; SCN5A;	GO:0086002~cardiac muscle cell action potential involved in contraction	3	16	18.75	0.0394933249321865	0.143408184207386	1	1	0.999999733847336	0.999999733847336	1
down	IGF1; HAND2; TWIST1;	GO:2000679~positive regulation of transcription regulatory region DNA binding	3	16	18.75	0.0394933249321865	0.143408184207386	1	1	0.999999733847336	0.999999733847336	1
up	CD74; NCKAP1L; IL2; FCRL3; CARD11; CLCF1; TNFSF13B; SASH3; BST1;	GO:0030890~positive regulation of B cell proliferation	9	41	21.9512195121951	0.0405261249577518	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
down	GLUL; ISL1; NKX6-1; NLGN2; SIRT3;	GO:0032024~positive regulation of insulin secretion	5	42	11.9047619047619	0.0406391620703817	0.147251368448707	1	1	0.999999733847336	0.999999733847336	1
down	CLDN4; RAMP2; GJB2; DSG1; NR1H3;	GO:0032570~response to progesterone	5	42	11.9047619047619	0.0406391620703817	0.147251368448707	1	1	0.999999733847336	0.999999733847336	1
down	CTDSPL; KLF4; CCL2; GPNMB; KANK2;	GO:2000134~negative regulation of G1/S transition of mitotic cell cycle	5	42	11.9047619047619	0.0406391620703817	0.147251368448707	1	1	0.999999733847336	0.999999733847336	1
up	CLDN3; SERPINE1; ALOX5; GJA1; WFDC1;	GO:0061045~negative regulation of wound healing	5	16	31.25	0.0408089085083392	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
up	KCNH2; SCN3B; CACNA1H; SCN1A; SCN3A;	GO:0086010~membrane depolarization during action potential	5	16	31.25	0.0408089085083392	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
up	MYH10; ACTB; INA; POTEKP; HCLS1;	GO:0098974~postsynaptic actin cytoskeleton organization	5	16	31.25	0.0408089085083392	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
down	HGF; NOX4; CDH18; CDH15; CDH5; CDH1; CDH26; CDH10;	GO:0000902~cell morphogenesis	8	88	9.09090909090909	0.040941842984513	0.148135565125197	1	1	0.999999733847336	0.999999733847336	1
down	HMGCL; RAB38; CXADR; EPAS1; SIRT3; PPARGC1A; SQSTM1; PTCD2;	GO:0007005~mitochondrion organization	8	88	9.09090909090909	0.040941842984513	0.148135565125197	1	1	0.999999733847336	0.999999733847336	1
up	ADAM12; CACNA1H; WNT1; MYH9; CAV3; ERVFRD-1;	GO:0007520~myoblast fusion	6	22	27.2727272727273	0.0417587913742933	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
up	ITGB3; ITGB6; ITGA11; ITGB2; ITGB7; ITGB4;	GO:0033627~cell adhesion mediated by integrin	6	22	27.2727272727273	0.0417587913742933	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
up	CYP27B1; SNCA; GRIN1; JPH2; KL; SNX10;	GO:0055074~calcium ion homeostasis	6	22	27.2727272727273	0.0417587913742933	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
up	LILRA5; IFNG; ORM1; LPL; ORM2; LILRA2;	GO:1904469~positive regulation of tumor necrosis factor secretion	6	22	27.2727272727273	0.0417587913742933	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
down	PRDM1; BMP4; DZIP1; MOV10L1;	GO:0007281~germ cell development	4	29	13.7931034482759	0.0430480285669722	0.154979039409677	1	1	0.999999733847336	0.999999733847336	1
down	SNAP25; ZNF804A; SFRP1; KLK6;	GO:0010975~regulation of neuron projection development	4	29	13.7931034482759	0.0430480285669722	0.154979039409677	1	1	0.999999733847336	0.999999733847336	1
down	ZFP36L1; HES5; AMBRA1; ZNF358;	GO:0021915~neural tube development	4	29	13.7931034482759	0.0430480285669722	0.154979039409677	1	1	0.999999733847336	0.999999733847336	1
down	HGF; HAVCR2; IL36RN; IRAK3;	GO:0032715~negative regulation of interleukin-6 production	4	29	13.7931034482759	0.0430480285669722	0.154979039409677	1	1	0.999999733847336	0.999999733847336	1
down	IL1B; SQSTM1; ANGPT1; PIDD1;	GO:0043122~regulation of I-kappaB kinase/NF-kappaB signaling	4	29	13.7931034482759	0.0430480285669722	0.154979039409677	1	1	0.999999733847336	0.999999733847336	1
down	NR2F2; PLK1; TFAP4; CDKN1C;	GO:0045736~negative regulation of cyclin-dependent protein serine/threonine kinase activity	4	29	13.7931034482759	0.0430480285669722	0.154979039409677	1	1	0.999999733847336	0.999999733847336	1
down	FGF10; IGF1; CSF1; KITLG;	GO:0046579~positive regulation of Ras protein signal transduction	4	29	13.7931034482759	0.0430480285669722	0.154979039409677	1	1	0.999999733847336	0.999999733847336	1
down	RGS12; RGS5; RAMP2; GNG4; PLCB1;	GO:0008277~regulation of G protein-coupled receptor signaling pathway	5	43	11.6279069767442	0.043910670515998	0.15785964183367	1	1	0.999999733847336	0.999999733847336	1
down	IL1A; ANG; IGF1; VEGFC; ADAM9;	GO:0050714~positive regulation of protein secretion	5	43	11.6279069767442	0.043910670515998	0.15785964183367	1	1	0.999999733847336	0.999999733847336	1
up	APOA2; IL10; LILRB1;	GO:0002740~negative regulation of cytokine secretion involved in immune response	3	6	50	0.0446796502716365	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
up	LYN; FGR; FPR2;	GO:0002768~immune response-regulating cell surface receptor signaling pathway	3	6	50	0.0446796502716365	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
up	BNIP3; GZMH; GZMB;	GO:0008626~granzyme-mediated apoptotic signaling pathway	3	6	50	0.0446796502716365	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
up	GJA1; SNCA; ACTB;	GO:0022898~regulation of transmembrane transporter activity	3	6	50	0.0446796502716365	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
up	PF4; SPI1; IL10;	GO:0045347~negative regulation of MHC class II biosynthetic process	3	6	50	0.0446796502716365	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
up	LYN; SPI1; B2M;	GO:0045646~regulation of erythrocyte differentiation	3	6	50	0.0446796502716365	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
up	IFNG; FCER2; PRF1;	GO:0051712~positive regulation of killing of cells of other organism	3	6	50	0.0446796502716365	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
up	UNC13B; SYT6; RIMS1;	GO:0060478~acrosomal vesicle exocytosis	3	6	50	0.0446796502716365	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
up	PIK3CD; PRTN3; JAML;	GO:0072672~neutrophil extravasation	3	6	50	0.0446796502716365	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
up	HLA-G; FCGR2B; LILRB1;	GO:2001199~negative regulation of dendritic cell differentiation	3	6	50	0.0446796502716365	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
up	PGLYRP1; HLA-B; CD1D; PGLYRP2;	GO:0016045~detection of bacterium	4	11	36.3636363636364	0.0450979065175718	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
up	SAG; GNAT1; CNGB1; GRK1;	GO:0016056~rhodopsin mediated signaling pathway	4	11	36.3636363636364	0.0450979065175718	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
up	IFITM1; IFNAR2; IFITM2; XAF1;	GO:0035456~response to interferon-beta	4	11	36.3636363636364	0.0450979065175718	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
up	VIL1; LMOD1; LMOD3; LMOD2;	GO:0045010~actin nucleation	4	11	36.3636363636364	0.0450979065175718	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
up	CD74; CD3D; ZAP70; CD3G;	GO:0045059~positive thymic T cell selection	4	11	36.3636363636364	0.0450979065175718	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
up	CD4; CD74; FES; DCSTAMP;	GO:0045657~positive regulation of monocyte differentiation	4	11	36.3636363636364	0.0450979065175718	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
up	ITGB3; INHBA; ITGB4; ITGA3;	GO:0048333~mesodermal cell differentiation	4	11	36.3636363636364	0.0450979065175718	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
up	VCL; IHH; BVES; KIFC3;	GO:0090136~epithelial cell-cell adhesion	4	11	36.3636363636364	0.0450979065175718	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
up	EDN3; FLNA; KCNQ1; KCNH2;	GO:1901381~positive regulation of potassium ion transmembrane transport	4	11	36.3636363636364	0.0450979065175718	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
down	IMPA2; INPP1; PPA2;	GO:0006796~phosphate-containing compound metabolic process	3	17	17.6470588235294	0.0451034952285463	0.160661321861345	1	1	0.999999733847336	0.999999733847336	1
down	AQP7; AQP1; AQP3;	GO:0006833~water transport	3	17	17.6470588235294	0.0451034952285463	0.160661321861345	1	1	0.999999733847336	0.999999733847336	1
down	BDKRB2; HTR7; ADRA1A;	GO:0006939~smooth muscle contraction	3	17	17.6470588235294	0.0451034952285463	0.160661321861345	1	1	0.999999733847336	0.999999733847336	1
down	F12; VWF; SERPING1;	GO:0007597~blood coagulation, intrinsic pathway	3	17	17.6470588235294	0.0451034952285463	0.160661321861345	1	1	0.999999733847336	0.999999733847336	1
down	P2RY1; MAPK8IP2; MUC4;	GO:0010469~regulation of signaling receptor activity	3	17	17.6470588235294	0.0451034952285463	0.160661321861345	1	1	0.999999733847336	0.999999733847336	1
down	MAP4K4; RAP2B; KLF5;	GO:0030033~microvillus assembly	3	17	17.6470588235294	0.0451034952285463	0.160661321861345	1	1	0.999999733847336	0.999999733847336	1
down	KITLG; TGFBR2; PBX1;	GO:0035162~embryonic hemopoiesis	3	17	17.6470588235294	0.0451034952285463	0.160661321861345	1	1	0.999999733847336	0.999999733847336	1
down	IL33; PLA2G4A; HAVCR2;	GO:0043032~positive regulation of macrophage activation	3	17	17.6470588235294	0.0451034952285463	0.160661321861345	1	1	0.999999733847336	0.999999733847336	1
down	OPHN1; FOXF1; CAMSAP3;	GO:0045198~establishment of epithelial cell apical/basal polarity	3	17	17.6470588235294	0.0451034952285463	0.160661321861345	1	1	0.999999733847336	0.999999733847336	1
down	EGFR; IL1B; SMO;	GO:0048143~astrocyte activation	3	17	17.6470588235294	0.0451034952285463	0.160661321861345	1	1	0.999999733847336	0.999999733847336	1
down	ABCA1; CD9; PPARG;	GO:0071404~cellular response to low-density lipoprotein particle stimulus	3	17	17.6470588235294	0.0451034952285463	0.160661321861345	1	1	0.999999733847336	0.999999733847336	1
down	CSNK2A2; HFE; HIPK2;	GO:2000059~negative regulation of ubiquitin-dependent protein catabolic process	3	17	17.6470588235294	0.0451034952285463	0.160661321861345	1	1	0.999999733847336	0.999999733847336	1
down	CEACAM6; NTRK2; PDK4;	GO:2000811~negative regulation of anoikis	3	17	17.6470588235294	0.0451034952285463	0.160661321861345	1	1	0.999999733847336	0.999999733847336	1
down	IL33; DNAJB2; PLK1; DAB2; SH3RF2; TRIB1; HSPA1B;	GO:0032436~positive regulation of proteasomal ubiquitin-dependent protein catabolic process	7	74	9.45945945945946	0.0457380545026788	0.162692192459881	1	1	0.999999733847336	0.999999733847336	1
down	TMPRSS11D; ELN; COX15; MAFB;	GO:0007585~respiratory gaseous exchange by respiratory system	4	30	13.3333333333333	0.0472805603580568	0.165052398827891	1	1	0.999999733847336	0.999999733847336	1
down	BMP7; AZU1; PLK1; CEMIP;	GO:0010800~positive regulation of peptidyl-threonine phosphorylation	4	30	13.3333333333333	0.0472805603580568	0.165052398827891	1	1	0.999999733847336	0.999999733847336	1
down	STAM2; VPS36; VPS37D; CHMP4C;	GO:0036258~multivesicular body assembly	4	30	13.3333333333333	0.0472805603580568	0.165052398827891	1	1	0.999999733847336	0.999999733847336	1
down	VSNL1; HADH; SFRP1; FAM3D;	GO:0046676~negative regulation of insulin secretion	4	30	13.3333333333333	0.0472805603580568	0.165052398827891	1	1	0.999999733847336	0.999999733847336	1
down	WASL; CCL21; NRP1; NLGN1;	GO:0051491~positive regulation of filopodium assembly	4	30	13.3333333333333	0.0472805603580568	0.165052398827891	1	1	0.999999733847336	0.999999733847336	1
down	SH3PXD2B; NAMPT; EBF2; PPARGC1A;	GO:0060612~adipose tissue development	4	30	13.3333333333333	0.0472805603580568	0.165052398827891	1	1	0.999999733847336	0.999999733847336	1
down	HSPB6; CRTAP; DNAJB2; PEX19;	GO:0061077~chaperone-mediated protein folding	4	30	13.3333333333333	0.0472805603580568	0.165052398827891	1	1	0.999999733847336	0.999999733847336	1
down	SULT2B1; CYP2E1; AKR1C2; CYP1B1; AKR1C1;	GO:0008202~steroid metabolic process	5	44	11.3636363636364	0.0473353621176462	0.165052398827891	1	1	0.999999733847336	0.999999733847336	1
down	TNFSF12; IL33; ACVR1B; IFI27; SMAD3;	GO:0097191~extrinsic apoptotic signaling pathway	5	44	11.3636363636364	0.0473353621176462	0.165052398827891	1	1	0.999999733847336	0.999999733847336	1
up	ALOX5; ALOX5AP; CYP4F3; LTC4S; DPEP2;	GO:0006691~leukotriene metabolic process	5	17	29.4117647058824	0.0488768499170475	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
up	SERPINE1; FCGR2B; PPP2R5B; PCSK9; HMGB1P1;	GO:0010469~regulation of signaling receptor activity	5	17	29.4117647058824	0.0488768499170475	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
up	GZMB; GZMA; PRF1; GZMH; GZMM;	GO:0019835~cytolysis	5	17	29.4117647058824	0.0488768499170475	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
up	FCN1; FFAR2; CD14; TLR1; CD244;	GO:2000484~positive regulation of interleukin-8 secretion	5	17	29.4117647058824	0.0488768499170475	0.791106548213278	1	1	0.999999999999999	0.999999999999999	1
